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Summary Ethics has been an integral part of medicine 
since ancient times. However, the atrocities committed 
as part of Nazi medicine necessitated a novel approach, 
resulting in a framework of modern bioethical standards. 
Since World War II, we have witnessed a broad move-
ment towards the introduction of normative regulations 
for medical research. This trend initially started with the 
Nuremberg Medical Trials and the “Nuremberg Code” of 
1947, followed by the Helsinki Declaration of the World 
Medical Association of 1964, including later modifica-
tions and amendments. Furthermore there are relevant 
recommendations issued by the organs of the Coun-
cil of Europe and by the World Health Organisation, the 
UNESCO Declarations and EU legislation, to name only 
the most important examples. Since the 1970s, the rapid 
and global development of the life sciences, with its un-
precedented possibilities to interfere with basic aspects 
of human life, for example in reproductive medicine, has 
led to an even greater necessity to confront bioethical 
questions worldwide. The HIV pandemic burdening the 
Global South has required conducting research in differ-
ent areas of the world and involving especially vulnera-
ble populations. In view of these developments, the main 
topic of the conference was the influence of Nazi medical 
crimes, the Nuremberg Medical Trial and the resulting 
Nuremberg Code on the development of international 
bioethical norms, including the enduring impact of this 
legacy on today’s medical research. In the 70 years since 
the promulgation of the Code, the world has changed: 
Research is based on the principles of exchange and co-
operation, researchers are mobile, the internet provides 
a supporting framework removing national barriers. Al-
though the European situation, with special attention to 
Austria, was part of the discussion, an important focus of 
the conference was on the role played by international or-
ganisations and their endeavours to establish normative 
standards for clinical research with a worldwide reach.
Editorial: Medical ethics in the 70 years after the 
Nuremberg Code, 1947 to the present
Markus Müller, President ( “Rector”) of the Medical 
University of Vienna 
markus.mueller@meduniwien.ac.at
In March 2017, our university commemorated the 70th 
anniversary of the implementation of the Nuremberg 
Code with the international symposium “Medical ethics 
in the 70 years after the Nuremberg Code, 1947 to the pre­
sent”. The Nuremberg Code constitutes one of the most 
important milestones in the history of medicine, provid-
ing for the first time a proper framework for research on 
human subjects. Sadly, this milestone was not a volun-
tary, precautionary measure resulting from enlightened 
humanity, it only came into existence in the aftermath 
of dreadful Nazi atrocities. Following its conception, the 
Nuremberg Code bore rich fruit in multiple legal regards, 
becoming a cornerstone of clinical research and bioeth-
ics [1]. 
For Austrian science in particular, the discourse on 
Nazi crimes and, thus, the Nuremberg Code became a 
special warning from history due to the involvement of 
prominent Austrian physicians in Nazi experiments [2]. 
Hitler’s alleged statement to Max Planck “If the dismiss­
al of Jewish citizens means the annihilation of German 
science, then we shall do without science for a few years” 
[3], proved to be self-fulfilling in two aspects: firstly, in a 
profound moral way, and secondly a long-lasting intel-
lectual breakdown in the Austrian scientific communi-
ty. The importance of the context of the Nuremberg Code 
cannot be overestimated and acts as a foundation for the 
very basis of the attitudes of a global medical profession, 
which today—in a world heavily focused on professional 
skills and practices—might sometimes be at risk of slip-
ping out of focus. 
In my inauguration speech as the newly elected rector, 
I drew attention to the fact that I consider the transfer of 
attitudes to the next generation to be more important for 
a university than the transfer of mere technical skills [4]. 
This idea is also exemplified by the Einstein quote “It’s 
not intellect that makes a great scientist, it is character”. 
Unfortunately, this very thinking disappeared in Austria 
with the annexation to Nazi Germany. It is to the particu-
lar credit of my predecessor, Wolfgang Schütz, and oth-
ers of his generation like Wilfred Druml, former editor 
of the “Wiener Klinische Wochenschrift”—the once high-
ly prestigious journal where Karl Landsteiner described 
his discovery of blood groups—that our university has fo-
cused on the dreadful time of 1938–1945 once more [5, 6]. 
In particular, the distressing fact was acknowledged that 
“little was done after the war, following the collapse of the 
Third Reich, to correct the flagrant injustice and barba­
rism” [5] and that many were allowed to continue their 
work, like Eduard Pernkopf, a former rector of the uni-
versity, who continued work on his notorious anatomi-
cal atlas [7, 8]. The question on how to deal with human 
remains was also a focus of the symposium, as reflected 
Dr. Christiane Druml ()
UNESCO Chair on Bioethics of the Medical University of Vienna 
Ethics, Collections and History of Medicine of the  
Medical University of Vienna
1090 Vienna, Austria
christiane.druml@meduniwien.ac.at
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by Rabbi J. Polak’s “Vienna Protocol for when Jewish or 
possibly-Jewish human remains are discovered” in this 
issue [9, 10] and a recent paper that originated from dis-
cussions during the symposium on transparency regard-
ing the origin of human tissues in research [11].
On behalf of our University, I am deeply indebted to 
Christiane Druml, Herwig Czech and Paul Weindling 
who took on the planning and organisation of the sym-
posium and who were also instrumental in helping com-
memorate the events of the dreadful year 1938 in March 
2018.
From the Nuremberg „Doctors Trial“ to the 
„Nuremberg Code“
Paul Weindling, School of History, Philosophy and 
Culture, Oxford Brookes University, Oxford OX3 0BP, 
United Kingdom  
pjweindling@brookes.ac.uk
At the close of the Nuremberg Medical Trial (NMT) on 19 
August 1947, the judges pronounced guidelines on per-
missible clinical experiments. From around 1963 these 
guidelines were called the “Nuremberg Code”, there-
by investing them with status as a fundamental docu-
ment on research procedure [12]. Their status as part of 
a judgement at an international court set a precedent in 
judging landmark cases of murderous and maiming con-
duct arising from coercive research. The aim of this paper 
is to correct some misconceptions concerning the ori-
gins and implications of these guidelines. The first mis-
conception is that the Guidelines/Code arose solely from 
courtroom proceedings. This overlooks an agenda which 
had existed since the liberation of concentration camps 
to secure a set of regulations to protect research subjects. 
In short, the victim had agency by protesting against, re-
sisting and sabotaging the coerced experiments, and 
when it came to being witnesses at the NMT, a reflective 
voice. Victims of research and liberated prisoner doctors 
made a profound impression on Allied scientific intelli-
gence officers, who then laid the knowledge-base for the 
NMT. Secondly, although the judges stressed the auton-
omy of the research subject and the obligation to inform 
about potential risks, the key term “informed consent” 
did not appear in the guidelines of 1947. Thirdly, it is a 
misapprehension that the principles promulgated by the 
judges received neither publicity nor recognition. The 
case against the Vienna internist Wilhelm Beiglböck il-
lustrates salient aspects.
1. Contextualizing the Code
The declaration, “The Prisoner Doctors of Auschwitz to 
the International Public” issued on March 4, 1945 stated 
that prisoners had been treated as experimental animals, 
that the Allies and neutral states should bring to trial those 
responsible, and that the prosecution of perpetrators 
would prevent coerced human experiments and medical 
atrocities in the future [13]. There were comparable efforts 
by liberated prisoner doctors to document Nazi medical 
experiments at the camps of Buchenwald and Dachau. 
Prisoner documentation came to the attention of Al-
lied scientific intelligence officers, notably the neuro-
physiologists Leo Alexander (with the US military) and 
John Thompson (as head of the British branch of the FIAT 
scientific organisation) [14]. Thompson interrogated the 
Belsen doctor Fritz Klein, who had conducted experi-
ments with mescaline and on the drug Rutenol in Ausch-
witz [15]. Concerned about the criminality of German 
wartime research, Thompson first identified the experi-
ments as “Medical War Crimes” in November 1945. This 
specific form of medical criminality required that scien-
tific intelligence and war crimes investigation teams col-
laborate. To attract attention to the problem of coerced 
experimentation, Thompson stated that 90% of German 
wartime medical research by leading scientists and clini-
cians was criminal [16: 115].
Thompson’s contacts with the United States war 
crimes agencies led to meetings with Andrew Ivy (1893–
1975), a Chicago-based physiologist who had conducted 
wartime research on desalination for the US Navy. Some 
servicemen had opted out during these experiments, and 
Ivy recognised their full autonomy. Ivy was nominated by 
the American Medical Association for an appointment 
as Special Consultant (on Nazi medical research) for the 
U. S. Secretary of War in 1946. Thompson organised a 
meeting on medical war crimes at the Pasteur Institute in 
Paris from July 31 to August 1, 1946, when Ivy outlined a 
set of principles on medical research. 
Ivy’s “Outline of principles and rules of experimenta-
tion on human subjects” stated that:
“I. Consent of the subject is required; i. e. only volunteers 
should be used.
(a)  The volunteers before giving their consent, should be 
told of the hazards, if any.
(b)  Insurance against an accident should be provided, if 
it is possible to secure it.
II. The experiment to be performed should be so designed 
and based on the results of animal experimentation, that 
the anticipated results will justify the performance of the 
experiment; that is, the experiment must be useful and 
be as such to yield results for the good of society.
III. The experiment should be conducted 
a. so as to avoid unnecessary physical and mental suffer-
ing and injury, and
b. by scientifically qualified persons
c. The experiment should not be conducted if there is a 
prior reason to believe that death or disabling injury 
will occur.” [17: 115, 261–5]
This long-overlooked draft code was drawn up a year be-
fore the Guidelines of August 1947. It was the basis for 
mounting the NMT as well as a series of revisions in the 
suggested code. Thompson’s investigations of medical 
crimes provided a basis for prosecution. The decision 
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by Chief Prosecutor Telford Taylor to hold the NMT was 
made shortly after the Pasteur Institute meeting in Au-
gust 1946 [17: 265].
Ivy was nominated by the American Medical Associa-
tion to the U. S. Secretary of War, who appointed him ex-
pert witness to the court at the NMT. Ivy reflected, “I ac-
cepted the invitation to serve at the Nuernberg trials only 
because I had in mind the objective of placing how hu-
man beings may serve as subjects in a medical experi-
ment [sic], so that these conditions would become the in-
ternational common law on the subject” [18].
The relevance of the 1931 Reich circular on human ex-
periments was to be an issue for the NMT defence and 
prosecution. That the Reich guidelines retained valid-
ity has been confirmed by Roelcke [19]. However, that 
all German research abided by the Reich directive was a 
misleading claim made by a defensive German medical 
establishment and defendants [20].
Ivy saw the matter in terms of violations of the Hip-
pocratic Oath. On December 28, 1946 the Journal of the 
American Medical Association (JAMA) published recom-
mendations for an abbreviated Code. This required the 
following:
“The voluntary consent of the individual on whom the 
experiment must be performed must be obtained. The 
danger of each experiment must be previously investigat-
ed by animal experimentation. The experiment must be 
performed under proper medical protection and man-
agement” [21].
During the NMT, Ivy assessed German/Austrian med-
ical research: he astutely observed that the defendant 
Wilhelm Beiglböck altered records of the Dachau experi-
ment on making seawater drinkable, so as to conceal the 
effects of the different types of desalinated seawater on 
victims. The judges consequently increased Beiglböck’s 
sentence [22, 17: 287].
Ivy’s main achievement was to drive forward the agen-
da of an ethical code. As Ivy reflected in 1964: “the judges 
and I were determined that something of a preventative 
nature had to come out of the ‘Trial of the Medical Atroci-
ties’ ” [23]. His special sense of mission is confirmed by a 
Special Press Release on January 22, 1945:
“Dr. Ivy … left Nuremberg with the recommendation 
that an international legalised code of ethics should be 
published on the use of human beings as experimental 
subjects” [24]. Ivy provides a clear agenda for the NMT, 
recommending that it should conclude with a set of ethi-
cal principles.
2. The victims’ voice
The Trial was distinctive in that victims had a key role as 
witnesses. The Medical Trial relied more on victim testi-
mony than either the four-power International Military 
Tribunal or the later American military-administered 
trials. The prosecutors made radio appeals in German, 
Czech, and Polish for witnesses and victims of medical 
experiments. Letters from experiment and sterilisation 
victims provided significant testimony. Victims’ organi-
sations—such as Opfer des Faschismus, and the Betreu­
ungsstelle für Sonderfälle—also sent evidence to the 
Nuremberg prosecution [23].
A victim of X-ray sterilization stated that he had come 
forward as a result of the radio call for witnesses. Leo Al-
exander, a US military expert in aviation medicine and 
originally a graduate of the University of Vienna, was 
appointed expert witness to the prosecution. He wrote 
about the aforementioned victim of X-ray sterilization 
experiments at Auschwitz:
“When he heard over the radio that the people respon-
sible for the German medical atrocities are going to be 
tried, he decided that it was his duty to come here and to 
testify although he is afraid that, especially if his name is 
printed in newspapers, his sisters might find out about his 
condition that way. However, he feels that it is his duty to 
be helpful in bringing those responsible for the atrocities, 
to which he and others have been subjected, to justice.
It appears that he is one of 100 young Jewish boys who 
were castrated for no reason other than to confirm the 
fact that they had been sterilised by sufficient X-ray radi-
ation, as if X-ray burns which resulted from a fifteen min-
ute exposure were not enough to prove that point” [24].
Victims took the initiative in alerting the police about 
medical criminals. In February 1946, Dachau survivors 
alerted the Austrian state police that Wilhelm Beiglböck 
had conducted allegedly fatal experiments in Dachau. 
The investigations uncovered the involvement of the in-
ternist Hans Eppinger of the Vienna Medical Faculty, and 
led to the arrest of Beiglböck in Lienz, in the British zone 
of occupation. Beiglböck was transferred to Nuremberg 
by the British in September 1946. He was the one Aus-
trian defendant at the Medical Trial [25]. Beiglböck was 
a member of the SA, and not one of the seven SS doctors 
on trial. 
There were three non-medical defendants, all SS mem-
bers: Viktor Brack of the Chancellery of the Führer, who 
was responsible for euthanasia killings and X-ray steri-
lization experiments; Rudolf Brandt, who, as Himmler’s 
secretary, was involved in arrangements for experiments 
on concentration camp prisoners; and Wolfram Sievers, 
manager of the SS Ahnenerbe research organisation. 
In the case against Beiglböck, the Sinto witness Karl 
Höllenrainer punched Beiglböck when asked to identi-
fy him in court. Höllenrainer’s testimony stressed Beigl-
böck’s role in mistreatment and coercion. Beiglböck 
was accused of drawing a pistol to force the Sinto Rudolf 
Taubmann, who had survived freezing water and malaria 
infection experiments at Dachau, to submit to the desal-
ination experiment. However, the prosecution failed to 
prove any fatalities from the experiment (although one 
research subject died before liberation, the connection 
with the experiment is unclear) [21].
On July 17, 1947 the defence lawyer Gustav Steinbauer 
made an eloquent and revealing final plea for Beiglböck, 
pleading that deaths should be accepted the necessary 
price of medical progress: 
“Over the entrance gate of the General Hospital in Vi-
enna we read the words ‘Saluti et solatio aegrorum—Ded-
history of medicine
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icated to the health and consolation of the sick.’ These 
words not only demand the highest accomplishment of 
the doctor’s duties but are the motive for the most suc-
cessful work in the large field of medical research. Theory 
and practice joined together in order to become a piece 
of living humanity. I would go beyond the limits of my 
task if I mentioned all the names that spread the glory of 
the University of Vienna throughout the world. But their 
penetration into the world of the unknown was always a 
hazardous enterprise which demanded courage and sac-
rifice. 
I want to quote the words of one of the great doctors, 
Professor Wagner-Jauregg, who says in his book ‘Fever 
and Infection Therapy’, 
‘The vaccination against malaria was certainly a risk, 
the outcome of which could not be foreseen. It was dan-
gerous for the patient himself and this to a much higher 
degree than the treatment with tuberculin and other vac-
cines, and it also was a danger for the surroundings and 
even for the community.’ 
And, on page 136, it states ‘Three patients died after 
having been vaccinated with blood infected with malar-
ia tropica and not with malaria tertiana’; and ‘The tragic 
outcome of this experiment was discouraging, and only 
a year later could the author decide to proceed with the 
malaria vaccinations …’ 
Nobody talks of these victims today, but Wagner-
Jauregg’s revolutionary discovery is known and adopt-
ed throughout the world and has become the common 
property of all peoples for the benefit of suffering man-
kind …” [26].
The judges’ concluding principles sought to refute 
such dangerous arguments made by a series of defend-
ants—that the injury and death of human subjects is nec-
essary for medical progress. 
With this aim in mind, US and British scientific intelli-
gence officers (Leo Alexander, Keith Mant, John Thomp-
son) collected evidence from victims. The Court pro-
ceedings ran on two levels: that of an international trial 
of the consequences of aggressive war resulting in crimes 
against humanity, and an ethics tribunal concerned with 
the medical validity of the research and consent of the 
research subject. The conduct of the trial involved fre-
quent ethical discussions. The judges asked defendants 
for their opinions: Kurt Blome and Karl Brandt gave their 
opinions on clinical experiments. Blome’s statement that 
that prisoners should always be volunteers and receive 
a reduction of sentence or an amnesty showed criticism 
of the concentration camp experiments. The defendants 
could cross-examine expert witnesses [27]. At one stage, 
Ivy was cross-examined by the defendants Ruff, Rose and 
Beiglböck. The Trial had a dual character as a criminal 
court and as an ethics debating chamber.
3. From ethical debate to the final declaration
On December 7, 1946, just after the commencement of 
the NMT, Alexander noted that he had “Completed ethi-
cal and non-ethical exp. on human beings.” This text out-
lined the conditions for “permissible experimentation 
by a doctor” [28]. As in Ivy’s draft guidelines of August 1, 
1946, Alexander required the consent and voluntary par-
ticipation of the experimental subject. While Ivy required 
the experiment to be useful, Alexander preferred a more 
generalised viewpoint, that the experiment should not be 
unnecessary; both concurred that results should be for 
the good of society. This overlap suggests that Alexander 
took Ivy’s report as a basis for his views. Alexander am-
plified the concept of consent, as based on proven un-
derstanding of the exact nature and consequences of the 
experiment. A doctor or medical student was most likely 
to have the capacity for full understanding. The degree of 
risk was justified by the importance of the experiment, 
and the readiness of the experimenter to risk his own life. 
Overall, Alexander produced a more rigorous set of re-
quirements than either Ivy or the minimalist AMA code. 
Rather than informed consent, the expression of 
choice at the trial was “Voluntary Consent”. This went 
with disclosure of risks. Alexander also noted the inten-
tion of the judges to rule on issues of experimentation 
at the end of the NMT: “As we have anticipated all along 
the defense is making a concerted effort to introduce a 
great deal of literature on human experimentation in oth-
er countries. So far we have been successful in keeping 
out most of the proof, but the Tribunal has stated that it 
will rule on this question at the conclusion of the case” 
[29]. The judges provided a distillation of the Alexander 
and Ivy drafts along with stress on the autonomy of the 
research subject. Voluntary consent meant that “the per-
son involved should have legal capacity to give consent; 
should be so situated as to be able to exercise free pow-
er of choice, without the intervention of any element of 
force, fraud, deceit, duress, over-reaching, or other ulte-
rior form of constraint or coercion; and should have suf-
ficient knowledge and comprehension of the elements of 
the subject matter involved as to enable him to make an 
understanding and enlightened decision …” [30: 267–8] 
4. Publicising the Guidelines
The declaration on permissible experiments provided 
criteria for the judgment of the 23 defendants. It was in-
tended to be circulated widely, thereby fulfilling Ivy’s 
hope of entering the international common law on medi-
cal experiments. Telford Taylor had been meticulous in 
allowing press access and in inviting international jurists 
as observers. The presence of the German medical del-
egation throughout the trial was remarkable. The judge-
ment was publicised in German by Alexander Mitscher-
lich and Fred Mielke in their NMT overview Wissenschaft 
ohne Menschlichkeit [30], and in French by François Bay-
le, the French military observer in his study of the Tri-
al [31]. Importantly, in 1949 Telford Taylor published the 
guidelines on “Permissible Medical Experiments” in his 
contribution to Doctors of Infamy, which was based on 
the interim publication by Mitscherlich and Mielke with 
additional contributions by Taylor, Ivy and Alexander 
[32]. The volume included a draft apology which the Ger-
history of medicine
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man delegation declined to make at the first World Medi-
cal Association (WMA) meeting, and a concise version of 
the WMA’s revised version of the Hippocratic oath, ori-
ented to practitioners. Commentators have suggested 
that the volume had an impact on various international 
conventions and agencies [33]. The WMA and WHO kept 
the issue of war crimes committed by the medical profes-
sion at the forefront with a preliminary report on “War 
Crimes and Medicine. The German Betrayal and a Re-
statement of the Ethics of Medicine,” which was prepared 
in 1948 [34]. U. S. military and official agencies took note 
of the NMT judicial guidelines [35].
The judges’ guidelines on permissible experiments 
were a distillation of a wider post-WWII discourse in 
which victims had a crucial role. Each version of the 
guidelines needs to be situated in context. The expert 
witness Ivy had a firm agenda which he impressed on 
the judges, prompting their guidelines on permissible 
experiments. These guidelines derived from Ivy’s origi-
nal principles of August 1946, which were then elaborat-
ed by Alexander and finally, the judges added the addi-
tional principle of the autonomy of the research subject. 
The guidelines were readily available as a reference doc-
ument in English, French and German in the period after 
the NMT. This explains the adoption of these guidelines 
in medical jurisprudence in the early 1960s as a definitive 
“Nuremberg Code”.
Post-war trials against perpetrators of Nazi 
medical crimes – the Austrian case
Herwig Czech, PhD, Medical University of Vienna, 
Ethics, Collections and History of Medicine, 
Währinger Straße 25, 1090 Vienna, Austria
herwig.czech@meduniwien.ac.at
After the defeat of Nazi Germany, there was a wide-
ly shared expectation that criminal proceedings could 
provide a measure of retributive justice, and that these 
would lay the groundwork for stronger ethical norms for 
the future. In the case of the Nazi medical crimes, the 
Nuremberg Medical Trial epitomises the link between 
criminal law and the hope to (re)establish binding ethi-
cal norms. In my paper, I will focus on how the courts af-
ter the war dealt with the medical crimes committed on 
present-day Austrian territory (or, as in the case of Wil-
helm Beiglböck, by Austrian perpetrators), and what we 
can learn from this about Austrian post-war society.
In legal terms, Austria regained its independence as 
a country in 1945, however the occupation by the Allies 
meant that the power of the Austrian state was limited, 
at least in the immediate post-war period. Therefore, I 
would like to start my brief overview of the legal response 
to Nazi medical crimes in Austria at the top level: the Al-
lied authorities.
The Mauthausen Concentration Camp Case
The first instance in which a perpetrator of Nazi medical 
crimes in Austria was indicted before an Allied military 
court was not the much more well-known Nuremberg 
Medical Trial (NMT), but the ‘Mauthausen Concentra-
tion Camp Case’ (or ‘USA vs. Altfuldisch et al.’), tried by 
a US Military Court at the former concentration camp of 
Dachau, between March and May 1946. Among the 61 de-
fendants, eight had a medical background: four SS camp 
doctors (Eduard Krebsbach, Waldemar Wolter, Friedrich 
Entress, Willi Jobst), two SS dental surgeons (Wilhelm 
Henkel, Walter Höhler), the Mauthausen pharmacist Er-
ich Wasicky, and one paramedic (Gustav Kreindl). They 
all received death sentences for their participation in the 
murder of prisoners, using among other methods benzol 
injections or poison gas. The two dental surgeons had re-
moved gold from prisoners’ dead bodies. At Gusen, nu-
merous unnecessary operations had been performed; 
human experiments with hormones and artificial nutri-
tion were also mentioned during the proceedings [36: 35–
6, 46, 49, 55, 58].
With the exception of Walter Höhler, whose sentence 
was commuted to life imprisonment (of which he served 
only a few years), the convicted perpetrators were exe-
cuted in May 1947. This seemingly resolute prosecution 
of medical crimes in Mauthausen and its satellite camps 
has to be contrasted with the fact that the number of SS 
doctors linked to the Mauthausen/Gusen complex alone 
amounted to at least 50; despite a series of further tri-
als, most of them never had to answer for their crimes 
[36: 36–7, 64–6].
The trial also established a link between the concen-
tration camp system and the so-called ‘Action T4’, ini-
tiated in 1939 for the extermination of psychiatric pa-
tients. Between 1941 and 1945, up to 8,000 prisoners from 
Dachau and the Mauthausen/Gusen complex were sent 
Fig. 1 Defendants during the ‘Mauthausen Concentration 
Camp Case’ (standing: former Ebensee concentration camp 
physician Willi Jobst) (United States Holocaust Memorial Mu-
seum/USHMM)
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to the ‘T4’ killing centre at Hartheim near Linz to be mur-
dered in the gas chamber [37: 63–4]. The only perpetrator 
from Hartheim whom the prosecution could secure for 
the trial, Vinzenz Nohel (1902–1947), stood out among 
the defendants. As a manual laborer responsible for the 
operation of the crematorium (court documents call him 
the ‘fireman at Castle Hartheim’), he represented the 
lowest rung of the hierachy. He was also the only defend-
ant who spoke openly about his participation in the mass 
extermination. Ironically, the man who helped murder 
tens of thousands of psychiatric patients hoped to evade 
punishment by pretending to be mentally ill himself. The 
court, however, did not accept this line of defense and 
sentenced him to death. The harshest sentence thus fell 
on one of the least significant cogs in the Hartheim killing 
machine [36: 47, 50, 61].
The Nuremberg Medical Trial and its significance for 
Austrian medicine
Without a doubt, the Nuremberg Medical Trial had a 
much stronger influence on the subsequent interna-
tional perception of Nazi medical crimes than any oth-
er event, including the Mauthausen Concentration Camp 
Case. For various reasons—chief among them the avail-
ability of defendants and the difficulty in prosecuting 
crimes committed by Germans against Germans before 
a military court—the extermination centre at Hartheim 
played only a marginal role; the vast majority of the ac-
cused had been involved in criminal human experi-
ments, not in the ‘euthanasia’ murders [38]. This was the 
case for the only Austrian among the 23 defendants, Wil-
helm Beiglböck (1905–1962), formerly an assistant at Vi-
enna University’s Clinic of Internal Medicine, who was 
indicted for his seawater drinking experiments on pris-
oners at Dachau concentration camp [most recently: 21]. 
Since Beiglböck was a relatively minor figure, the trial’s 
impact on the medical public at the time was limited. The 
Österreichische  Ärztezeitung, the official mouthpiece of 
the Austrian medical profession, did not mention the tri-
al once in 1946 or 1947. The significance of the NMT for 
Austrian medical ethics, which today is not in doubt (see 
the chapter by Christiane Druml in this volume), must 
have emerged much later, via its international reception.
Beiglböck’s superior at the Vienna University Clinic for 
Internal Medicine, Prof Hans Eppinger Jr. (1879–1946), 
given his international renown and his position in the 
Viennese medical community, would have made an in-
teresting witness or even defendant. Despite having rec-
ommended his assistant for the Dachau experiments and 
having personally visited the camp on at least one occa-
sion, he initially escaped scrutiny by Allied war crimes 
investigators [39, 40]. In September 1946, however, Ep-
pinger killed himself after being summoned to Nurem-
berg as a witness, probably out of fear of being personally 
implicated [41]. With his suicide, he saved the universi-
ty some embarrassment, which has not since been very 
eager to remember this dark chapter. Furthermore, there 
was also the suspicion that patients had been harmed in 
ruthless medical experiments at Eppinger’s clinic, allega-
tions which were never further investigated after his sui-
cide [42: 139–40]. Beiglböck was originally sentenced to 
15 years imprisonment, but had his sentence reduced to 
10 years in 1949; in 1951, he was released and could con-
tinue his medical career in Germany. Repeated attempts 
to return to Austria failed [21: 159–62].
Erwin Jekelius, ‘child euthanasia’, ‘Action T4’ and the 
Soviets
Perhaps surprisingly, the only key perpetrator of the ‘eu-
thanasia’ extermination programme on Austrian territo-
ry to be tried by Allied authorities was held to account 
not by the US or British, but the Soviets. A paediatrician 
trained at the Vienna Children’s University Clinic un-
der Franz Hamburger (1874–1954), Erwin Jekelius (1905–
1952) was the founding director of the child ‘euthanasia’ 
clinic ‘Am Spiegelgrund’ from 1940 to 1942 (for details on 
this institution, see below). Much less well-known is his 
role as the secret representative of the ‘T4’ organisation in 
Vienna, tasked with coordinating the patient transports 
to the gas chamber at Hartheim. The main reason for the 
relatively late uncovering of Jekelius’ role in the ‘T4’ pro-
gramme was that he was arrested and tried by the Sovi-
ets. While the trials held in the British, French or Amer-
ican zones of occupation were widely publicised and 
served as a stage to teach the world about Nazi crimes, 
Erwin Jekelius was tried in secrecy in Moscow, where he 
died from cancer in prison in 1952. When transcripts of 
Jekelius’ interrogations by the NKVD were obtained by 
German journalists from a Russian archive in 2005, they 
not only provided new details on the execution of ‘T4’ in 
and around Vienna, they also revealed that Jekelius had 
been relieved of his post at Spiegelgrund and drafted into 
the military in 1942 on personal orders from Hitler, who 
Fig. 2 The Viennese physician Wilhelm Beiglböck pleads ‘not 
guilty’ at the Nuremberg Medical Trial (United States Holo-
caust Memorial Museum/USHMM)
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disapproved of a romantic relationship between his sister 
Paula and Jekelius [43: 60].
Trials before the Volksgerichte against ‘T4’ perpetrators
Overall, the war crime trials held by the Allied powers 
represented only the tip of the iceberg of all criminal 
prosecutions of Nazi perpetrators. In Austria, the bulk of 
cases was dealt with by the so-called Volksgerichte (‘Peo-
ple’s Courts’), which were created in 1945 for this pur-
pose. During the ten years of their existence, from 1945 
to 1955, these courts opened proceedings against more 
than 130,000 individuals. In principle, they had the re-
sources and the determination to deal with Nazi crimes 
on a systematic basis. In the reality of post-war Austria, 
however, the initial enthusiasm to deal with Nazi crimes 
quickly subsided, so that in the end relatively few convic-
tions or even trials resulted [44: 46].
Under the code name ‘T4’, 70,000 patients were de-
ported from psychiatric hospitals all over Germany (in-
cluding Austria and other annexed territories) to one 
of six killing centres, to be murdered in gas chambers. 
The most important of these was the above-mentioned 
Hartheim Castle near Linz, were 18,000 psychiatric pa-
tients and at least 8,000 prisoners from the Dachau and 
Mauthausen concentration camps were killed [45]. From 
the prosecution’s standpoint, these murders should have 
been clear-cut cases; even by the legal standards of Nazi 
Germany, there could be no doubt about their criminal 
nature according to the Reichsstrafgesetzbuch (the Ger-
man criminal code), let alone the Austrian penal code. 
Murdering so many people required many participants, 
not just the personnel necessary to operating the killing 
centres, but also staff at the various hospitals who sent 
patients to their deaths, and not least the so-called ‘ex-
perts’ who decided who would be killed. Bringing the 
perpetrators to justice was complicated by a number of 
factors, however: Hartheim medical director Rudolf Lo-
nauer (1907–1945) committed suicide with his family af-
ter Germany’s defeat; his deputy, Georg Renno (1907–
1997), went into hiding. He was put on trial in 1967 in 
West Germany, but the efforts to hold him responsible 
failed when he presented medical certificates claiming 
that he was unfit for trial [44: 52, 46: 95, 108–12]. Anoth-
er of the main perpetrators at Hartheim, former admin-
istrative director Christian Wirth (1885–1944), was killed 
by partisans near Trieste [47]. His deputy and successor 
in Hartheim was Franz Stangl (1908–1971), who was lat-
er transferred to ‘Aktion Reinhardt’ (the code name for 
the extermination of three million Jews in occupied Po-
land) and a striking example for the failings of the Austri-
an authorities. In 1948, he managed to escape from pre-
trial detention in Linz, and, with the help of the Austrian 
bishop Alois Hudal (1885–1963) in Rome, could flee first 
to Syria, then to Brasil. Stangl was only held accountable 
for his crimes in 1970, when a West German court sen-
tenced him to lifelong imprisonment. He died one year 
later [46: 156–8]. With the main Hartheim perpetrators 
out of the authorities’ reach, the Volksgericht (in this case 
in Linz) was limited to adjudicating the responsibility of 
bus drivers, nurses and guards, handing down verdicts 
in November 1947, and July 1948. In a separate trial, the 
leading Nazi health functionary in the Tyrol, Hans Czer-
mak (1892–1975), was sentenced to eight years imprison-
ment in connection with the ‘T4’ transports to Hartheim 
[44: 50]. 
‘Decentralised euthanasia’
Prosecution was more successful in the case of three psy-
chiatric hospitals, two in Lower Austria and one in Carin-
thia, where doctors had directly murdered hundreds of 
patients—clear-cut examples of how after the stop of ‘T4’ 
in August 1941, many psychiatric hospitals were turned 
into sites of ‘decentralised euthanasia’ [48]. In April 1946, 
the Volksgericht Graz (External Senate in Klagenfurt) 
handed down death sentences against the psychiatrist 
Franz Niedermoser (1901–1946) and three nurses at the 
Klagenfurt State Mental Hospital (Siechenhaus und Irren­
anstalt des Landeskrankenhauses), Eduard Brandstätter, 
Antonie Pachner and Ottilie Schellander. Only the death 
penalty against Niedermoser was executed; Brandstätter 
committed suicide on the day of the verdict, and the two 
others saw their sentences commuted to prison terms. 
Five other nurses received prison terms of 10 or 15 years 
[49].
According to testimony given during the proceedings, 
seriously ill patients, starting as early as 1940, were killed 
at the Klagenfurt mental hospital through lethal drug 
dosages. After the deportations to the gas chambers at 
Hartheim were suspended—around 700 patients from 
the Carinthian institution were also among the victims—
the killings in Klagenfurt were intensified. Between 1941 
and 1945, under Niedermoser’s direction, the nursing 
staff killed approximately three to four patients per week. 
While initially mainly patients with advanced stages of 
mental disorders were murdered, over time the death 
spiral absorbed ever more groups, among them elderly 
people, cardiac cases and cancer patients. The killing of 
incurable, care-dependent, or simply just troublesome 
patients turned into a normal routine for hospital staff. 
While the Volksgericht considered 400 murders as prov-
en, an even higher number is probable [43: 66, 50: 42–62; 
51, 52].
Another noteworthy trial dealt with the murder of 
hundreds of patients in the mental institutions of Gug-
ging and Mauer Öhling in Lower Austria. Most of the vic-
tims were killed by drug overdoses, but the main perpe-
trator, Emil Gelny (1890–1961), also introduced a new 
killing method by repurposing an electric shock device. 
When the trial opened in June 1948, the main culprit was 
missing; Gelny had managed to escape to Syria and lat-
er Iraq, where he died in 1961. Instead, 23 doctors, nurs-
es and administrative staff from the two institutions and 
two of Gelny’s former superiors in the regional admin-
istration found themselves in the dock. Gelny’s absence 
from the criminal proceedings meant that the other ac-
cused could downplay their own involvement and push 
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the blame onto him. An admission of guilt was the abso-
lute exception. Marie Gutmann represented the attitude 
of the majority of the accused in her appeal to the presi-
dent for clemency: ‘I myself am a victim of the time and 
circumstances known as the Nazi dictatorship.’ The high-
est sentences (12 to 10 years imprisonment) were handed 
down to the head of the Gau administration, Joseph May-
er (1890–?), and Gau physician leader, Richard Eisen-
menger (1899–?). They were found guilty of high treason 
under the War Crimes Act, as well as being remote ac-
complices to the crime of ‘hired assassination.’ The court 
said it could not be proven that they had ‘ordered’ Gel-
ny to murder, which would have incurred a much heavier 
penalty. Furthermore, the court handed down sentences 
of between two and four years to ten members of the hos-
pitals’ staff. Eight of the accused nurses were acquitted, 
and one case was classified as manslaughter and hand-
ed over to an ordinary court. The acquittals were due to 
a ‘lack of convincing evidence of guilt,’ whereas the court 
did not consider the serious suspicions against the ac-
cused as refuted. Although some of those convicted were 
sentenced to long prison terms, the sentences that they 
actually served were—in view of the fact that they were 
involved in hundreds of murders—ultimately relatively 
short. The defendant who originally had the highest pun-
ishment, Josef Mayer, was freed in July 1951, after less 
than six years in prison [53–55].
No other instances of ‘decentralised euthanasia’ on 
Austrian territory ever led to a trial, much less to a con-
viction. Thousands of deaths due to starvation and ne-
glect (such as at the Vienna ‘Steinhof’ psychiatric hos-
pital), and in some cases additionally by drug overdoses 
(such as at ‘Feldhof’ in Styria) remained unpunished.1
Trials against the ‘Spiegelgrund’ perpetrators
The Austrian courts’ response to the ‘child euthanasia’ 
programme followed a similar widespread pattern of rel-
atively harsh sentences immediately after the war, which 
gave way to a rapidly decreasing interest from prosecu-
tors and courts to go after Nazi criminals. In Vienna, 
close to 800 children had died at ‘Spiegelgrund,’ one of 
the largest killing institutions within the ‘child euthana-
sia’ programme. Many of the children had been poisoned 
because they suffered from some kind of mental disabili-
ty. The fate of the Spiegelgrund’s first director Erwin Jeke-
lius, who was arrested by the Soviets, has already been 
mentioned. His successor Ernst Illing (1904–1946) was 
sentenced to death in 1946 by the Vienna Volks gericht. 
The press widely reported on the case. Since Illing had 
come from Germany, his death sentence fit well into 
the Austrian narrative of victimhood at the hands of the 
1 There were plans for a trial against seven Steinhof physicians for 
‘euthanasia’ killings and other crimes, but the case was closed in 
1949. More consequential was a trial against two doctors who had 
mistreated inmates at the ‘Workhouse for Antisocial Women and 
Girls’ founded in 1941 on the Steinhof premises that ended with 
prison sentences [44: 50, 55].
Nazi German occupiers. Together with Illing, two other 
Spiegelgrund physicians were indicted. Marianne Türk 
(1914–2003) was sentenced to 10 years imprisonment, 
but released in 1948 on health grounds before being par-
doned in 1952. Margarethe Hübsch (1903–1983) was ac-
quitted [56–58]. In 1948, a further trial was held against a 
number of nurses from Spiegelgrund [44: 50].
Another former Spiegelgrund physician, Heinrich 
Gross (1915–2005), weathered the phase of relatively in-
tense denazification as a prisoner of war. Although he was 
arrested and put on trial when he returned from the Sovi-
et Union in 1948, he was acquitted in all but form in 1950, 
and could subsequently embark on a successful career as 
one of Austria’s most prominent psychiatrists. After his 
release from pretrial detention, decades would have to 
pass before a perpetrator of Nazi medical crimes—or in-
deed, any Nazi criminal—could be put on trial in an Aus-
trian court again. Tellingly, the first trial in Austria that 
dealt with Nazi medical crimes after a hiatus of more 
than 25 years was a civil law suit that Gross, in the mean-
time one of Austria’s foremost forensic psychiatrists, filed 
against Werner Vogt, the protagonist of a group of pro-
gressive physicians who had publicly criticised him for 
his involvement in the Spiegelgrund crimes. Gross won 
in the first instance in 1979 but two years later lost the 
appeal process because the court considered his involve-
ment a proven fact. Although this decision, which coin-
cided with Gross reaching pension age, marked the end 
of his career, another two decades past before the prose-
cution initiated criminal proceedings, resulting in a high-
ly publicised trial in 2000. This last attempt at seeking 
justice for the Spiegelgrund victims was thwarted by the 
claim that Gross was unfit to stand trial [59]. It is possi-
ble that a conviction even at this late point in time would 
have provided some sense of closure. However, the rather 
disappointing ending to the Heinrich Gross case certain-
ly did not come as a surprise if we consider the mixed re-
sults of earlier attempts to provide justice for the victims.
Fig. 3 Physicians from the ‘Spiegelgrund’ killing clinic in the 
dock (Neues Österreich, 16 July 1946)
history of medicine
Medical Ethics in the 70 Years after the Nuremberg Code, 1947 to the Present1 3 S169
Conclusion
Trials dealing with medical crimes on Austrian territory 
(or by Austrian perpetrators) were, with few exceptions, 
limited to the first half decade after liberation. Memories 
of the atrocities were still fresh, and the Allied powers ap-
plied pressure on the Austrian authorities to investigate 
and adjudicate crimes committed under Nazi rule. At the 
same time, Allied war crimes trials—most importantly, 
the Mauthausen Camp Trial and the Nuremberg Medical 
Trial—were held to adjudicate crimes against Allied na-
tionals, and lay the groundwork for further prosecutions 
before Austrian and German courts. Despite considera-
ble efforts to bring the perpetrators to justice, the record 
of both the Allied powers and the Austrian authorities in 
this regard is mixed.
The Allies’ efforts were hampered by difficulties in get-
ting hold of many of the perpetrators. Some had commit-
ted suicide at the end of the war, others were dispersed 
over various zones of occupation, with cooperation be-
tween the four powers increasingly strained. The adjudi-
cation of the ‘euthanasia’ murders was further complicat-
ed by a focus on crimes against non-German nationals, 
which could be prosecuted as war crimes. In the end, 
only a tiny number of perpetrators were brought to jus-
tice this way.
The task of prosecuting the many doctors, nurses and 
other staff responsible for the implementation of the kill-
ing programmes—not to speak of other inhuman acts 
such as forced sterilisations and abortions—fell on the 
so-called People’s Courts (Volksgerichte), which were 
specifically created in 1945 for the prosecution of Nazi 
crimes. Despite some undeniable achievements (e. g., 
trials concerning the Spiegelgrund child ‘euthanasia’ 
clinic in Vienna, and various psychiatric hospitals in 
Lower Austria and Carinthia), the People’s Courts’ over-
all record in dealing with medical crimes is also mixed. 
After an initial phase of active prosecutions that lasted 
until around 1950, the judiciary’s willingness to pursue 
such cases quickly subsided, in keeping with Austria’s 
overall increasingly lenient approach to Nazi criminals. 
When the anti-fascist consensus of the immediate post-
war years broke up, denazification and prosecution gave 
way to the reintegration of the former National Socialists 
into Austrian post-war society. During the following dec-
ades, Nazi medical crimes were rarely ever mentioned 
in public; according to our current knowledge, nearly 50 
years passed without a single criminal trial. This slowly 
began to change in the late 1970s, when Heinrich Gross 
came under increasing scrutiny for his past; the fact that 
it took another 20 years before a final attempt was made 
to bring Gross to justice demonstrates how slowly Austri-
an society came to terms with this part of the past. 
The failure of the West German judicial system in 
serving justice: the case of Dr. Horst Schumann
Aleksandra Loewenau, PhD, Deutsche Akademie der 
Naturforscher Leopoldina e.V., Leipzig, Germany
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1. Introduction: the case against Dr. Schumann
On September 23rd, 1970, nineteen years after the first 
arrest warrant had been issued, Dr. Horst Schumann fi-
nally appeared before a German judge. Schumann, who 
at the time of the trial was a sixty-year-old trained physi-
cian, had been actively involved in providing expert opin-
ions to hereditary courts [60], directing T4 centres, select-
ing ill prisoners in 14f13 action and conducting coercive 
medical experiments in Auschwitz Concentration Camp. 
After the war, in June 1945, Schumann was captured by 
the Allies and placed in a detention centre for Nazi crimi-
nals in Southern Germany. The American Army authori-
ties failed to identify him and Schumann left the camp a 
free man. It took another five years for the arrest warrant 
to be issued. By the time the authorities arrived at Schu-
mann’s door in Gladbeck, he had already fled the coun-
try. He then spent ten years living and working in Africa. 
In 1966, he was extradited to Frankfurt. The trial prepara-
tions took another four years. State prosecutor Johannes 
Warlo, who had previously been involved in the Frank-
furt Auschwitz Trial and other euthanasia trails, pre-
pared an indictment according to which Schumann was 
accused of “killing 15,314 people in the euthanasia cen-
tres in Berlin, Grafeneck, Sonnenstein, Buchenwald, and 
Auschwitz between 1939 and 1941” [61]. In addition, he 
was allegedly responsible for “conducting human exper-
iments on hundreds of male and female inmates, but at 
minimum on 180 Jewish inmates, without their consent, 
to test a mass-scale sterilisation and castration method 
via x-rays” [62]. By March 1971, Schumann began self-in-
flicting stomach injuries and high blood pressure in or-
der to delay the court proceedings [63]. As a result, he 
had to be hospitalised. On November 1st, 1971, a medi-
cal report was submitted to the court stating that: 
sometimes he suffers greatly from chest pain and ir-
regular heartbeat […] In addition, there is dizziness, 
and severe headache. At night he has to urinate twice. 
Sometimes he suffers from abdominal pain [62]. 
Consequently, Schumann was found not fit to contin-
ue the legal case. Despite the widespread knowledge 
of Schumann’s crimes, international attention given to 
the Nazi atrocities following Eichmann and Auschwitz 
Frankfurt trials, the impressive experience and dedica-
tion of the prosecution team and considerable evidence, 
the proceedings were suspended in April 1971 [63]. The 
prosecution did not even have the opportunity to put any 
of the sterilisation victims on stand. On July 29th, 1972, 
after six years of detention, Schumann was quietly re-
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leased from prison. He lived another thirteen years as a 
free man. 
This article aims to emphasise how the issues related 
to the reconstruction of judicial system in post-war Ger-
many, the public perception of Nazi crimes and German 
law impacted on the process of punishing former Nazis, 
taking the case of Dr. Schumann as an example. 
2. The allied occupation: punishment and 
denazification
The silent acceptance of the constant breaching of the 
Versailles Treaty by the Third Reich indirectly led to the 
outbreak of the Second World War, which claimed the 
lives of millions and caused massive destruction to Eu-
ropean cities. Thus, in 1945, there was a need for a tough-
er approach towards defeated Germany. Shortly after the 
war ended, the Allies began manifesting differences in 
their opinion regarding important issues, one of which 
was punishment of war criminals. After months-long de-
liberations, on December 20th, 1945, the decision was 
made that the Allied-controlled courts would prosecute 
Nazi crimes against the Allied citizens, and the crimes 
against Germans were given at disposal of the German 
judges. This became known as the Allied Control Coun-
cil Law 10 [64–66]. Prior to allocating criminal cases to 
German courts, the Allies had to clear the German judi-
cial system. In March 1945, the Allies created denazifica-
tion boards that intended to investigate German public 
service sector staff. This led to an immediate dismissal 
of judges who had been actively involved in the creation 
and implementation of laws passed by the former Nazi 
government. The Control Commission’s Law 4 of Novem-
ber 30th, 1945 stated:
To effect the reorganization of the judicial system, 
all former members of the Nazi party who have been 
more than nominal participants in its activities and all 
other persons who directly followed the punitive prac-
tices of the Hitler regime must be dismissed from ap-
pointments as judges and prosecutors and will not be 
admitted to these appointments [67].
Soon after, the Allies realised that the number of dis-
missed judges was greater than anticipated. Effective-
ly, the activity of the German courts was suspended. To 
solve this issue, judges who had been dismissed by the 
Nazis or had retired prior to 1933 were called back into 
service. This solution was insufficient. The strict imple-
mentation of denazification was unrealistic regarding the 
justice system staff. Towards the end of 1945, the major-
ity of Germans, who had been investigated by the denazi-
fication courts, were placed within 4th category, i. e. fol­
lowers or 5th category—exonerated [68]. As a result, most 
of judges who had been dismissed by the Allies now had 
the possibility to apply to be reinstalled. This process ef-
fectively introduced a renazification. Taking the British 
zone as an example, in 1948 80% of the judges were for-
mer Nazis, who in the Third Reich blindly adapted exist-
ing law to racial orders [69, 70]. After the war, a number 
of those judges kept their positions or were reinstalled 
and maintained the same pro-Nazi attitude. As years fol-
lowed, their students, who were educated in a similar 
trend, took over the benches and maintained the same 
order [69]. As a result, crimes committed by the Nazis 
during the war were often justifiable and advisable in the 
eyes of jurists, and thus the wartime activity of those re-
sponsible for the deaths of thousands of people—such as 
euthanasia centre staff—was viewed as implementing or-
ders rather than killing innocent people. 
3. Collective guilt v. collective innocence
At the time when the International Military Tribunal was 
being created, collective guilt as a form of judgement was 
not intended. The aim was to put the decision-making 
Nazi officials on trial, while the rest of the nation was un-
dergoing democratic transformation. Unlike the Soviets, 
who managed to maintain a collective guilt­free attitude 
towards defeated Germans, the Americans struggled with 
it, most likely due to the influence of German Jews and 
gentiles who were admitted to the US after they had been 
forced out by the Nazis in the 1930s. Imposing collective 
guilt awakened a strong defensive reaction among Ger-
mans; their resistance was manifested by labelling ver-
dicts of the Allied courts as victor’s justice. Moreover, the 
crushing defeat of the Wehrmacht and the Allied bomb-
ings that devastated German cities resulted in the devel-
opment of feelings similar to victimhood within German 
society [71, 68]. While Jewish survivors belonged to the 
victors club, German gentiles were viewed as the defeat-
ed perpetrators and were judged collectively by the rest 
of the world. Eugen Kogon, opponent of the Nazis and a 
survivor of Buchenwald, once said: 
Bystanders were an effect of ‘a political error’ and 
should not be compared to actual perpetrators. ‘A po-
litical error’ does not belong to the court [71]. 
Opposing collective guilt was effectively denying collective 
responsibility. While a large portion of the German pop-
ulation had not enthusiastically supported Nazi policies, 
they had not condemned them either. Thus, one could as-
sume that silence implied acceptance. Germans reacted 
with a great degree of reluctance to those accusations. 
German post-war society showed signs of a mentali-
ty familiar to perpetrators—i. e. the public felt burdened 
with the conscience and thus was eager to forget the past 
and move forward as soon as possible. The triggered de­
fence mechanism of the German society resulted in re-
placing collective guilt with collective innocence. The gen-
eral belief implied that citizens of the Third Reich had put 
their faith and loyalty in the Nazi government and the 
ruler by whom they were misled and betrayed [71]. This 
rhetoric treats the whole nation as vulnerable, incapable 
of thinking or distinguishing between right and wrong, 
which in legal terms would make them unfit to stand tri-
al. As Frank Buscher claims, “Germans were not interest-
ed in digging into crimes of the past because they were 
too afraid that it would be like opening a Pandora’s box”. 
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Deeply implicated in the crimes of the Nazi regime were 
not only high-ranking officials in the different ministries, 
leading industrialists, and the officer corps of the armed 
forces, but also ordinary people who sought employment 
in camps and ghettos [72]. 
4. Adenauer’s Federal Republic: the state and the 
public
Over the years, the supposedly strong Allied coalition 
proved unsustainable. In 1947, the differences in opinion 
between the United States and Soviet Russia led to a geo-
political conflict known as the Cold War, which resulted in 
the creation of two separate German states. The German 
Federal Republic, with Konrad Adenauer as the Chancel-
lor, was covered by the Marshall Plan—financial and po-
litical support from the United States. The general policy 
of West Germany in the 1950s was avoiding any confron-
tation with the Nazi past. Adenauer’s cabinet was not only 
uninterested in chasing Nazi criminals, but also openly 
criticised the Allied efforts to bring criminals to justice 
by demanding an amnesty for convicted former Nazis. 
Thanks to Adenauer’s intervention, approximately 1500 
Germans, who had been convicted and imprisoned in the 
Soviet Union, were granted amnesty and returned to Ger-
many. Among them was Prof Carl Clauberg, who was re-
sponsible for sterilisation experiments on Jewish female 
prisoners at Auschwitz concentration camp [72, 65]. Ade-
nauer’s politics were a reflection of a general trend mani-
fested by the German public, i. e. forgetting the past and 
focusing on building a new democratic Germany. Hence, 
a double integration was proposed, which allowed for-
mer Hitler’s middle men, including physicians, lawyers, 
journalists, etc., back into their professions. During Kon-
rad Adenauer’s tenure, Nazi criminals could avoid any 
punishment as long as no charges had been filed under 
their names for a period of twenty years [72].
The efforts of the Allies to bring Nazi criminals to jus-
tice were abandoned after the Cold War had intensified. 
Most of convicted criminals, even those who had been 
charged with mass murder, were freed. In 1955, the Tran­
sition Agreement was signed between the US, Great Brit-
ain, France and West Germany according to which those 
who had already been prosecuted by the occupying pow-
ers could not be prosecuted again for the same crimes 
[73]. The number of prosecutions of Nazi criminals de-
creased drastically from 871 between 1945 and 1950 to 76 
between 1951 and 1960 [72, 68].
5. International law v. the German Penal Code
In the 1940s, after the German justice system had been 
reactivated, German judges had the choice of wheth-
er they wanted to apply international law or the German 
Penal Code of 1871 when putting Nazi criminals on tri-
al [66]. Although the international law that derived from 
the Nuremberg Trials was designed to prosecute offences 
such as crimes against humanity and genocide, the major-
ity of German jurists decided to stick with the German law 
ignoring the fact that it was unsuitable given the severity 
of crimes committed in the Third Reich. Thus, the German 
Penal Code effectively worked to the accused’s advantage, 
since: 1) there was a  strict ban on retroactivity—an act 
that was not considered criminal between 1933 and 1945 
could not be treated as such in the post-war period; 2) in-
ternationally recognised crimes against humanity and 
genocide were not defined in the German Penal Code, 
and thus were classified as common murder; 3) the statute 
of limitation—20 years for a murder—allowed thousands 
of Nazi criminals to go unpunished for their crimes [73]. 
Another serious concern was the way the law was de-
fined. According to the German law, a murderer was a per-
son who committed the crime on his own initiative, and 
the murder was performed out of base motives. Thus, the 
euthanasia killings that had been supposedly performed 
as a duty were not considered as acts of cruelty by the 
court. The deciding factor between perpetrating and aid­
ing and abetting was an individual’s initiative rather than 
the act itself. The German public was in favour of using 
the German Penal Code when prosecuting Nazi criminals. 
Such court proceedings were more palatable for the pub-
lic if the accused of murder was presented as a psychopath 
rather than as an average German citizen following orders. 
In the 1960s, television and press reports influenced pub-
lic awareness worldwide. However, press coverage of Nazi 
criminals’ trials in West Germany was far from objective. It 
focused on the most gruesome crimes and those individu-
als who had committed those offences were presented as 
outcasts. The majority of the accused, however, were por-
trayed as reluctant participants [74]. That way, only mali-
cious individuals were targeted by the judicial system, and 
the rest of the society perceived themselves detached from 
the Nazi past and Nazi criminals [74]. 
6. Conclusion
In 1966, when Schumann was being extradited to the Fed-
eral Republic of Germany, the international Jewish com-
munity, and victims in particular, hoped for a smoothly-
run trial and an adequate verdict. Their expectations were 
not entirely unsubstantiated, given the high level of pub-
lic awareness regarding Nazi crimes, a strong prosecution 
team led by the renowned Fritz Bauer and, after his death 
in 1968, by the experienced Johannes Worle, and a con-
siderable number of witnesses who were willing to testify. 
All those efforts were insufficient due to two factors. First-
ly, the lack of interest in prosecuting Nazi criminals. Years 
of Allied occupation, imposing victors’ justice, enforced 
denazification and a broadly applied collective guilt re-
inforced the reluctance of the public, the government 
and the judicial system to deal with the Nazi past. A sur-
vey conducted shortly after the Auschwitz Trial revealed 
that 40% of Germans said “they haven’t heard of the tri-
al” when asked about the Auschwitz court proceedings. 
Of the remaining 60%, 40% were keen to “let the grass 
grow over the past.” About 70% of the German popula-
tion wished for the trials to be stopped and were against 
an extension of the statute of limitation [74]. Secondly, 
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the insufficiency of the German Penal Code to prosecute 
Nazi Criminals. By 1992, approximately 103,823 Germans 
had been investigated; of them only 6,487 were prosecut-
ed and 5,513 were convicted, most for non-lethal crimes. 
About 7% of those convictions were for crimes against 
Jews [73, 66]. In the German Federal Republic, putting 
those on trial who had been active in the euthanasia pro-
gramme proved difficult. Karl Brandt, for example, was 
indicted and sentenced to death in Nuremberg because 
his conduct had been classified as a crime against hu-
manity as defined in Control Council Law No. 10. The 
West German judiciary, the government and the public 
rejected the possibility of applying the international law 
when trying former Nazis. Thus, Schumann was tried ac-
cording to the traditional definition of murder as stipulat-
ed by the German Penal Code [69]. Therefore, one could 
assume that, had he maintained good health during the 
trial, he would most likely have received a maximum of 
six years imprisonment for aiding and abetting, rather 
than a life sentence for murder.
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The Nuremberg Code and ethical questions pertaining 
to the history of medicine during the Holocaust
The Nuremberg Medical Trial, from October 1946 to Au-
gust 1947, aroused far less global interest than the previ-
ous trial of the Nazi leaders before the International Mil-
itary Tribunal. Its practical benefit, besides bringing a 
handful of physicians to justice, was the formulation of 
the Nuremberg Code—the first internationally author-
ised document outlining ethical principles for human 
experimentation. Despite subsequent changes (manifest 
in the Declaration of Helsinki, the Declaration of Tokyo, 
and others), the Code is a fundamental landmark in the 
discussion of the binding bioethical principles from after 
WWII to the present day. It was an attempt to react to the 
inhuman criminality of the Nazi experiments, and to pre-
vent such atrocities in the future [75].
Nevertheless, a re-reading of the Code brings us back 
to basic questions regarding the history of medicine dur-
ing the Holocaust. Even though the Code refers specifi-
cally to human experimentation, its ten principles consti-
tute a kind of “Ten Commandments” of medical ethics, 
notwithstanding disagreements on its different aspects. 
These principles, in the spirit of human dignity and human 
rights, of physicians’ moral obligations toward patients—
already clear in ancient culture—already pervaded the 
Hippocratic Oath and other texts. The apparent need to 
reword the clearest principles of universal humanistic 
thought in the second half 
of the twentieth century, 
more than anything else, 
raises the cardinal question 
about which so much ink 
has been spilled: How come 
physicians, medical institu-
tions and scientific organi-
sations trampled the most 
basic principles of human-
ity in such an extreme and 
sweeping manner?
A look at the ethical di-
lemmas confronting the 
Jewish physicians and nurs-
es in the ghettos shows the 
complexity of the bioethi-
cal issues facing the medi-
cal staff and leadership as 
persecuted victims. It shows also that the nature of these 
moral dilemmas and decisions was greatly influenced by 
the medical workers’ ethics education. Moral considera-
tions were expressed in extreme situations that confront-
ed different groups of medical staff, both the “perpetra-
tors” and the “victims” under the Nazi regime. A humane 
ethical system seemingly led to medical ethical dilem-
mas and (albeit tragic) humane decisions, and a racist 
ethical system led to cruel acts by physicians, even while 
“wearing the cloak” of pseudoscience.
In its historical context, the Nuremberg Code inspires 
readers to deepen the study of the history of medicine 
during the Nazi period. This field of research offers an 
important observation of the personal and institution-
al moral lows of some medical practitioners and scien-
tists, manifested during this period, and the strengths of 
other individuals and groups among medical and health-
care staff, put to the test and forced to deal with tragic di-
lemmas according to outstanding ethical principles. The 
Fig. 1 Dr. Adina Blady-
Szwajger worked in the Ber-
son and Bauman Children’s 
Hospital in the Warsaw 
Ghetto. Ghetto Fighters’ 
House Archive, 1824
Fig. 2 Dr. Mordechai Lens-
ky, a physician at the Czyste 
Jewish Hospital in the War-
saw Ghetto and in the ghet-
to clinics. Courtesy of his 
son, Prof. Yaakov Lensky
Fig. 3 Sabina Gürfinkel-Glo-
cer, a nurse at the Czyste Hos-
pital in the ghetto. Yad Vas-
hem Photo  Archive, 3526/4
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study of both sides is paramount to the global bioethical 
discussion “after Auschwitz.”
The next section describes some of the ethical dilem-
mas that confronted the medical staff in the Warsaw 
Ghetto—the largest ghetto. These and other dilemmas 
arose in nearly all the ghettos.
Characteristics of ethical dilemmas in the ghettos
The cruel reality enforced on Jews during the Holocaust 
led to terrible moral dilemmas. In the moral luck terms 
of philosopher Thomas Nagel, these dilemmas were a 
clear case of bad circumstantial luck, when any mode of 
action comes at a heavy moral price [76]. Ghetto physi-
cians faced the most difficult dilemmas. Some of these 
are encountered daily by medical staff in normal times 
and certainly in emergency medicine or in mass-casualty 
incidents. However, ghetto physicians faced dilemmas of 
incomparable severity: from fitness assessments before 
deporting men to forced labour, which amounted to col-
laboration in their almost certain death; to fulfilling Ger-
man orders to make direct life and death selections from 
among their colleagues and patients, between extermi-
nation in Treblinka and work in the ghetto. Physicians in 
normal life circumstances are not faced with such dilem-
mas [77: 53–61, 127–43, 465–8, 481–580]. 
In his book, Moral Dilemmas, Daniel Statman ex-
plores the concept of tragic dilemmas as referring to a 
moral choice which comes at the cost of either destroy-
ing the decision-maker, or strongly undermining his life 
[78]. Such choices were not unusual for the ghetto phy-
sicians, especially during selections. In the tragic situa-
tions described, even though some medical staff worked 
according to the “lesser of two evils” principle, the sourc-
es provide evidence of their continued torment over 
whether their decisions were correct. These were dif-
ficult, tragic dilemmas in the full sense of the word. Al-
though many office-holders in the ghettos, rabbis, and 
especially Judenrat members, faced some of these ethical 
problems, they were most prominent in the day-to-day 
lives of the medical staff. 
The dilemma pertaining to active killing was theirs 
alone, such as when people begged the physicians to put 
their old, hospitalised parents “to sleep” to spare them 
from brutal murder by the Germans, who entered the 
hospital and shot anyone who was unable to walk to the 
Umschlagplatz. 
Alongside heroic and courageous acts was poor mor-
al behaviour such as the abandoning of professional du-
ties, shirking obligations and corruption. A physician’s 
individual behaviour did not apparently differ from that 
of many other ghetto office-holders: all faced impossi-
ble moral tests. Some withstood them and others failed. 
Collectively, however, the situation was different. Jewish 
physicians made a professional, ethical, moral, and hu-
mane choice: to establish medical services under geno-
cide conditions that had led to epidemics and mortality. 
The Jewish medical staff and leaders in the ghetto estab-
lished these systems under their own steam, as persecut-
ed victims, motivated by ethical and moral imperatives 
that saw the saving of life as a supreme value. The obli-
gation to heal the sick is so central to Jewish perception, 
that even under impossible conditions, they succeeded 
in setting up medical services based on modern profes-
sional conceptions [77], including preventive medicine2 
[77], hospitalisation3 [77, 79], medical research4 [80, 81], 
academic study, and training [82, 83].
The strategies of coping with the ethical dilemmas em-
ployed by the ghetto medical staff must be discussed in 
the broader context of the medical systems collective-
ly established by the Jewish physicians. Notwithstand-
ing these tragic dilemmas, as described below, they did 
not shirk their collective responsibility, preventing the 
collapse of the medical services. Quite the opposite; de-
spite coping with dilemmas in the tragic reality, with re-
inforced ethical and professional commitment to the 
Jewish cultural tradition, they attempted to “bring heal-
ing to a drifted leaf”5 while suffering from the same tor-
ment and diseases as their patients, and as the rest of 
their brothers and sisters imprisoned in the ghettos [80].
I suggest distinguishing between two types of dilem-
ma, even though the differences between them are not 
always absolutely clear. One type includes dilemmas in 
which, on the one hand, the medical staff were required 
or expected to help patients in distress while risking their 
own lives. Here the general question is: To what extent 
should medical workers endanger themselves to save the 
needy? Another type of dilemma does not involve per-
sonal risk, but a conflict between values or moral norms. 
These are moral dilemmas, as accepted in contemporary 
philosophical discourse. In this sense, dilemmas are sit-
uations in which one faces two conflicting obligations, 
which cannot both be fulfilled [78]. The philosophical 
literature has debated the question of whether these di-
lemmas exist; is it possible to have two conflicting obliga-
tions, from which there is no way out, because either op-
tion will leave the person morally deficient [84, 85, 78]? 
A study of the medical staff’s difficult dilemmas casts 
doubt on the validity of the philosophical stance that de-
nies the authenticity of these dilemmas. The problematic 
ethical nature of the situations is not derived from back-
2  The Jewish health organisation, TOZ (Zdrowia Ludności 
Żydowskiej), which operated within the Jewish communities in 
Poland during the interwar period was particularly well-known for 
its advancement of preventive medicine and social medicine for 
the weaker sectors of society.
3  Czyste, the large Jewish hospital which served the Jewish and 
non-Jewish population in Warsaw, was not located within the 
ghetto boundary. The Jews established a replacement institution 
in buildings scattered throughout the ghetto, to serve the ghetto’s 
patients. In addition, the Bersohn and Bauman children’s hospital, 
which operated in Warsaw during the interwar period, continued 
to operate in the ghetto. 
4  The Jewish physicians in the Warsaw Ghetto, while suffering 
from hunger along with the rest of the Warsaw Ghetto inmates, 
conducted a study of the effects of hunger on the human body 
among adults and children. Most of the findings were documented 
and were smuggled to the Aryan side. 
5 From a liturgical prayer recited on the eve of the Day of Atone-
ment, the holiest day in the Jewish calendar.
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casting, but was recognised as such at the time. I distin-
guish between “self-endangerment dilemmas” and mor-
al dilemmas in the other sense6 [86, 87].
Dilemmas involving personal risk
Abandon patients to save oneself? When the mili-
tary front advanced towards Warsaw in 1939, the med-
ical workers faced the dilemma of whether to continue 
to care for their patients and thus put their own survival 
at risk. Many respected professionals tried to save them-
selves. When the Germans invaded Warsaw, fear gripped 
the hospital workers. At that time, Dr Amsterdamski 
and Nurse Sabina Gürfinkel-Glocer were working at the 
Czyste Hospital: “Now hell will gape before us,” said Sa-
bina, to which he answered: “Do not despair—Not all the 
Jews will be destroyed … the Jewish people will not be de-
stroyed … and therefore we must be strong and save who-
ever we can …” He worked tirelessly throughout the peri-
od. “It was a question of honour for us to help the doctors 
and together save those that could still be saved,” wrote 
Sabina [88].
This dilemma was especially prominent immediately 
before and during the Warsaw Grossaktion of 1942, when, 
like everyone else, the medical staff wanted to save them-
selves.
Dilemmas in which medical workers are required to 
treat patients while risking their own lives are also dis-
cussed today. For example, the Ethics Board of the Israel 
Medical Association has formulated its stance on endan-
gering medical staff. In an emergency, when physicians 
are forced into life-threatening situations by caring for 
patients, “then the physician, together with other safety 
authorities, will evaluate the risk of entering the scene of 
the incident versus the obligatory need to save lives” [89]. 
In other words, the Medical Association does not take an 
absolute stance regarding the most appropriate response 
in such a case.
The historian Emanuel Ringelblum expressed his ap-
preciation of medical staff and described their altruistic 
behaviour in the ghetto: “Earlier we mentioned the … he-
roic stand of the educators and primarily of Dr Korczak … 
The conduct of the doctors and nurses at the Jewish hos-
pital was similar … a few dozen doctors and nurses stood 
guard and did not abandon the patients until the very last 
moment. When … more than 1000 patients were loaded 
onto the train cars, a small number of doctors and nurs-
es went with them. Such was the behaviour of the people 
who were viewed as subhuman by the Nazis” [90].
Risk infection by patients or stop working with them?
The work of physicians and nurses in the ghetto carried 
the risk of contracting very serious illnesses to which 
they would not normally be exposed. The medical staff 
were faced with the dilemma as to whether or not to con-
6 I have written widely about the ethical dilemmas facing the 
medical staff in the Warsaw Ghetto and the Šiauliai Ghetto. 
tinue their medical duties. When typhus raged through 
the ghetto, about 30 percent of the 800 physicians work-
ing there contracted it. The disease claimed the lives of 
about eight percent of those who were working in the 
Czyste Hospital emergency room, who were especially at 
risk. In his memoirs, the renowned scientist, Prof Lud-
wik Hirszfeld, described widespread infection among 
physicians and nurses working at the ghetto refugee 
centres, many of whom died. The living quarters of the 
masses of refugees who flocked to the Warsaw Ghetto 
were a hotbed of morbidity and mortality. Dr Lensky’s 
descriptions are a window into the dilemmas facing the 
physicians; aware of the refugee centre’s terrible condi-
tions, his response to the offer of a post there was am-
bivalent. His wife tried and succeeded in dissuading him 
from taking the position, but he was wracked with pangs 
of conscience:
“Mixed feelings raged in me, my love for my family was 
at odds with my conscience … I was obliged to be with 
the refugees … help make them less bitter, rekindle their 
hopes, relieve their desperation. I couldn’t fall asleep 
that night …” [91].
The Israeli Medical Association’s paper on the physi-
cians’ risk of exposure while treating infectious patients, 
reads as follows: “Should the system be unable or unwill-
ing to provide the means … the doctor is not obliged to 
endanger himself beyond the limits he shall voluntarily 
set upon himself along with his colleagues and other ex-
perts” [89].
Moral dilemmas: conflicting values
Moral dilemmas in the second sense include cases of 
several conflicting moral requirements, which each in-
volved a bad choice.
Physicians required to perform selections: One of the 
most difficult dilemmas was having to decide who would 
be sent to the extermination camps. Directors of Jewish 
hospitals, senior physicians, and other medical profes-
sionals in the ghetto were sometimes required to per-
form selections from the hundreds of medical workers 
and their families employed in the medical institutions, 
as well as from among the hospital patients. This meant 
implementing the Nazi decrees, and physicians’ direct 
and personal involvement in sealing the fate of their col-
leagues. Dr Marek Balin wrote:
“The Jews themselves are obliged to hand their broth-
ers over to death  … three prominent physicians had 
to make the judgments. They had  … a list of patients’ 
names. Alongside each name, a (+) sign meant deporta-
tion or death, while a (-) sign meant to remain in the hos-
pital. The doctors stopped at each bed for a longer time 
than usual. They whispered quietly, with anguished voic-
es … Dr. Szenicer was … holding a handkerchief in front 
of his face. He not only evaded the staring of patients 
but he seemed also ashamed before his colleagues. He 
walked through the rooms with his head lowered and the 
handkerchief covering part of his face … Terrified, Chana 
Rosenfeld … grasped the situation as she started crying at 
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the moment the (+) sign was being marked alongside her 
name. The doctors kept … wiping their own tears …”7 [92].
In the final stages of the Grossaktion to deport the War-
saw Ghetto’s Jews to Treblinka, every Judenrat depart-
ment received a quota of people exempt from deportation, 
those recognised as workers needed by the Germans. Un-
der these circumstances, senior physicians had to decide 
who would receive a “life number.” The exemption selec-
tion criteria were different in each department. For in-
stance, senior physicians were left to serve as department 
heads; another criterion was saving entire families rath-
er than individuals. When it was decided to spare the de-
partment heads, their wives and children were given “life 
numbers” as well. This made sense, but the general work-
ers and some of the ordinary doctors paid the price. Some 
felt that as many workers as possible should be saved, 
specifically individuals without children, but apparently 
no principle was adhered to absolutely. Dr Polisiuk, a gy-
naecologist in the Czyste Hospital, writes that the quota 
for the hospital wards, which held some 800 people, was 
only 200. According to Dr. Polisiuk, the view of the gener-
al public was that the council and the department heads 
should not have undertaken this task. They should have 
left it to the Germans, even at the cost of a larger num-
ber of victims. Polisiuk also wrote that it was known that 
when the lists were compiled, the power of personal con-
nections would override the value of rights and the work-
ers’ devoted labour of many years; the majority were cer-
tainly doomed to suffer. It is clear that the ability to leave 
such a limited number of people in the ghetto could not 
offer a just solution to such a tragic problem. 
Since none of the members of the Judenrat wished to 
read out the list, and as many of the workers had request-
ed Polisiuk’s assistance with the task, he agreed with a 
heavy heart:
“It was the most tragic moment in my life. While read-
ing out the list, I handed out a death sentence to 600 in-
nocent people: close friends, colleagues … I was obliged 
to read through the list several times! They did not believe 
they had not been included …”8 [93].
Euthanasia by physicians and nurses during the 
Aktions
When the Germans penetrated the hospital and all hope 
was lost, some physicians and nurses performed “eutha-
nasia” on their family members, as well as on old people 
and children who lay in the hospital.
Blady-Szwajger described the Aktion in the hospital in 
her memoirs:
“… Doctor, please give my mother an injection. I can’t 
do it. I beg you, please. I don’t want them to shoot her 
in bed, and she can’t walk.” So I asked her what was in 
7  Balin M. Testimony of a physician (Polish). Yad Vashem Archive, 
03–441.
8  Notebooks of Dr. Polisiuk, 06.09.1942–07.09.1942, Meruba 
[Square], memoires of the Czyste hospital. Ghetto Fighters House 
Archive. File 3182.
the syringe and she told me it was morphine … When I 
left the room … we took a spoon and went to the infants’ 
room. And just as, during those two years of real work in 
the hospital, I had bent down over the little beds, so now 
I poured this last medicine into those tiny mouths … told 
them that this medicine was going to make their pain dis-
appear. They believed us and drank the required amount 
from the glass …” [92].
“This is very problematic behaviour,” argues Prof 
Steinberg. “Any action of killing a person, even if the mo-
tivation to do so is humane, is still an act of murder”.
The American physician Ralph Yodaiken disagrees: “I 
believe that Dr. Blady-Szwajger, who gazed into the wells 
of life and death and knowing what was expected, chose 
the only option for her beloved patients and allowed 
them to die with dignity. Her action should be seen as an 
act of resistance par excellence …” [93].
In conclusion
In his memoirs, Dr. Lensky wrote: “Of the 830 physicians, 
very few did not measure up morally  … But such cases 
were rare, and the number of doctors whose deeds would 
have been condemned by any society was negligible” [91: 
86].
The ethical question was never far from the minds of 
health workers, and moral challenges were apparently 
one of the dominant experiences of their unique work 
under ghetto conditions. Despite the difficult and trag-
ic ethical dilemmas facing each individual worker, the 
ghetto medical staff, as a collective, strove to establish 
a professional, ethical and humane medical system un-
der unimaginable conditions. In many ways, this system, 
with all its dilemmas, was unique and unprecedented in 
the history of humanity and of medicine. 
In the historical context of the Nazi era, as a “Ten Com-
mandments” for medical experimentation, the Nurem-
berg Code is a beacon, for both practitioners and pa-
tients, against scientists’ and physicians’ abuse of power. 
Adherence to its principles, such as enforcing voluntary 
informed consent, preventing harm and human suffer-
ing, and preserving the subjects’ freedom to stop the ex-
periment at any stage, is an attempt to ensure against the 
repetitious violation of human rights, as perpetrated in 
the Nazi medical experiments. In this sense, it can be 
said, in retrospect, that the activities of the Jewish medi-
cal staff in the ghettos proves the possibility of uphold-
ing these fundamental principles, even under extreme 
conditions. This case study reinforces the spirit of the 
Nuremberg Code, which does not lose its validity, even 
under the most difficult enforced conditions of mass 
atrocities, ethnic cleansing and genocide.
It is also important to note that, in addition to the 
medical treatment, hospitalisation and the study of med-
icine, physicians and scientists in the ghettos conduct-
ed valuable research on the inmates’ morbidity. As the 
diseases that spread throughout the ghettos were typical 
to genocide conditions but rare during normal times, the 
staff lacked knowledge of how to treat these phenome-
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na. Research was, therefore, necessary to improve treat-
ment methods as well as to document the Nazis’ crimes 
for posterity. Prominent research examples are the stud-
ies of hunger and of typhus conducted in the Warsaw 
Ghetto. The researchers, who were suffering from the 
same troubles themselves, did not exercise coercion, did 
not cause additional suffering, did not worsen the sub-
jects’ state of health, and showed sensitivity toward the 
patients and their conditions—thus adhering to the lat-
er Nuremberg Code criteria. Needless to say, the fate of 
these medical workers was no better than that of the rest 
of the Jews in the ghetto. After their long, exhausting, and 
dangerous service to the community, most were deport-
ed to the camps. 
One of the thousands of physicians who worked in 
the ghettos was Dr Julius Moses, who had been a gener-
al practitioner in Berlin from 1920 to 1932 and a member 
of the Social Democratic Party in the Reichstag. In 1930, 
when about 75 children died in Lübeck, after receiving 
an inadequately tested tuberculosis vaccine, Dr Moses 
harshly criticised this appalling medical disaster. In his 
role as physician and legislator, with the aim of prevent-
ing a recurrence of such cases, he formulated a series of 
guidelines for experimentation on new vaccines and for 
medical experiments in general. They included inter alia 
full explanations and informed consent requirements for 
clinical trial subjects or their guardians. His recommen-
dations were promulgated by the Reich Health Council 
in 1931, but the legislation procedure was aborted with 
the Nazis’ rise to power. In the summer of 1942, Dr Mo-
ses was deported to Theresienstadt and died there. How-
ever, his fight to uphold these ethical principles was not 
in vain. During the Medical Trial, his recommendations 
were discussed, alongside other documents, as ethical 
standards for performing medical experiments, and ap-
pear to have had great influence on the formulation of 
the Nuremberg Code. [94, 95: 2, 120].
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“The defendants [most …trained physicians and some …
distinguished scientists]…are charged with murders, 
tortures, and other atrocities committed in the name 
of medical science … The victims of these crimes …for 
the most part are [the] nameless dead  … The charges 
against these defendants are brought in the name of 
the United States of America. They are being tried by a 
court of American judges …and … [it is …important …
that] this Court, as the agent of the United States and as 
the voice of humanity, stamp these acts, and the ideas 
which engendered them, as barbarous and criminal … 
It is our deep obligation to all peoples of the world to 
show why and how these things happened …” -Edited 
excerpt from Telford Taylor’s Opening Statement of 
the Prosecution in the “Medical Trial,” Nuremberg, 
Germany, 1946 [96]
American roots of the Nuremberg Code
In 1945, the International Military Tribunal (IMT) con-
ducted by the Allied powers including the United States 
(US), France, the United Kingdom and the Soviet Union 
tried high-level Nazi war criminals for “war crimes” and 
“crimes against humanity” [96]. After the IMT, the Al-
lied Control Council gave authority to the US to conduct 
twelve additional trials. The first case was the Medical 
Trial conducted with US judges by US prosecutors based 
on “landmarks in international law which [were] erect-
ed in Nuremberg [and] rest[ed] on a foundation of legal 
procedure which  …satisfied the traditional safeguards 
of … American law” [97]. Thus, although the Medical Tri-
al was considered an international tribunal not “bound” 
by US law and only nominally conducted by the US, it was 
nonetheless permeated by American jurisprudence and 
could be viewed as singularly American [98].
The physician defendants were on trial for murder 
committed under the guise of human experimentation, 
among other criminal activities. At the close of this crim-
inal tribunal, one would expect an adjudication of guilt 
or innocence. However, the judges included in the fi-
nal decision a nuanced code of ethics of human experi-
mentation subsequently known as the Nuremberg Code. 
During the trial, US judges heard evidence of unethical 
human experimentation conducted on subjects where 
death was the end result. The Nazi doctors, in their de-
fense, presented evidence of internationally-sponsored 
unethical research exploiting the vulnerable, particu-
larly prisoners. US judges sitting at Nuremberg were dis-
turbed by what they heard during the tribunal. Appar-
ently, there were no universally-accepted international 
ethical guidelines for the protection of human subjects 
until the Nuremberg Code. Though the Code was not rel-
evant to the murder carried out by the Nazi doctors, it 
sought to prevent future unethical human experimenta-
tion through the protection of human subjects. 
The Code has two important principles, the first of 
which is the protection of the rights of the human subject 
and the second is the focus on the welfare of the human 
subject. Informed consent (Principle 1) and the right to 
refuse to participate or terminate participation as human 
subjects at any time (Principle 9) underscore the indi-
vidual’s rights in human experimentation [99]. The other 
eight principles of the Code focus on the welfare of hu-
man subjects and include the necessity of a comprehen-
sive research design, the assessment of risk to the sub-
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ject, and the investigator’s assurance that no imminent 
harm or death may befall the subject [99]. The Nurem-
berg Code was to apply to normal, healthy volunteers. 
The Code ultimately focuses on voluntary, informed, and 
understanding consent as the hallmark to protect the 
rights and welfare of the human subject.
Although emerging from the context of the Medical 
Trial, the Code itself provides a proscriptive ethical and 
legal framework for the future of human experimentation 
[100, 101]. The inclusion of “voluntary consent” is a cru-
cial indicator that the Code was indeed intended to be 
proscriptive. This is based on the premise that the lack 
of informed consent from concentration camp prisoners 
was an irrelevant charge to bring against the Nazi doctor-
murderers, given that the victims of these camps had no 
chance of self-determination or autonomy, as they were 
destined for death. Rather, this principle indicates the 
American judges’ intention to safeguard against future 
human experimentation abuses [101, 102].
The Code’s emphasis on both informed consent as ab-
solute and the right of the human subject to end an ex-
periment at any time exemplify how its principles are 
focused on protecting the individual’s autonomy [103]. 
The foundational tenet of voluntary informed consent 
parallels the US Constitution. Such examples are found 
in the Constitution’s Preamble, 4th Amendment, and 
14th Amendment, which protect against infringement 
of the individual’s inviolability including “unreasonable 
searches and seizures” as well as prohibiting any state 
from “[depriving] any person of life, liberty, or property, 
without due process of law” [104, 105]. Clearly, the Amer-
ican judges “being  … steeped in the self-determinism 
ideal, so much celebrated in [US] political tradition  …
wanted their first principle to safeguard human dignity 
and inviolability, in research and civilized life” [101]. Ini-
tially in the US, the Nuremberg Code’s emphasis on safe-
guarding future medical experimentation for the most 
part was felt to be unnecessary in the US research con-
text [96, 106].
Reaction to the Code in the US
Renowned Holocaust survivor, Elie Wiesel, hypothesized 
that the doctor-murderers of the Nuremberg trial viewed 
human beings as abstractions. He astutely captured the 
danger in the subjugation of an individual’s humanity, 
which is often a risk in conducting human experimen-
tation. Wiesel believed that the legacy of the Nuremberg 
Code was to act as a force against scientific hubris and 
that “respect for human rights in human experimenta-
tion demands that we see persons as unique, as ends in 
themselves” [96, 107].
In the US, medical experimentation had consistently 
challenged the ideal of treating human beings as “ends 
in themselves,” when human subjects were used sole-
ly for the purpose of creating new knowledge [107]. An-
other factor limiting the Code’s influence in the US was 
medicine’s long-established reliance on the physician as 
the sole arbiter of the patient’s/subject’s care and pro-
tection. While there has been a modern progression to-
ward a more fiduciary doctor-patient partnership, at the 
time of the Code’s promulgation there was widespread 
consensus among American physicians that the patient’s 
compliance was essential to appropriate care. In essence, 
physicians had historically relied on a personal moral 
adherence to primum non nocere, “first, do no harm.” 
Additionally, physicians had used the ethical principle 
of beneficence to guide them, but tended to “submerge 
the patient’s authority” even when augmented with in-
formed consent [108]. The inherent paternalism in physi-
cian decision-making inevitably compromised the indi-
vidual’s autonomy even amidst attempts to observe the 
Code’s principles. Ultimately, this contributed to the di-
lution of the strength of the Nuremberg Code. 
Moreover, because the Code was formed in response 
to the barbarous acts of the Nazis, many in the US medi-
cal and research community avoided the guidelines, be-
lieving the Code was intended for only those perpetrat-
ing violations akin to the defendants in the Medical Trial. 
“Human subjects” were brutally tortured, maimed, and 
killed at the hands of the Nazi doctors in the name of sci-
entific progress while “…respect for human dignity [was] 
totally abrogated” [101]. The revelation of these unspeak-
able acts prompted the US medical and research com-
munity to distance itself from the Code, despite the fact 
that the Code’s general principles were intended to curb 
exploitation in all human experimentation. Historical-
ly, medical research in the US was often conducted on 
the most vulnerable, including children, terminally ill 
individuals, women, and the impoverished [101]. The 
fact that researchers used these socially disenfranchised 
populations as research subjects provides evidence that 
Wiesel’s hypothesis of the human being’s abstraction ex-
isted even within the medical community in the US [107]. 
In essence, the researchers dehumanized these individu-
als due to their social status as a means to an end, rather 
than seeing them as “unique” ends in themselves [107].
Contributing to the Code’s dismissive reception in the 
US was the belief that the Code’s safeguards applied only 
to non-therapeutic research on “healthy” subjects. As 
human experimentation extended beyond “healthy” in-
dividuals into the realm of therapeutic research, where 
individual subjects with diseases might derive a benefit 
from the results of or even from participation in research, 
the distinction between treatment and research became 
obscured. Physicians regarded their research as part of 
a treatment plan for a patient-subject, not requiring in-
formed consent. Additionally, as the Code originated 
within the context of a criminal trial, it was often viewed 
as too “legalistic”; and therefore deemed irrelevant by 
US researchers [103]. At the same time, physicians and 
researchers believed that its principles were a threat to 
medical progress [109]. Nonetheless, ignoring the Code 
and its precept of informed, voluntary consent placed in-
dividual human rights in peril. Consequently, significant 
abuses have been perpetrated in the name of medicine 
and research throughout post-Nuremberg US history.
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Application of the Code in US federal regulations
Since the time of the Code’s promulgation, medical re-
search has proliferated worldwide, amplifying the po-
tential for research abuses. The increase in US medical 
research activity precipitated the necessity for the in-
creased protection of human subjects in biomedical and 
behavioral research. The Code’s initial inconsistent in-
corporation into US statutes, regulatory requirements 
and policy-making bodies at the federal level demon-
strate that the Code was either applied as if its principles 
were “enduring ethical statements,” or were dismissed 
as irrelevant because the Code was seen as “narrowly fo-
cused on assessing the activities of specific defendants” 
of the Medical Trial [96, 110].
The Code’s principles have largely been adopted into 
US federal regulations. The National Institutes of Health 
(NIH) adopted ethical, but not legal, guidelines begin-
ning in the mid-1950s that referred to the Nuremberg 
Code as the ‘ten commandments of human medical re-
search.’ Subsequently, in 1961, the NIH handbook cited 
the Code as a central guiding principle [96, 110]. In 1962, 
the Food and Drug Administration (FDA) became in-
volved in regulating research with the introduction of the 
Drug Amendment Acts. Thus, another federal body began 
regulating human experimentation, but only within its 
purview to regulate FDA-related research. Notable guide-
lines that the FDA and NIH enacted at this time includ-
ed the requirement for research subjects’ consent and the 
assignment of experimentation responsibility to the insti-
tution, respectively. These guidelines “set the tone for fu-
ture federal involvement regulating research. Both sets of 
rules view research in a positive light and try to protect 
subjects, but not at the expense of hindering research” 
[96, 110]. Building upon the National Research Act of 
1974, federal governmental bodies subsequently estab-
lished an extensive set of regulations for government-
sponsored research by mid-1975 [96, 110]. Within these 
regulations were special stipulations on research with fe-
tuses, pregnant women, and in vitro fertilization. In 1981, 
the National Commission for the Protection of Human 
Subjects of Biomedical and Behavioral Research includ-
ed prisoners and children as special protected research 
classes [96, 110]. Both of these sets of regulations go a step 
beyond the Nuremberg Code, which does not stipulate 
specific principles for special populations. However, sig-
nificant gaps remained in the US regulatory framework 
for other vulnerable populations, such as the mentally ill. 
In a stark departure from the Code that makes protect-
ing human subjects the obligation of researchers alone, 
the federal regulations place responsibility for the pro-
tection of the human subject’s rights and welfare on the 
institutions that receive federal funding. For example, In-
stitutional Review Boards (IRBs), who review ethics and 
compliance with federal regulations, may allow research-
ers to waive consent in certain situations at the discretion 
of an IRB. These changes make it “seem that non-bene-
ficial research could be conducted on a non-consenting 
subject, precisely the behavior the Nuremberg Code ex-
plicitly prohibits” [96, 110]. Other citations of the Code in 
the US include the 1995 Advisory Committee on Human 
Radiation Experiments (ACHRE) report, the 2001 reports 
by the National Bioethics Advisory Commission (NBAC), 
and the 2011 Presidential Bioethics Commission which 
published a report entitled, Moral Science: Protecting 
Participants in Human Subjects Research [111]. However, 
the Code was not and has not been completely observed 
by those conducting research with human subjects. 
While the Code’s principles have been robustly adopted 
into the contemporary regulatory framework in the US, 
the failure to apply the “spirit” of the Code in clinical ap-
plications has resulted in “insufficient guidance” to pro-
tect the inviolability of all human research subjects [112].
Application of the Code in US courts of law
Considered “the most complete and authoritative state-
ment of law” on informed consent in human research, 
the Nuremberg Code could also potentially be applied in 
US courts in both criminal and civil cases [96, 113]. How-
ever, the Code has rarely been utilized in the US legal sys-
tem—a paradox given that it is the most authoritative 
statement on voluntary, informed consent [114]. In fact, 
no criminal cases have cited the Code since its inception. 
Furthermore, in the few civil cases in which the Code has 
been cited, there have been no damages awarded for in-
juries to subjects, nor punishments prescribed by law for 
researchers who have violated the Code [114].
Nonetheless there exist some notable examples when 
the Code has been cited in US courts. A case that raised 
the question of whether an involuntarily committed in-
dividual could consent to psychosurgery to treat ag-
gressive behavior (Kaimowitz v. Michigan Dept Mental 
Health, 1973) referred to the Code. The court cited the en-
tire Nuremberg Code in its decision and ultimately ruled 
that the individual could not give “voluntary, competent, 
informed or understanding consent” [114]. This could be 
viewed as the court enforcing the Code’s hallmark feature 
of informed consent at the state level. In contrast, in a suit 
filed by a former US soldier who was injured during Cold 
War experiments, the US Court of Appeals stated that 
“The majority neither endorses nor sanctions a concen-
tration camp mentality … what we are called upon to de-
cide is simply whether the plaintiffs are entitled to money 
damages” [114]. Years later, a federal district court judge 
further discounted the Nuremberg Code as a “discussion 
document without legal force in the United States” [114].
The US Supreme Court has decided only one case 
which referred to the Nuremberg Code. United States v. 
Stanley involved an attempt to retrieve records on the 
CIA’s program that administered LSD and other agents to 
“uninformed human subjects” beginning in 1953 [114]. 
This was the Supreme Court’s opportunity to determine 
whether or not the Nuremberg Code, which was original-
ly formulated by a US military tribunal, at least applied 
to the US Army [114]. US courts have consistently ruled 
that national security matters supersede the precepts 
of the Code [115], despite the fact that the Armed Forc-
history of medicine
Medical Ethics in the 70 Years after the Nuremberg Code, 1947 to the Present1 3 S179
es Medical Policy Council (AFMPC), a division of the US 
Pentagon, recommended to the Department of Defense 
in 1953 that the Code’s principles be entirely adopted in 
national security matters regulating human experimen-
tation [115]. The US Supreme Court’s decision to side 
with the CIA in United States v. Stanley, in which the CIA 
had administered hallucinogens to unsuspecting sub-
jects, again demonstrated that the Code was secondary 
to national security. Four justices dissented to the deci-
sion. In her dissent, Justice Sandra Day O’Connor cited 
the Nuremberg Code, and stated “…the standards that 
the Nuremberg Military Tribunals developed to judge the 
behavior of defendants stated that the ‘voluntary consent 
of the human subject is absolutely essential’…our Con-
stiution’s guarantee of due process of law guarantees 
this much” [114]. The Code has been relegated to a legal 
gray area by the courts. In turn, American courts have in-
terpreted the Code’s application in contradictory ways, 
thereby complicating its role in protecting the rights of 
human subjects.
The Code in the US research context
There are several concerns associated with the imple-
mentation of the Code in the US research context. By 
leading with informed consent, the authors of the Code 
were arguably emphasizing its importance. This is its 
strength; however, while voluntary, understanding and 
informed consent is necessary to protect the subject’s 
autonomy and inviolability when conducting human ex-
perimentation, consent alone is necessary but not suffi-
cient. Informed consent is the grounding principle of the 
Code, but the welfare of the human subject is equally im-
portant and arguably certain parameters and research 
protocols must be in place prior to ascertaining informed 
consent. Subsequent principles of the Code outline other 
crucial, prerequisite safeguards, such as a competent in-
vestigator, adequate facilities to prevent harm to the sub-
ject, and a proportional risk-benefit analysis which must 
be in place before the human subject can be approached 
to participate and give consent in human experimenta-
tion. Unfortunately, physicians and researchers often 
pay attention to the Code’s leading principle, operating 
under the false assumption that informed consent alone 
is both necessary and sufficient to conduct human ex-
perimentation. Therefore, while this first principle is in-
deed an essential safeguard, it should not overshadow 
other ethical requirements of the Nuremberg Code. 
US research abuses
Despite the Code’s promulgation in 1947, research abus-
es have persisted in the US. In his seminal 1966 paper, 
Ethics and Clinical Research, Henry Beecher compiled 50 
studies that were unethical and in direct violation of the 
Nuremberg Code. He detailed 22 studies of the 50 that in-
cluded instances of treatment withheld, lack of informed 
consent and even death [116]. Beecher insists, “An exper-
iment is ethical or not at its inception; it does not become 
ethical post hoc—ends do not justify means. There is no 
ethical distinction between ends and means” [116].
In 1972, it was revealed that the US Public Health Ser-
vice (USPHS) was exploiting 400 poor black men in the 
“Tuskegee Study of Untreated Syphilis in the Negro Male.” 
USPHS investigators followed these men from 1932 to 
1972 to study the natural progression of untreated syphi-
lis. Despite treatment in the form of penicillin, which was 
considered the standard of care and widely used as early 
as the 1950s, the USPHS left these men untreated for the 
duration of the experiment [117–119].
Another example of research abuse occurred at Wil-
lowbrook State School, an institution for intellectually 
disabled children on Staten Island, New York. From the 
mid-1950s until the 1970s, investigators infected children 
with live hepatitis virus to study the potential for devel-
opment of a hepatitis vaccine. In both Tuskegee and Wil-
lowbrook, the researchers maintained that they were 
merely conducting observational studies. In reality, they 
were taking advantage of a socially vulnerable popula-
tion under the guise of scientific progress [117].
In 1963, another case of research abuse occurred at the 
Jewish Chronic Disease Hospital in Brooklyn, New York 
where live cancer cells were injected into 22 patients with-
out written consent. The researchers claimed that oral 
consent was obtained, but this did not constitute informed 
consent, as the researchers did not disclose that they were 
injecting the subjects with live cancer cells. In this case, re-
searchers believed that full disclosure “might agitate [pa-
tients] unnecessarily” and some did not even have capac-
ity to consent [120]. Although the responsible researchers 
were found guilty of unprofessional conduct, deceit and 
fraud, they attempted to defend themselves by claiming 
that they acted according to research customs practiced at 
the time, where consent was often not documented [120].
A more recent example of the citation of the Code sur-
faced in the Maryland US Court of Appeals’ August 2001 
decision in Grimes v. Kennedy Krieger Institute (KKI). KKI 
of the Johns Hopkins University was charged with expos-
ing poor black children to lead paint in order to test eco-
nomical abatement options during its study, Lead­Based 
Paint Repair and Maintenance Interventions, conducted 
during the 1990s [121]. In delivering its opinion, the Court 
stated, “Of special interest to this Court, the Nuremberg 
Code, at least in significant part, was the result of legal 
thought and legal principles, as opposed to medical or sci-
entific principles, and thus should be the preferred stand-
ard for assessing the legality of scientific research on hu-
man subjects. Under it, duties to research subjects arise” 
[121]. According to the Court, healthy children should not 
become participants in “non-therapeutic research” where 
there is no direct benefit to the child, even with consent 
from a parent or guardian [121]. This is a valid concern in 
research involving children, as they are a special protected 
research class. As such, consent from a parent or guardian 
does not necessarily constitute voluntary, informed, and 
understanding consent. Moreover, the court recognized 
that children involved in this study were especially vulner-
able as they were also economically disadvantaged. With 
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comparisons to Tuskegee, the Jewish Chronic Disease 
Hospital, and Nazi human experimentation, the Court in-
sisted: “These programs were somewhat alike in the vul-
nerability of the subjects; uneducated African American 
men, debilitated patients in a charity hospital, prisoners 
of war, inmates of concentration camps and others falling 
within the custody and control of the agencies conducting 
or approving the experiments. In the present case, chil-
dren, especially young children, living in lower economic 
circumstances, albeit not as vulnerable as the other exam-
ples, are nonetheless, vulnerable as well” [121, 122].
The legacy of the Nuremberg Code in the US
The Nuremberg Code emphasizes the protection of the 
individual’s rights and welfare through autonomy, hu-
man dignity and self-determination. These concepts are 
firmly rooted in the international human rights move-
ment, but are also values fundamental to the US, as es-
poused in the US Bill of Rights of the US Constitution. 
By embracing the Nuremberg Code’s view of the in-
dividual’s inviolability as sacrosanct, physicians and re-
searchers serve the interests of the individual human sub-
ject as well as the overall goals of society. An antidote to 
a mechanistic and atomized view of science and medi-
cine is to put the human rights agenda at the forefront, as 
the US judges attempted to do in Nuremberg. If US medi-
cine and its authoritarian roots were to embrace human 
rights as superseding scientific discovery, it would serve 
as a bulwark against the scientific thrust of depersonaliza-
tion–a thrust that contributed to the egregious torture and 
murder perpetrated by Nazi physician-researchers. Un-
fortunately, US history has provided evidence time and 
time again that abuses can occur when scientific inquiry 
and breakthroughs come at the expense of the individual. 
On this 70th anniversary of the Nuremberg Code and 
The Medical Trial, we remember the words of Elie Wiesel: 
“We must not see any person as an abstraction. Instead, 
we must see in every person a universe with its own se-
crets, with its own treasures, with its own sources of an-
guish, and with some measure of triumph” [96]. 
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In international debates on medical ethics, it is frequently 
assumed that due to the Nazi past, there are specific, re-
strictive positions regarding euthanasia, human subject 
research, and human reproduction in Germany. For ex-
ample, the author of an essay on “The Dilemmas of Ger-
man Bioethics” in the US-American political journal The 
New Atlantis wrote about the “burden of history” respon-
sible for the hesitancy to accept new biotechnologies in 
relation to medicine and human reproduction. Suppos-
edly, “Germany has enacted some of the strictest bioeth-
ics policies in the world” on euthanasia, experimentation 
with human subjects, and “manipulation of nascent hu-
man life” [123]. Others speak of the public discussion in 
Germany as being “haunted” by its past [124–126]. Thus, 
the impact of the Nazi past on present-day German de-
bates in medical ethics is widely taken for granted. It ap-
pears almost self-evident, and beyond the need for any 
further investigation into whether this impact is the 
same for all the fields of medical ethics named above, or 
whether the references to and consequences drawn from 
the past might potentially change over time [123, 126].
It is certainly true that the legal trials of the immedi-
ate post-war years and the public knowledge about med-
ical atrocities had profound repercussions on the field of 
medical ethics in Germany. However, recent historical 
work has amply documented that ethical positions and 
legal regulations in post-war Germany were not at all ho-
mogeneous and static, but changed considerably over 
time. In addition, ethical positions during the post-war 
period may not simply be characterised as restrictive for 
all the issues mentioned. Rather, the dynamics of change, 
and the factors influencing this change, were quite differ-
ent for the various issues at stake, be it questions of hu-
man subject research, end of life-decisions, or human 
reproduction [127]. One of the aims of this contribution 
is to illustrate that the story is much more complex than 
assumed in the stereotypic image of generally restrictive 
post-war German medical ethics, and that in order to 
more adequately understand the intricacies and dynam-
ics of the core bioethical issues, actors in the field should 
be aware of this complexity.
Overall, a historical account of post-war medical eth-
ics in Germany is far from being accomplished. It would 
have to look at five spheres of activities:
1. Debates in the public sphere
2. Strategies and statements of professional functionar-
ies
3. Informal “behind the scenes” activities of medical 
representatives, health  officials, and “moral authori-
ties” (e. g. theologians, philosophers)
4. Developments in the emerging sphere of institutional-
ised medical ethics
5. Developments in the legal sphere.
Until now, historical accounts have mainly focused on 
the second and the fourth sphere [127, 128]. The follow-
ing will go a step beyond this limited scope by addressing 
two aspects:
First, the focus is on the attempts of the profession 
in post-war Germany to construct a historical narra-
tive which accounts for the medical atrocities, and at the 
same time exonerates the majority of physicians and the 
medical profession. It will be argued that medical repre-
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sentatives to a certain extent succeeded in constructing 
such a narrative, and that this enabled the profession to 
sustain its comparably strong position in public debates 
and health policies.
Second, ethical and legal issues around human sub-
ject research will be addressed by sketching the link be-
tween one of the Nuremberg trials and a significant “be-
hind the scenes” discussion on the regulation and ethics 
of clinical trials at the end of the 1940s. This informal dis-
cussion, I argue, may have had a strong impact on the 
late enactment and quite liberal content of the German 
Pharmaceuticals Act of the 1960s.
An exonerating narrative of Nazi medical atrocities
In the immediate post-war years, representatives of Ger-
man physicians were deeply concerned about the impact 
of the atrocities committed during the Nazi period on the 
reputation of the medical profession. Already during the 
Nuremberg Medical Trial, in June 1947, the delegates of 
the West German Chambers of Physicians convened and 
discussed potential consequences and outlines for a fu-
ture code of conduct. They passed a pledge, the so called 
Bad Nauheimer Gelöbnis (Vow of Bad Nauheim), named 
after the location of the meeting. The pledge combined el-
ements of the Hippocratic Oath with very explicit and re-
strictive statements on abortion, sterilisation, euthana-
sia, and human subject research [129]. These norms quite 
clearly referred to the historical facts exposed during the 
Trial. The Vow in fact preceded the Declaration of Gene-
va of the World Medical Association by more than a year. 
It lacked, however, the core sentence of the Geneva Dec-
laration which proclaimed that the health of the patient 
is the supreme value to be pursued by the physician. In 
practice, the Vow was superseded by the later Declaration.
This remarkable pledge of 1947 has to be understood 
as a reaction of the representatives of the profession to 
the ongoing Nuremberg Medical Trial. The Trial and the 
parallel de-Nazification procedures of the Allies had a 
broader cultural dimension—beyond the sentences for 
a few individual physicians and functionaries; it seemed 
possible to quite clearly judge who was a guilty person, 
who had only been opportunistic, and who had been a 
victim. Thus, the process of confronting and analysing 
the past was primarily perceived as a legal problem, and 
therefore left to the courts. In the courtroom, complex 
and interrelated conditions and ramifications from the 
medical, the political, and the economic spheres were 
reduced to the singular question of individual culpabil-
ity. Such concentration on individual behaviour caused, 
or at least consolidated, an attitude according to which 
Nazi atrocities in general, and medical crimes in particu-
lar were the result of isolated, ideologically minded or 
even perverted fanatics. By prosecuting these individuals 
in court, it was implied that the burden of the past could 
be decreased little-by-little, and finally lifted [130, 131]. 
In this context of individualising responsibility, and 
identifying “real” Nazis, the organised medical profes-
sion succeeded in establishing a specific interpretation 
of the past which integrated three features: an explana-
tion for the atrocities, an exoneration of the profession, 
and a kind of condensed historical narrative. This inter-
pretation may be summarised as follows: With the Nazi 
takeover in 1933, medicine and healthcare fell victim to 
the new regime. Nazi ideology was imposed from out-
side—namely the realm of politics—onto the profession 
and led to the atrocities of forced sterilisation, system-
atic patient killings and forced human subject research. 
Those physicians who were actively involved were few, 
and they were fanatic Nazis. In sum, following this inter-
pretation, medicine was instrumentalised and abused 
for the ideological agenda of the regime [130, 132].
The implicit message of this historical narrative and 
explanatory model was that medicine itself was intrinsi-
cally apolitical, imbued with a clearly-defined, pre-exist-
ing and supposedly universal medical ethos which was 
contaminated by the intrusion of outside political forces. 
One of the supposed lessons was that in the future, phy-
sicians should defend their autonomy against infringe-
ments from external political instances.
This historical narrative served obvious purposes. 
However, already during its emergence in the late 1940s, 
it was not consistent with available historical knowledge 
[132]. Nevertheless, it met with strong resonance in the 
public sphere. In the next decades, medical function-
aries, such as the successive presidents of the German 
Chamber of Physicians (Bundesärztekammer), used this 
narrative when they were confronted with medicine’s 
Nazi past, or in contexts where they sought to avert pol-
icies which appeared to threaten the supposed autono-
my of the profession [132]. Only in 2012 did the German 
Medical Assembly (Deutscher Ärztetag) formulate an of-
ficial statement, based on up-to-date historical evidence, 
acknowledging the responsibility of physicians for medi-
cal atrocities, and urging for continuous self-reflection on 
the frailties of and temptations for physicians [132, 133].
Regulating human subject research
The period immediately following the Nuremberg Trials 
was marked by attempts to “normalise” medical activities 
in the realm of both clinical services and research. In this 
context, medical researchers were not only concerned 
with their public image regarding the ethics of their ac-
tivities; they were also eager to safeguard their scope of 
action and to prevent the state from insisting on—as they 
perceived it—too narrow limitations of human subject 
research. The Guidelines for Human Subject Research 
(Richtlinien für neuartige Heilbehandlung und die für Vor­
nahme wissenschaftlicher Versuche am Menschen) were 
an important document in this context. These Guide-
lines had already been proclaimed by the Reich Ministry 
of the Interior in 1931, and they were in force throughout 
the Nazi period as well as in post-war Germany until the 
early 1960s [19]. They did not constitute direct legal rules 
for medical research activities, but rather specified exist-
ing legal norms regarding the behaviour of physicians, 
thus setting standards for carrying out human subject re-
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search, similar to the formula “the state of science and 
technology” used in the context of technology law [19].
As documented by a significant “behind-the scenes” 
discussion, these Guidelines were seen as an obstacle 
for proper research in the immediate post-war years. The 
discussion is documented in the correspondence be-
tween Heinrich Hörlein, representative of the pharma-
ceutical company IG Farben/Bayer Leverkusen, and Paul 
Martini, professor of internal medicine at Bonn Univer-
sity Medical School [134: 139–46].
Hörlein was not only the director of pharmaceutical 
research at IG Farben/Bayer Leverkusen, a member of the 
managing board of the IG Farben enterprise and member 
of the Reich Health Council during the Nazi period; he 
had also been one of the defendants at the Nuremberg IG 
Farben Trial in 1947/48 (which followed the Medical Tri-
al) where he was accused of involvement in human ex-
perimentation in concentration camps and responsibili-
ty for the development and production of war chemicals. 
In 1948, he was acquitted due to lack of evidence that he 
had been aware of the production of Zyklon B or the atro-
cious experiments [19].
Martini, on the other hand, had kept some distance 
from the more active party members on the academic 
staff at Bonn University Medical School during the Nazi 
period. In the immediate post-war, he was the first pres-
ident of the German Association of Internal Medicine. 
Martini was also the author of the reference work on 
the methodology of clinical trials, the second edition of 
which had been published in 1947 [134, 135].
In a letter to Martini, dated 17th May 1949, Hörlein 
wrote:
“[…] on page 10 of your Methodenlehre I read that for 
a [methodologically sound] trial of new drugs, to ex-
clude psychological factors it is essential that the set-
ting include a ‘blind’ application, that is, an intake by 
research subjects without their knowledge” (quoted in 
[19: 43].
This, Hörlein argued, was in contrast with paragraph 
five of the Guidelines from 1931 (the paragraph referring 
to informed consent). Hörlein went on: 
“This discrepancy played a role in the IG Farben Tri-
al in which I […] was to be branded a war criminal. 
[…] It took two expert witnesses […] to clarify to the 
Court the difference between an experiment and a 
clinical trial [which entailed a potential benefit for 
the research subject, but where, for reasons of meth-
odology, consent was not obtained]. Fortunately, the 
Court did not know the Richtlinien, otherwise my situ-
ation would have been even more difficult. Resulting 
from this experience, I see in the Richtlinien a certain 
risk for clinicians involved in trials of new drugs that 
should be eliminated” [19: 43].
In his response to Hörlein, Martini wrote:
“You are certainly right that article five represents such 
a trap [Fussangel]. It contradicts our present modus 
procedendi, and if one would adhere to this rule, this 
would imply a severe hindrance for clinical therapeu-
tic research. I have considered what should and could 
be done to solve this problem. The present situation is 
perhaps not yet well suited to attack article five. Cer-
tainly, a step in this direction would not be helpful and 
would meet with critical resonance in the public. But 
in general I am aware that something has to be done, 
and I shall approach the Ministry of Social Affairs […] 
Since this is an issue regarding research, I shall put 
this on the agenda of the German Research Council 
(Deutscher Forschungsrat)” ([19: 44].
For this kind of activity, Martini was in a privileged po-
sition; the new German federal government was estab-
lished in Bonn in 1949, and as full professor and direc-
tor of the University Department of Internal Medicine, 
he had both official and private access to members of 
the new political establishment. In particular, he was the 
personal physician of Konrad Adenauer, the first chan-
cellor of the Federal Republic. Like the Nobel laureates 
Werner Heisenberg and Adolf Butenandt, Martini was 
also a member of the newly established German Re-
search Council, where he represented clinical medicine 
[19]. In a further letter, a few weeks later, Martini wrote:
“[…] I am […] convinced that it will become necessary 
to correct the Richtlinien. They are really not com-
patible with clinical research, and for everybody who 
takes the Richtlinien seriously, such research is un-
dermined. However, I am of the opinion that the pre-
sent time is not suitable—for two reasons: On the one 
hand, as a result of the experiences during the Nazi 
period, the minds are still so unfavourably sensitised 
that it would be easy for anybody, be it in government, 
or the parliament […] to impede a change to the regu-
lations. On the other hand, I am convinced that it will 
become ever more obvious in the near future in Ger-
many that any unjustified restriction of research will 
also have most serious economic consequences […]” 
[19: 45].
Thus, with this exchange, we have two protagonists 
in the field of clinical research in the early post-war pe-
riod who—in spite of Nazi medical atrocities—agreed 
that the existing regulations for human subject research 
should be liberalised. Further research is needed to ana-
lyse the exact impact of this discussion between Hörlein 
and Martini.
There is additional evidence for similar reservations 
towards the Guidelines amongst clinical researchers. 
This is documented in an unpublished survey amongst 
university professors of paediatrics regarding their evalu-
ation of the Guidelines in the mid-1950s. It shows that an 
overwhelming majority of these professors considered 
the Guidelines to be a hindrance for clinical research and 
that they were in favour of revising them.
In view of this very critical attitude of leading physi-
cians to the existing restrictive regulations of clinical tri-
als in the 1940s and 50s, it is perhaps not surprising that 
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the Federal Republic was the last member state of the Eu-
ropean Economic Community (later to become the EU) 
to introduce a national law regulating the admission of 
new pharmaceuticals to the market. The Treaty of Rome 
from 1957 had made it a requirement that all member 
states introduce such a law, which happened for exam-
ple in the Netherlands already one year later, in 1958. In 
contrast, in Germany, the national Pharmaceuticals Act 
(Arzneimittelgesetz) was passed only in 1961, and as re-
gards the conditions for the admission of new drugs, it 
was exceptionally liberal. It only required that the phar-
maceutical company registered the new compound with 
the responsible state agency, without any necessity of 
preceding clinical trials on the efficacy, efficiency, or 
side-effects of the drugs—a requirement which was es-
sential at the time, for example, according to the regula-
tions of the US Food and Drug Administration, and also 
according to the Dutch pharmaceuticals Act [136, 137: 
247–51]. In stark contrast, the producer of a new com-
pound in Germany was only expected to submit a report 
of experiences (Erfahrungsbericht) on problematic side-
effects, compiled by physicians employed by the compa-
ny. Since, according to the law, human subject research 
to test new drugs was not required, the Richtlinien with 
their strict rules regarding informed consent were in ef-
fect bypassed.
Conclusion
In the preceding, I have argued that since the early post-
war period, the German medical profession has managed 
to establish an interpretation of Nazi medical atrocities 
that combined a specific kind of historical narrative with 
an exoneration of physicians and the profession in gen-
eral. This interpretation of the past shifted the responsi-
bility for the atrocities to forces external to medicine, in 
particular to the sphere of politics. Allegedly, only a few 
fanatic Nazi doctors violated the alleged eternal medical 
ethos, whereas the majority had suffered from the sup-
posed political intrusion.
This exculpatory narrative was widely accepted in pub-
lic and helped the profession to continue its role as a cen-
tral player in matters of healthcare policies and research 
regulation—much more so than in the United States, for 
example [136]. The strong public status of the profession, 
its proclamation of physicians’ autonomy, combined 
with state support and an openness to the interests of the 
pharmaceutical industry resulted in comparatively late 
and liberal legal norms regarding the admission of new 
drugs which sidestepped the existing restrictive rules for 
human subject research.
Thus, it has been demonstrated that the image of gen-
erally restrictive bioethical positions in post-war Germa-
ny as a consequence of the Nazi past is a significant over-
simplification. The situation is much more complex, and 
in order to more adequately understand the intricacies 
and dynamics of the core bioethical issues, actors in the 
field should be aware of this complexity. This knowledge 
may also help to increase public understanding of and 
engagement in an informed and nuanced bioethical de-
bate today.
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Introduction: The focus of this article is the influence 
of Nazi medical crimes, especially euthanasia killings 
and human experiments, on the medical practice and 
discourse in Palestine and later the state of Israel. I ar-
gue that the Nuremberg Medical Trial and Nazi medical 
crimes had and still have very little impact on Israel and 
its medical establishment. In the 1950s and the 1960s, 
only a small group of physicians—mainly Holocaust sur-
vivors—were interested in the trial and tried to promote 
a local discussion about Nazi medical crimes. Moreover, 
even today, Israel does not have a specific law regarding 
medical experiments on human beings and all regula-
tions on the subject are based on ordinances related to 
public health matters [138]. This is surprising given that 
Jews were one of the main victims of Nazi ideology and 
one of the groups subject to Nazi medical experiments. I 
will first describe historical developments leading to this 
state of affairs and then offer possible explanations.
First Attempts: News of medical crimes carried out by 
German doctors against helpless individuals reached 
doctors in Palestine almost as the crimes were commit-
ted. For many doctors from the Jewish local community, 
who received their medical education in German insti-
tutions, this terrible phenomenon was felt on a personal 
and professional level. In autumn 1942 the Hebrew Med-
ical Association asked publicly: “What is the worth of our 
achievements in the medical field, if the grandchildren 
of Virchow and Loch and their students are part of these 
horrors? Where is the hope if in the 20th century the 
beast takes over and controls human actions?” [139: 349].
The central objective of doctors’ organizations in Pal-
estine following the end of WWII was to ensure that Nazi 
doctors guilty of medical crimes would stand trial, and 
that post-war German medical professionals would not 
be welcome in international medical forums. As early as 
1946, doctors in Palestine were already demanding that 
German doctors not be granted membership into the re-
cently formed World Medical Association (WMA) [140]. 
The rationale behind this demand was that even if only a 
few German doctors had actually committed crimes, the 
others had been aware of them, and had kept quiet. Since 
the German medical establishment did not express any 
regret over its involvement in Nazi crimes, demands per-
sisted to prevent German doctors from joining interna-
tional medical associations until the arrival of a new gen-
eration of doctors that had no connection to the crimes 
perpetrated during the Second World War.
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In 1945 the Hebrew Medical Association called to 
“punish the Nazi physicians, who violated the profession 
of medicine, who were active in the various death camps 
and concentration camps. […] for not alleviating the suf-
fering of the victims and to their disgrace, they assisted 
perpetrators, the rulers of the camps, and exploited the 
disaster to ‘expand their medical experience’ ” [141: 1025].
However, the Nuremberg Medical Trial (NMT) re-
ceived rather scarce media coverage in Palestine. The 
Hebrew Physician’s Union’s newsletter published part of 
the indictment issued by Chief Counsel Telford Taylor at 
the NMT on October 25, 1946. In July of 1947, the Israel 
Medical Association (IMA) published the charges against 
the doctors on trial in the periodical Letter to a Friend, 
providing details on the experiments carried out by the 
accused, which included malaria, mustard gas, sterili-
zation, typhoid-fever, phosphorus, toxins, and simula-
tions of high altitudes and low temperatures. The piece 
was published six months after it was presented in court 
in Nuremberg.
The first occasion on which the Hebrew association 
attempted to bring Nazi physicians to trial and to pre-
vent German medical participation in international pro-
fessional forums was the World Medical Association’s 
first international conference in September 1947 in Par-
is. Mark Dvorjetski, a physician and Holocaust survivor 
[142, 143: 126–32], asked his fellow medical profession-
als to “show courage and investigate the crimes conduct-
ed in the name of medical science and to use all means 
it has to prevent its reoccurrence, and to declare a boy-
cott against the murderous physicians” [144: 1538]. The 
Jewish delegation demanded that German physicians be 
denied membership in the new organization for a period 
of a whole generation; this effort was, ultimately, unsuc-
cessful.
Despite these attempts, public awareness of the NMT 
and other related trials was minimal and limited to the 
symbolic level. The medical community in Palestine 
and later Israel paid very little attention, if any, to the 
trials. For example, in 1945 a proposed ethics codex of 
the Hebrew Medical Association in Palestine included 
traditional topics of medical ethics, such as physicians 
etiquette and self-advertisement, but nothing on eutha-
nasia and medical experimentation on humans. Another 
example is a special issue on the health and sanitary situ-
ation of Jews in the ghettos, published a few months be-
fore the NMT in Dapim Refuiyim, the professional jour-
nal of the General Sick Fund of the Hebrew Workers in 
the Land of Israel [145]. The publication was based on 
firsthand testimony from Jewish physicians. However, 
there was not a single reference to Nazi medical crimes in 
the whole issue. Instead, it underlined the courage and 
activity of Jewish physicians under inhumane conditions 
in the ghettos.
After the foundation of the state of Israel in 1948, it was 
still the involvement of a few engaged physicians—and 
not collective action—that brought Nazi medical crimes 
to the public’s attention. The second time that the Israeli 
Medical Association made a statement on Nazi medical 
crimes was a declaration issued during the second World 
Congress of Jewish Physicians in August 1952. The so-
called “Jerusalem Declaration” was again the outcome of 
Dvorjetski’s efforts to discuss Nazi medical experiments 
at the conference [146].
The declaration included references to ‘euthanasia’, 
compulsory sterilization, the moral and physical degen-
eration of humans by terror and deprivation, and crimi-
nal medical experiments. The declaration stated that “no 
one is granted the right to sacrifice any human being for 
scientific ends” calling to “consolidate anew the founda-
tion of medical consciousness: no physician is permit-
ted, under any circumstances to utilize scientific ends for 
the destruction and damaging of human beings” [146].
Comparing the Nuremberg Code to the “Jerusalem 
Declaration” reveals a number of crucial differences. In 
general, the declaration addresses Nazi medical crimes 
in a much broader and more inclusive way than the 
Nuremberg Code. It prioritizes ‘euthanasia’, which is ful-
ly absent from the Nuremberg Code. Second, it refers to 
eugenics and compulsory mass sterilization. And third, it 
distinguishes between physiological experiments for the 
sake of science and therapeutic trials. On the other hand, 
the principle of informed consent, which is central to the 
Nuremberg Code, is not mentioned at all. Thus, where-
as the Nuremberg Code focused on physicians’ attitudes 
towards their patients in order to quickly legitimize and 
regulate contemporary medical experiments, the “Je-
rusalem Declaration” aimed to awaken the ethical con-
sciousness of Jewish physicians.
During the first twenty years of Israel’s existence, med-
ical discourse on Nazi medical crimes was characterized 
by two main points. First, the recognition of the medical 
crimes as universal; they were considered crimes against 
all of humanity, not just against Jews. Thus, the crimes 
had left a stain on medical science and had to be studied 
to serve as a warning for future generations. Second, a 
consensus that the Nazi medical experiments had lacked 
a sound scientific base, and were therefore completely 
worthless to medical science. In this context, Israeli doc-
tors prepared for the day a German doctor might attempt 
to present findings from Nazi medical experiments as if 
they were the results of legitimate medical studies [147: 
102; 148].
New Tendencies: Despite the large number of Holo-
caust survivors in Israel and the centrality of the Holo-
caust in the Israeli collective memory [149–151], the in-
fluence of ethical questions stemming from Nazi medical 
crimes on medical discourse in Israel was minimal. The 
Nuremberg Medical Trial, and the resulting Nuremberg 
Code had no immediate impact, and the majority of Is-
raeli doctors remained indifferent to the topic. Fewer 
than 30 articles on the subject of medicine and the Holo-
caust were published in local medical journals between 
1946 and 1986, and there was no attempt to examine the 
influence of Nazi medical crimes on Israeli medical prac-
tice [152]. The topic was kept alive by a few figures, who 
eventually failed to awaken a more general discussion 
on the implications and consequences of Nazi medical 
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crimes on post-war medical practice within the Israeli 
medical community [153].
During the 1980s there was growing interest in both 
medicine during the Holocaust and in bioethics. Howev-
er, these interests did not develop in relation to each oth-
er. Bioethics began to be included in curricula at Israeli 
medical schools, although much of the focus was on the 
legal aspects of the field. Medicine and law, or law and 
bioethics, were taught at all medical schools, mostly as 
elective courses. Simultaneously, official bioethics bod-
ies were established: The Ministry of Health founded a 
supreme ethics committee, primarily focusing on studies 
conducted on humans. The Israel Medical Association 
(IMA) transformed its ethics board, which had previous-
ly focused on doctors’ misleading the public or engaging 
in prohibited advertising practices, into an organization 
dealing with bioethical principles, and issued position 
papers on a variety of related subjects.
In addition to the official entities already mentioned, 
other Israeli organizations were created to deal with 
bioethical issues. The Unit for Genetic Policy and Bioeth-
ics at the Gertner Institute of the Sheba Medical Centre 
is one of several departments of bioethical studies estab-
lished at various universities, either within the respective 
medical schools, as at Ben Gurion University, or as part 
of the law department, as at Haifa University.
In 2008, the IMA published a book that focused on 
medicine and the Holocaust, originally initiated by Tomi 
Spenser. The work consolidated all publications in IMA 
medical journals on the subject [154]. Spenser’s work, 
however, did not address modern ethical questions, or 
discuss possible implications of Nazi medicine for pre-
sent-day medical practice.
Interestingly, the introduction of a medical ethics text-
book published in 2010 by the Israel Medical Associa-
tion contains an explicit reference to the Holocaust: “The 
Declaration of Helsinki  … which constitutes one of the 
central pillars of medicine’s ethical code, determines the 
basic ethical guidelines for experiments on human be-
ings … as a reaction to the horrific actions of Nazi doctors 
that conducted experiments on humans” [155]. There 
is, however, no further mention of the Holocaust in the 
book.
The explanations: How does the shadow of the Holo-
caust affect bioethical discourse in Israel? How have Is-
raeli medical professionals and bioethicists related to 
Nazi medical crimes, in terms of possible implications 
for modern medicine? 
As our short examination of medical discourse in Is-
rael between the 1940s and the 1990s reveals, Nazi med-
ical crimes (including the ‘euthanasia’ killings), hardly 
played a role in discussions on issues of medical ethics in 
Israel. Only a small group of doctors, comprised mostly 
of Holocaust survivors, tried to promote the discussion 
of Nazi medical crimes in the context of moral and ethi-
cal questions in medicine. However, they only dealt with 
a specific aspect of the subject, mainly focusing their ef-
forts on documenting Nazi medical crimes and ensur-
ing the pursuit of justice. Questions regarding the possi-
ble influence of the Nazi crimes on Israeli medicine were 
largely ignored.
How can we explain this marginality, especially since 
the Holocaust plays such an important role in Israeli cul-
ture and history? The obvious answer is that Israeli doc-
tors were among the victims of the crimes, and not the 
perpetrators. As victims, they did not feel the need to ask 
themselves uncomfortable questions about their own 
practices. This answer is, however, too simple. 
It is possible that the almost all-encompassing disre-
gard of Nazi medical crimes stemmed from the emergen-
cy situation that the Israeli health system was forced to 
deal with during the first decade of its existence–primar-
ily the massive wave of immigrants to Israel from Europe 
and Arab nations, many of whom were in need of medi-
cal treatment [156]. It is possible that under such circum-
stances discussions of bioethics were viewed as unnec-
essary.
It is also possible that the disregard stemmed from the 
fact that Israeli medicine, which was originally strongly 
influenced by German medical practice, gradually shift-
ed to be more in line with the American medical com-
munity, particularly in the field of medical study. On 
this basis, Israeli doctors perhaps viewed these issues as 
something in the past, and not something they had a re-
sponsibility to consider.
Another possible explanation is that in Israel, bioethi-
cal discussions began relatively late, despite the fact that 
it is one of the most advanced nations in terms of medical 
technology [157, 158]. By the end of the 1980s and begin-
ning of the 1990s, however, Nazi medicine began to fig-
ure more prominently in Israeli medical discourse, as a 
result of changes at a local and international level. Israe-
li doctors began to understand that the events that oc-
curred during the Holocaust had ramifications for the 
present [152]. Between 1986 and 2006, roughly 30 articles 
on medicine and the Holocaust were published in Israe-
li professional medical journals–the same number of ar-
ticles that had been published during the first four dec-
ades following the Second World War. Another 11 articles 
on topics related to medicine and the Holocaust have 
been published in the IMA journal since 2007, and these 
include themes such as Jewish medicine in Poland dur-
ing the Holocaust, the liberation of the Bergen-Belsen 
concentration camp and the absorption of medical ref-
uges in Israel after the war.
Today, awareness of the subject is more widespread 
due to the efforts of a small, dedicated cadre of doctors 
that initiated conferences, compiled anthologies, and 
lectured on the subject at Israeli medical schools. Thanks 
to their work, the topic of medicine and the Holocaust 
began to enter the curricula of various medical schools 
in Israel. The Rappaport Faculty of Medicine at the Tech-
nion in Haifa now offers a course entitled The Holocaust 
and Medicine—A Medical Education Agenda, which was 
originated by the late Tomi Spenser. The ethics and Holo-
caust program at the International Centre for Health, 
Law and Ethics at the University of Haifa is another ex-
ample, as are the courses on humanism and the Holo-
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caust, which are taught at Tel Aviv University’s medical 
school [159].
A course on medicine and the Holocaust developed by 
the historian Daniel Nadav was broadcast on Israel’s na-
tional Army Radio, and also led to a book [160]. Recent-
ly, the Israeli Defence Forces’ Medical Corps has begun 
sending doctors, both those serving in compulsory and 
in reserve capacities, on tours of death camps in Poland 
to engage in bioethical discussions. According to an arti-
cle published in the Journal of Medical Ethics in Decem-
ber 2010, discussions during the tours addressed sub-
jects such as the wellbeing of the individual in the face 
of the common good, questions of how best to allocate 
limited medical resources, and the problematic aspects 
of experimentation on human beings.
In contrast to the prevailing discussion in the field of 
medicine in the United States, the connections drawn in 
Israel between medicine and the Holocaust generally do 
not refer to bioethics. In the event that ethical questions 
do arise, they are generally presented dichotomously—
the Nazi doctors, who lost their humanity, as opposed 
to the Jewish doctors, who continued to perform their 
duties under the most extreme circumstances in ghet-
tos and camps—, and the discussion generally does not 
touch upon possible connections between Nazi medi-
cine and “normal” medicine. Also left out of the discus-
sion are current, relevant bioethical issues of the 21st 
century in Israel, such as bioethics during wartime, the 
bioethical aspects of medical research on humans, in-
cluding soldiers, and the bioethical aspects of public 
health during emergency situations.
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The Nuremberg Medical Trial (NMT) was a singularly im-
portant event in the history of medicine. Despite the fact 
that the trial included only a small number of accused, 
the resultant Nuremberg Code has had an enduring im-
pact that will continue for generations to come. The sev-
en decades since the NMT have revealed many secrets 
that were purposely withheld, secrets involving the trans-
gressions of university professors and senior and inter-
nationally respected researchers, many associated with 
the prestigious Kaiser Wilhelm Research Society (KWG). 
A notable example of this was in 1989 with reports from 
Germany that uncovered the exploitation of the brains of 
murdered victims of the Nazi ‘euthanasia’ programmes 
by scientists associated with two of the world’s foremost 
neurological/psychiatric research institutions: the Max 
Planck institutes of Brain Research in Frankfurt a Main 
(MPIBR) and the renowned Munich-based Institute of 
Psychiatry (MPIP). The historian Götz Aly, in a paper pub-
lished in German in 1986, showed that scientists at the 
two institutes—originally known as Kaiser Wilhelm insti-
tutes—were well aware of the killing programme and ac-
tively pursued the acquisition of brain specimens which 
remained in the collections of the respective institutions 
for decades after the war [161–164]. Despite a widely pub-
licised memorial service in 1990, the Max Planck Society 
(MPS), which is the successor to the Kaiser Wilhelm Soci-
ety (KWS), revealed in April 2015, that specimens thought 
to have been buried in 1990 had been recently discovered 
in the archives of the Munich psychiatric institute and 
the main archives of the MPS in Berlin [165, 166]. 
Aly’s original research, and the subsequent reports 
and commentary [163, 164], focused on two individuals; 
professors Julius Hallervorden and Hugo Spatz, both in-
ternationally renowned neuroscientists and leaders of 
the Kaiser Wilhelm Institute for Brain Research (KWIBR) 
during the Nazi period who were linked with the exploi-
tation of the brain specimens from the murdered ‘eutha-
nasia’ victims. Hallervorden and Spatz’s names are hon-
oured by an eponym that marks their discovery of a rare 
neurological disorder identified through their collabora-
tive research at the German Psychiatric Research Insti-
tute (DFA) and published in 1922. 
Due to the 1989 reports, along with documentation on 
Hallervorden and Spatz’s role in the crimes of the Third 
Reich, increasing efforts were made to remove their 
names from the honorific designation and to substitute it 
with a neutral clinical/scientific term. The ensuing con-
troversy led to revelations involving other physicians and 
scientists associated with nefarious activities during the 
Third Reich whose names are similarly honoured. The 
discussion also provoked a questioning of the value of 
eponymous designations in general, including alterna-
tive approaches to the problem [7, 167–176]. Some, in-
cluding this author, believe that such “tainted” eponyms 
should continue in their original form [177, 178]. 
Building on the views of Whitworth, Zaller and Hilde-
brandt, this paper argues that “medical” eponyms rep-
resent a complex intellectual and historical construct 
within the culture of medicine that should continue, ir-
respective of the reputation or malfeasance of those they 
honour. The construct of the eponym references not only 
the names of the honouree(s), but also the context of their 
work; the impact of the discovery; the historical circum-
stance of the research, including the history of the insti-
tution or organisation in which the designated discovery 
occurred; and the life career path of the honourees. It is 
the thesis of this paper—and something which has also 
been considered by others—that irrespective of evidence 
of malfeasance, the eponym should not be changed, but 
its continued use includes an obligation to document 
the history of malfeasance as evidence of an historical 
truth that must not be forgotten. It is proposed that this 
be done through the required use of a footnote that doc-
uments the scientific discovery and the misdeeds of the 
honourees, including the responsible research bodies, 
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sponsors and funders and a dedicated tribute to the suf-
fering of the victims. 
The tainted eponym: Hallervorden-Spatz disease
While Hallervorden-Spatz disease may be a rare and ob-
scure disorder, it represents an important example of 
the effort to change a well-established eponym because 
of the malfeasance of the individuals after whom it is 
named. An important consideration is the role played 
by two world-renowned scientific institutions: the Mu-
nich-based German Research Institute for Psychiatry 
(Deutsche Forschungsanstalt für Psychiatrie, DFA), and 
the Institute for Brain Research in Berlin. Established in 
1917, the DFA became part of the Kaiser Wilhelm organi-
sation (KWG) in 1924 and became the Kaiser Wilhelm In-
stitute of Psychiatry (KWIP) [179]. The roles of the Munich 
and Berlin research institutions, including the parent or-
ganisation (KWG), were pivotal, not only in the careers 
of these two scientists, but also for the critical part they 
played in the Nazi programmes of eugenics, racial hy-
giene, ‘euthanasia’, human exploitation for pre-mortem 
experimentation and post-mortem research, and mass 
extermination.
The nexus begins with Alois Alzheimer, includes the 
Nazi period, and extends up until today. In 1903, Alz-
heimer relocated from Frankfurt to join Professor Emil 
Kraepelin at the Department of Psychiatry at the Uni-
versity of Munich where he directed the Anatomisches 
Laboratorium der Psychiatrischen und Nervenklinik. 
Kraepelin and his colleagues in Munich represented the 
foremost psychiatric research team in the world [180]. 
The research that brought distinction to Julius Haller-
vorden and Hugo Spatz took place in the same clinical 
and research tradition founded by Prof Emil Kraepelin. 
It was also in the multidisciplinary research environment 
established by Kraepelin at the University of Munich that 
Alzheimer completed his histopathological studies on 
the brain of his former patient from Frankfurt, August 
D., in investigations that formed the basis of his first re-
ports on dementia. It was Kraepelin who, unbeknownst 
to his colleague Alzheimer, coined the eponym “Alzhei-
mer disease” or “Morbus Alzheimer,” by incorporating it 
in a new section of the 1910 edition of his textbook of psy-
chiatry [181].
Whereas the Hallervorden-Spatz eponym, almost a 
century after its discovery and designation and despite 
its rarity, is immersed in controversy, the designation 
“Alzheimer’s disease” has become an immutable uni-
versal eponym embedded within the language and dis-
course of human society.
When Alzheimer left Munich in 1912, he was suc-
ceeded by his colleague, the neuropathologist Walther 
Spielmeyer, who had recently moved to Munich from the 
University of Freiburg. In 1917/18, Spielmeyer shifted to 
Kraepelin’s newly founded DFA, where he was joined by 
Franz Nissl, who had given up the Chair in Psychiatry in 
Heidelberg to join Kraepelin and colleagues in Munich 
[182]. Alzheimer and Spielmeyer’s “Laboratorium” had 
been the functional antecedent to the “Laboratorium” of 
the DFA at the time of Hallervorden and Spatz.
The DFA was a relatively independent and well-funded 
research institute. Like Alzheimer before him, Spielmeyer 
attracted a number of researchers who joined him in Mu-
nich [183]. In 1919, Hugo Spatz joined the DFA, where he 
would remain for eighteen years. His interest in neuropa-
thology arose from his student days in Heidelberg, where 
he had worked in the laboratory of Franz Nissl. In 1921, 
Spatz collaborated with Julius Hallervorden, who had 
come to Munich on a research fellowship at the invitation 
of Spielmeyer [184]. Hallervorden brought with him the 
brains of two patients who had died of a severe disabling 
neurological disorder. A pathological examination of the 
patients’ brains identified previously unknown findings, 
specifically iron deposits in the corpus pallidum and re-
ticulate zone of the substantia nigra. Hallervorden and 
Spatz reported their results in 1922 [179]. There is nothing 
to suggest that Hallervorden and Spatz’s research which 
resulted in the eponym was unethical [168]. Rather, the 
attempt to retroactively remove their names is because of 
events that took place after their appointments in 1937 to 
the leadership of the KWIPBR in Berlin-Buch.  
After completing his research fellowship at the DFA, 
Hallervorden returned to his position as a physician 
at the Landsberg/Warthe Hospital and Sanatorium. In 
1929, Hallervorden assumed the directorship of the Cen-
tral Pathological Department of the Psychiatric Institu-
tions for the state of Brandenburg. Hugo Spatz remained 
at the Munich institute until 1937, when he accepted the 
appointment as successor to Prof Oskar Vogt as the direc-
tor of the renowned KWIBR. Soon after, he invited Julius 
Hallervorden to join him as director of the Histopatholog-
ical Department and deputy director of the KW institute. 
The conditions for Hallervorden’s appointment included 
the transfer of the administrative responsibility from his 
previous position to the KWIBR. In 1938, the laboratory of 
the Brandenburg State Institution was moved from Pots-
dam to the state hospital at Brandenburg-Görden, where 
it became a critical link between the killing of patients 
and the study of their brains by the KWIBR [185].
The KWIBR had its origins in a small neurological re-
search institute in Berlin that had been established in 
1898 by Oskar Vogt, together with his French-born neu-
ropathologist wife, Cecile. Then known as the Zentral­
station, in 1902 the Vogts’ institute was incorporated 
into the University of Berlin under the name Neuro bio­
logisches Laboratorium der Universität Berlin. In 1914, 
the “Laboratorium” became part of the prestigious Kai-
ser Wilhelm organisation. In 1931, an expanded KWIBR, 
the largest and most preeminent of its kind in the world, 
was opened in the Berlin suburb of Buch. The expand-
ed KWIBR received support from the Krupp family, the 
German Reich, the State of Prussia, the City of Berlin and 
the Rockefeller Foundation (RF). The RF funded the con-
struction costs of the new institute [186, 187]. 
According to Sachse, the KW institute’s structures 
were modelled on the Rockefeller Institute for Medi-
cal Research. The RF provided a majority of the funding 
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for five KW institute’s, including the Munich KWIP and 
four Berlin based KWI’s: Brain Research, Cell Physiol-
ogy, Physics and Foreign and International Private Law. 
The RF funded a “Genetic Index of the German People” 
coordinated by Prof Eugen Fischer, the director of the 
KWI for Anthropology, Human Genetics and Eugenics. 
RF funding for projects in Nazi Germany was suspended 
in 1935 following public criticism in the United States 
[188, 189]. 
Due to a prolonged conflict over leadership style and 
differing political views following the rise of the Nazi re-
gime, Oskar Vogt was forced into retirement. Oskar and 
Cecile Vogt’s successors, Hugo Spatz and Julius Haller-
vorden, were more accommodating towards the Nazi re-
gime. Hugo Spatz was an officer in the Luftwaffe and di-
rected a satellite department of the KWIBR that focused 
on brain injuries in the air force. A total of 3335 brains 
of Luftwaffe personnel who had died from brain injuries 
were sent to the satellite unit. The KWIBR, Spatz in par-
ticular, was the probable recipient of the brains of victims 
of low-pressure experiments performed on prisoners at 
the Dachau concentration camp [185].
The KWIBR formed the link in a network of neuro-
pathologists, who exploited the Nazi ‘euthanasia’ kill-
ing programmes to acquire brain specimens for the in-
stitute [190]. Hallervorden attended the actual killing 
centre where victims of the Aktion T-4 ‘euthanasia’ kill-
ings were murdered in gas chambers disguised as shower 
stalls [191] and had a neuropathology laboratory at the 
large psychiatric hospital of Brandenburg-Görden where 
the brains of ‘euthanasia’ victims were processed. 
Evidence of this activity was provided by Prof Haller-
vorden himself shortly after the end of the war [192, 193]. 
It is unlikely that Hugo Spatz, as the overall director of 
the KWIBR, would have been unaware of the KWIBR’s in-
volvement in the exploitation of the victims of the ‘eutha-
nasia’ killings. Whereas the vast majority of victims were 
non-Jewish, the neuropathologist and documentarian of 
neuropathology in Nazi Germany, Prof Jürgen Peiffer, in 
a personal note to the author dated April 2nd, 1998, re-
ported:
“I found in old correspondence of the Hallervorden-
Institute in Frankfurt a list of nearly 200 names of Yewish 
(sic) people, mostly from the Warschau Ghetto [sic], some 
from Lublin, all with the clinical diagnosis of ‘Fleckfie-
ber’ (epidemic louse-borne typhus). The brains were ex-
amined by Hallervorden, but all protocols and other no-
tices are failing [sic], probably destroyed after the war. I 
sent the list to Prof. Tych in Warschau, but did not get any 
answer til now. … In the files of the Max Planck Institute 
of Psychiatry in Munich I found one Yewish name among 
the victims of euthanasia (Leo ‘Israel’ Seligsber ger, 21 
years old, coming from the Schönbrunn institution to 
Eglfing-Haar, the killing place)” [194].
Despite the bombing of Berlin, Hallervorden and 
Spatz were able to save the collection of brain specimens 
as well as some of the equipment, which were moved to 
the Western Sector of Germany. In 1947, Hallervorden 
relocated his department and its collection to Dillen-
burg. According to Wässle “… in 1949 the departments of 
Spatz and Hallervorden were transferred then to the Max 
Planck Society as the Max Planck Institute for Brain Re-
search (MPIBR) and moved to the University of Giessen 
Physiological Institute”. The MPIBR remained at the Uni-
versity of Giessen until 1959, with both scientists being 
granted academic appointments by the university’s med-
ical faculty. The brain specimens eventually found a per-
manent home in a newly constructed MPIBR in Frank-
furt am Main. 
Professors Hallervorden and Spatz were never prose-
cuted. They were able to continue their careers after the 
war in association with the MPS, the University of Gies-
sen Faculty of Medicine and the new MPIBR in Frankfurt 
am Main as emeriti [184]. Hallervorden died in 1965, and 
Spatz in 1969.
Kaiser Wilhelm (Kraepelin) Institute of Psychiatry
The institute that would become the world’s foremost 
centre for academic psychiatric research arose out of a 
cauldron of activity at the beginning of the 20th centu-
ry involving leading German psychiatrists and univer-
sities and the German Psychiatric Association. The new 
institute would be based in Munich in association with 
the Department of Psychiatry of the University of Munich 
which had been chaired by Prof Emil Kraepelin since 
1903. Kraepelin had achieved fame as the author of a ma-
jor textbook of psychiatry, which incorporated his new 
classification of psychiatric disorders. He assembled an 
internationally renowned team of researchers from mul-
tiple disciplines including psychiatry, neurology, neuro-
pathology, physiological chemistry, serology, genetics 
and genealogy.
In 1915, Kraepelin developed a proposal for a psychi-
atric research unit and was successful in obtaining pri-
vate financial support from two wealthy patrons, the in-
dustrialist Gustav Krupp von Bohlen und Halbach, and 
the expatriate American-Jewish philanthropist, James 
Fig. 1 Burial site of brain specimens from “euthanasia” 
victims from Max Planck Institute for Brain Research. Wald-
friedhof Munich, special section for victims of Kaiser Wilhelm 
research
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Loeb who had been a patient of Kraepelin [195]. He es-
tablished the DFA, the foremost psychiatric research in-
stitute in the world, which served as a model for the fu-
ture Institute of Psychiatry in London and the National 
Institutes of Mental Health in the United States. The DFA 
included the first ever research institute for psychiatric 
genetics, headed by the Swiss-born psychiatrist Ernst Rü-
din. In 1924, the DFA became part of the prestigious Kai-
ser Wilhelm organisation and was subsequently known 
as the Kaiser Wilhelm Institute of Psychiatry (KWIP). 
From 1933 until 1939, the RF provided funding specifi-
cally for the study of the methodology of psychiatric ge-
netics in Munich by young researchers from outside Ger-
many [187].
Upon Kraepelin’s death in 1926, Walther Spielmeyer 
and Felix Plaut assumed the directorship of the Munich 
institute. Five years later, in 1931, the directorship passed 
to Prof Ernst Rüdin, who remained in the position until 
the end of the war. Rüdin was an active supporter of the 
Nazi regime and was known amongst his colleagues by 
the nickname “Reichsführer for Sterilisation” [196]. He 
was an important influence on the Nazi programme of 
enforced eugenic sterilisation and a contributor to both 
the implementation of the ‘euthanasia’ killing of psychi-
atric patients and the inhumane and deadly experimen-
tation on children at the University of Heidelberg [187]. 
Rüdin was made responsible for the psychiatry and neu-
rology professional associations, which were merged un-
der the new regime. During Rüdin’s tenure the Munich 
psychiatric institute received specimens from the brains 
of children murdered in the child ‘euthanasia’ pro-
gramme. These misbegotten specimens were received by 
the neuropathology division headed by Willibald Scholz. 
Scholz is known to have published two papers after the 
war which were based on research conducted on the 
brains of ‘euthanasia’ victims [190].
Rüdin and the Munich institute were the beneficiaries 
of significant financial support from the RF and the es-
tate of James Loeb; funding which began before the rise 
of the Nazi regime and continued after 1933. Major sup-
port from the RF ended in 1935, while that from the Loeb 
estate continued until 1940 [195, 197]. With the discon-
tinuance of support from the American funders, Rüdin 
turned to state organisations, including Hitler’s  Reich 
Chancellery, the Reich Ministry of Interior, and the SS 
terror organisation, for funding [187, 198, 179]. Thus, the 
world’s foremost institute of psychiatric research, the 
prototype for internationally renowned psychiatric re-
search institutes in the United Kingdom and the United 
States, the one-time home of Emil Kraepelin and Alois 
Alzheimer, and the institution where 1921–1922 Julius 
Hallervorden and Hugo Spatz completed their research 
and began their lifelong partnership, became the most 
influential psychiatric institution in the Third Reich, pos-
sibly the world. The authority of the KWIP extended to 
every aspect of psychiatry in Nazi Germany including 
government policy, university curricula, academic ap-
pointments, research funding priorities and professional 
publications [187]. 
The influence of the KWIP extended to the Depart-
ment of Psychiatry at the University of Heidelberg where 
a research unit was established under Dr Julius Deussen, 
a member of the KWIP and Rüdin’s team. Deussen’s re-
search, which was sponsored and supported by Rüdin 
and done in collaboration with the Heidelberg profes-
sor Carl Schneider, included inhuman experiments on at 
least 21 disabled children prior to their murder and stud-
ies of the victims’ brains after deaths [187].
Ernst Rüdin’s directorship of the Munich institute 
ended in 1945 with the collapse of the Nazi state. He was 
incarcerated and investigated by the authorities, but 
never prosecuted. In a tribute to Rüdin after his death in 
1952, the Max Planck Society wrote that he “was one of 
the most prominent founders of genetic research in psy-
chiatry.” In 1996, the American Journal of Genetics pub-
lished a special issue on the subject of Rüdin’s “Munich 
School” of psychiatric genetics [198–202]. The KWIP con-
tinued on its original site in Munich as a much expand-
ed MPIP. 
At the time of the revelations involving brain speci-
mens in the 1980s, the parent organisation MPS—despite 
its scientific mission of research and discovery—did not 
undertake any investigations into the origins of the speci-
mens, the identity of the victims or the role played by in-
stitutes and staff of the antecedent KWS. It would appear 
that the focus of the MPS was on the burial of the speci-
mens. 
In March of 1991, during a visit to Germany under the 
auspices of the Foreign Office, I visited the gravesite of 
the brain specimens of the “euthanasia” victims from the 
MPG collections at the Forest Cemetery (Waldfriedhof ) 
in Munich. During this visit, I was informed that the Mu-
nich cemetery was chosen because Munich is the home 
of the parent MPS. The gravesite is in a location reserved 
for the remains of victims of Kaiser Wilhelm/Max Planck 
scientists from the Nazi period. 
In 1997, the then President of the MPS, the late Pro-
fessor Hubert Markl, formed a Presidential Commission 
entitled “History of the Kaiser Wilhelm Society in the Na-
Fig. 2 Spielmeyer “Laboratorium” (ca. 1927): German Re-
search Institute for Psychiatry. Walther Spielmeyer: bottom 
row in center. Julius Hallervorden: top row 2nd from right. 
Hugo Spatz (with goatee): bottom row 3rd from left
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tional Socialist Era.” This was a five-year research pro-
gramme that commenced in March 1999 [203]. On June 
7th, 2001, Professor Markl addressed a special symposi-
um entitled “Life Sciences and Human Experimentation 
at Kaiser Wilhelm Institutes—The Auschwitz Connec-
tion”. In his symposium address, Markl acknowledged 
the continuity between the former KWS and the MPS and 
the acceptance of responsibility for everything, positive 
and negative, including the admission of guilt. He recog-
nised “… scientific evidence historically proving beyond 
the shadow of a doubt that directors and employees at 
Kaiser Wilhelm Institutes co-masterminded and some-
times even actively participated in the crimes of the Nazi 
regime, thus allowing—indeed demanding—clear rec-
ognition of these facts”. Regarding the brains specimens 
of the “euthanasia” victims, Markl stated:
“Involvement in criminal euthanasia based on eu-
genics and ‘racial hygiene’ or even the mere use of 
murdered victims for scientific experiments by Kaiser 
Wilhelm scientists such as Hugo Spatz or Julius Haller-
vorden was a clear and indubitable violation of the 
boundaries of ethically responsible research” [204].
The research and published reports of the Presidential 
Commission provide stark evidence of the role played 
by the Kaiser Wilhelm institutes and scientists during 
the National Socialist regime. Prof Markl’s statement of 
June 2001 represents a profound juncture in the history 
of science, in which one of the world’s foremost scientif-
ic research organisations explicitly acknowledges its cul-
pability in some of the most egregious abuses of human 
beings in the history of mankind.
The challenge of memory
The removal of the Hallervorden-Spatz eponym, in this 
author’s opinion, would constitute an act of historical re-
visionism by medical science that would erase the histor-
ical context, not only of the careers of professors Haller-
vorden and Spatz, but also the history of psychiatry and 
neuropathology at its height of achievement and depth 
of evil. 
Paradoxically, scientific organisations that contrib-
uted so much to the elucidation of human memory and 
its pathology have themselves manifested a form of in-
tellectual dementia that may impair medicine’s ongoing 
memory of critical events of the past. While the campaign 
to remove the Hallervorden-Spatz eponym has met with 
some success [205], efforts to substitute a new name for 
the clinical syndrome also include bracketed reference to 
the original name. The names of the two scientists have 
also resurfaced due to the recent discovery of specimens 
of brains of victims of the Nazi “euthanasia” in the ar-
chives of the Munich psychiatric institute as well as the 
main archives of the MPS in the Berlin suburb of Dah-
lem [206]. Given this discovery, and the implications of 
malfeasance in both the retention of the specimens and 
falsification of evidence, the MPS has established a new 
formal commission to examine the evidence including 
the provenance of all the discovered specimens and to 
attempt to identity the victims. The recent troubling dis-
coveries and controversy has resulted in the revival of the 
names of the two neuroscientists involved in the original 
misdeed; professors Julius Hallervorden and Hugo Spatz. 
The designation of the eponym may have changed for 
some, but the memory, and the evidence, of their trans-
gression continues to haunt the Max Planck Society, the 
MP institutes of Psychiatry and Brain Research and the 
world of neurology. 
The recent discoveries emphasise the importance of 
continuing to document historic truths, bad and good, 
including the continued use of eponyms that honour 
scientists, or others, with well-documented histories of 
malfeasance. The Hallervorden-Spatz eponym conveys 
not only the role of the two scientists, but also that of the 
institutions they were part of. The recent revelations and 
planned investigations reinforce the historical context 
and memory of the transgression as well as the suffering 
of the victims [165]. Consequently, it is hereby proposed 
that any future use of the term “Hallervorden-Spatz dis-
ease” in peer-reviewed, scientific, scholarly publications 
include the following footnote:
“Hallervorden-Spatz disease*”
* “Hallervorden-Spatz disease” is named after two 
German physician/scientists, professors Julius Haller-
Fig. 3 Professor Jürgen Peiffer: 1922–2006
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vorden and Hugo Spatz who, in 1922, published a re-
port on the pathological findings on the brain of a 
young woman who died of an unusual neurological 
condition. The research and discovery occurred under 
the auspices of the world’s foremost research institute, 
the German Psychiatric Research Institute in Munich, 
which became part of the renowned Kaiser Wilhelm 
research organization. Profs Spatz and Hallervorden 
became leaders of the world’s foremost brain research 
organization in Berlin, the Kaiser Wilhelm Institute for 
Brain Research (KWIBR). It is well-known and well-
documented that after 1939 the KWIBR under Spatz 
and Hallervorden intentionally exploited the Nazi ‘eu-
thanasia’ killing programmes to acquire the brains of 
hundreds of innocent institutionalized men, women 
and children who were murdered by the Nazi state.”
“We continue to use the name “Hallervorden-Spatz 
Disease,” not only to commemorate a scientific dis-
covery, but to remember the victims of professors 
Hallervorden and Spatz’s immoral research. We must 
never forget what can happen when science super-
sedes humanity.” 
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Legal basics
While both the International Military Tribunal of Nurem-
berg and various Allied Military Trials have been scruti-
nized in many articles and books, German legal proceed-
ings have attracted much less scholarly attention. In fact, 
even text books often omit the early judicial activities of 
German courts in the immediate post-war era [207–211]. 
The deterrent for a closer look at the legal situation in the 
occupation years in Germany was probably the confus-
ing and unclear picture they presented. Furthermore, 
many relevant documents describing the situation of the 
German courts are in American, British, French or Rus-
sian archives.
German courts in both East and West Germany re-
opened in the summer of 1945 (some even as early as 
spring  1945), and by 1946 most local, district and also 
high courts in all German Länder were functioning again 
[212]. Initially, these courts used the German penal code 
only, which had to be purged of Nazi influence. This was 
by no means an easy undertaking as not even the legal 
profession entirely agreed on what exactly constituted a 
Nazi law.
From 1946 onwards, Control Council Law No. 10 
(which defined crimes against humanity) was applied in 
German courts in the British, French and Soviet Zone of 
Occupation. However, Control Council Law No. 10 was 
not used in German courts in the American Zone, with 
the only exception of the American Sector of Berlin. In 
East Germany, from August 1947 onwards Control Coun-
cil Directives 24 and 38 were put in use: these were in-
itially guidelines for denazification and the political 
purge, but were applied as penal laws in East Germany 
only. So although the structure of the German legal au-
thorities was overall unchanged, the application of laws 
differed from Zone to zone as did denazification of legal 
personnel.
While German legal personnel had to deal with new 
Allied authorities and their regulations, the basic princi-
ples of legal groundwork continued to be applied. This 
meant that state prosecutors investigated according to 
what in German is called the “Tatortprinzip”, i. e. the ju-
risdiction of the court is decided according to the site 
of crime. Less frequently the “Wohnortprinzip” applies, 
wherein the place of residence of a defendant is the cri-
terion.
What was the line of demarcation between Allied and 
German courts? The Allies decided according to a sim-
ple guideline: if the victims were of Allied nationality, Al-
lied courts were in charge. If the victims were Germans or 
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stateless, then German courts were responsible for adju-
dicating the case. 
Investigating the so-called Euthanasia crimes was 
clearly a task for German state prosecutors: the victims 
were of German nationality and many of the so-called 
euthanasia institutions were located in Germany prop-
er. For reasons of brevity I will concentrate in my paper 
on court proceedings dealing with the first phase of mer-
cy killings which took place in six institutions under the 
code ‘T4’. Two of these were located in West Germany 
(Grafeneck and Hadamar), three in East Germany (Son-
nenstein, Bernburg, Brandenburg) and one in Austria 
(Hartheim near Linz).
The ‘euthanasia’ killing program was one of the most 
striking Nazi crimes German legal authorities had to deal 
with after 1945. Unlike the Holocaust, the number of per-
petrators was quite limited, which made trials manage-
able. Each institution had had a couple of doctors, sever-
al dozens of nurses, clerical staff and personnel handling 
the cremation of the bodies. As those experts in kill-
ing were detached in 1941 to the “Aktion Reinhard” in 
the Government General and later assigned to the fight 
against the partisans in the region of Triest, a number of 
perpetrators were killed in action during the war. Fur-
thermore, others committed suicide immediately after 
the war, for example doctors Rudolf Lonauer (Hartheim) 
and Irmfried Eberl (Brandenburg, Bernburg).
Grafeneck and Hadamar trials in West Germany
The two most important trials concerned the two killing 
centres in West Germany, namely Grafeneck and Had-
amar [213]. Investigating the crimes in Grafeneck fell into 
the responsibility of the state prosecutor of Tübingen (ac-
cording to the Tatortprinzip, as Grafeneck was located in 
the circuit of Tübingen, in the French Zone of occupa-
tion) [214]. The task proved difficult: many documents on 
the national, Länder and local level had been destroyed. 
Doctors and adminstrative staff had used pseudonyms. 
Personnel had been recruited mostly from outside the re-
gion of Württemberg and thus stemmed from all parts of 
Germany. Many of those still alive had returned to their 
home towns; this proved a nearly insurmountable obsta-
cle in the early post-war era as communication between 
different state attorneys was difficult. Letters would take 
weeks, and requests for interrogations or arrest warrants 
in different zones were nearly impossible to obtain.
By the beginning of March 1948, only half of 24 sus-
pects who had formely belonged to the killing centre 
Grafeneck were arrested, only four of which had been 
found near Münsingen. Two others were in the Ameri-
can zone, one in the American sector in Berlin, another 
in the British Zone and four in the Soviet Zone. The state 
attorney in Tübingen decided against an extradition of 
suspects from the Soviet Zone, and transferred the mate-
rial to the East German state attorneys of East Berlin and 
Weimar instead.
A further issue was the “rivalry” to the trials in the 
American Zone of occupation. Hadamar had been 
Grafen eck’s successor institution, thus “inheriting” 
many of the perpetrators who had been involved in the 
killing of patients before. This caused the problem that 
suspects were either imprisoned for the atrocities com-
mitted in Hadamar or Grafeneck. This was true for ex-
ample for the nurses sentenced in the second Frankfurt 
Hadamar trial, who had all been in Grafeneck before. A 
further challenge was the fact that other main culprits 
were no longer available, for example Viktor Brack, who 
had been sentenced to death in the Nuremberg Medical 
Trial and was executed in June 1948. Before his death, he 
gave evidence on Grafeneck twice. The Grafeneck kill-
ing doctors Dr. Horst Schumann, Dr. Ernst Baumhard 
and Dr. Günther Hennecke, who all happened to be from 
Halle an der Saale, were also unavailable: Baumhard 
and Hennecke had fallen in action in 1943. Schumann 
was considered unidentifiable—in fact he had been re-
leased unchallenged from an American POW camp. He 
practiced as a doctor in the British Zone until he fled the 
Federal Republic of Germany in 1951. He was extradited 
from Ghana in 1966.
This left a poor turn-out for the Grafeneck trial in 
Tübingen. Two administrators—the head and a mem-
ber of the public health department in the Württemberg 
ministry of the Interior—were investigated as early as 
summer 1945. The head of the public health department, 
Dr. Stähle, who had picked Grafeneck from a number of 
other mental institutions and was clearly aware of the 
purpose of the transfer of patients, died in 1948 in pre-tri-
al detention. His subordinate, Dr. Otto Mauthe, was sen-
tenced to 5 years imprisonment for abetment of crimes 
against humanity. Two other defendants also received 
verdicts as they had transferred patients from a mental 
institution (Zwiefalten) to Grafeneck and Hadamar. Five 
others, among them nurses, clerical staff, and a doctor 
were acquitted. The Grafeneck trial with three verdicts 
and five acquittals remained singular: apart from the sec-
ond Frankfurt trials on Hadamar (which also concerns 
Grafeneck) there was never another trial or legally bind-
ing verdict concerning Grafeneck–neither in the occupa-
tion years nor since 1949.
As is well known, the state prosecutor’s offices in 
Frankfurt am Main were a focal point for investigations 
regarding so-called euthanasia. This was due to the fact 
that the province Hesse-Nassau played a key-role for 
the operation: apart from the Hadamar killing centre, 
there were three so-called Zwischenanstalten (mental 
hospitals used to hold patients on their way to the gas 
chamber). The three Zwischenanstalten were Herborn, 
Weilmünster and Eichberg. As in the previous case, the 
prosecutor at Frankfurt had trouble locating several sus-
pects who were not residents of Frankfurt or Hesse. Pro-
ceedings against several suspects were thus split off the 
main case.
As already described for Grafeneck, the search for the 
murderous doctors proved mostly futile. Baumhard and 
Hennecke, who had also been in Hadamar, had died as 
soldiers; Dr. Friedrich Berner had suffered the same fate. 
Another doctor, Dr. Kurt Schmalenbach, had lost his life 
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in 1944. This left only one doctor to stand trial: Bodo Gor-
gaß. 27 individuals were indicted at the Hadamar trial. 
This was less than one fifth of the complete staff, which 
allegedly had numbered about 140 employees.
The Hadamar trial dealt with perpetrators who had 
been active in both the gassing of patients in the first 
phase (until August 1941), and the lethal injections of the 
second phase (since September 1941) [215]. Two doc-
tors stood trial: one was the aforementioned Dr. Gorgaß, 
who was indicted for the gassing of approximately 2000 
patients, and Dr. Wahlmann, who had participated in 
the killings by medication. Gorgaß and Wahlmann were 
found guilty of murder in one thousand—respectively 
900—cases, and sentenced to death in March 1947. Af-
ter the enacting of the West German constitution, the Ba-
sic Law, both sentences were commuted to life imprison-
ment. Nurses were found guilty of abetment to murder 
with verdicts between eight and two-and-a-half years of 
imprisonment. Others were acquitted. 
A second Hadamar trial in 1948 dealt exclusively with 
nurses employed in Hadamar, Grafeneck, Eichberg, 
Bernburg or Irsee. Four nurses were found guilty in 1948 
as accessories to murder, they went to jail for a duration 
of three to four years [216]. 
Although of the sentences concerning Hadamar and 
Grafeneck one was reached in the American, the oth-
er in the French Zone, and in one case (Frankfurt) ap-
plied the German Penal code, and the Control Council 
Law No. 10 in the other (in Tübingen), they did not dif-
fer substantially. The more severe penalties meted out in 
Frankfurt (two death penalties) are owed to the fact that 
the state prosecutor in Frankfurt had succeeded in call-
ing to account a larger circle of perpetrators and actual 
killers (whereas Tübingen had had to center its indict-
ment on the ministerial bureaucracy). Besides, Frankfurt 
began its trial ahead of Tübingen. Moreover, the Frank-
furt investigating team could draw on American prelimi-
nary work concerning the Nuremberg Medical Trial and 
the Hadamar trial, which dealt with the murder of Soviet 
and Polish foreign workers towards the end of the war.
Trials concerning the Reich level (‘T4’) and 
Zwischenanstalten in West Germany
It was far more complicated to reconstruct the sequence 
of events on the national level of ‘Action T4’. The position 
of individual perpetrators, their responsibilities and guilt 
incurred within the killing network, proved difficult to 
establish. In 1949, both the local courts of Frankfurt and 
Hadamar refused to issue a warrant of arrest for one of 
the main culprits of ‘T4’, Dietrich Allers (director of the 
Reichsarbeitsgemeinschaft Heil­ und Pflegeanstalten), as 
he was then living in Lower Saxony while the scene of the 
crime had been in Berlin. It would take until 1968 for a 
verdict against Allers (he received eight years for acces-
sory to murder)—to be reached of all places in Frankfurt, 
which nearly 20 years before had refused to deal with the 
case on procedural grounds. 
The search for culprits on the national level was particu-
larly difficult. Many were dead, either by their own hand 
(Dr. Herbert Linden, Obergutachter/Reichsbeauftragter 
für die Heil­ und Pflegeanstalten; Philipp Bouhler, Kanz­
lei des Führers) or had been executed after trials (Viktor 
Brack, Karl Brandt at the Nuremberg Medical Trial).
Only few trials took place against the so-called ‘experts’ 
(Gutachter). Proof of abetment of murder was particular-
ly difficult here, as for each victim three expert opinions 
were gathered, and only the ‘chief experts’ (Werner Hey-
de, Hermann Paul Nitsche or Herbert Linden) took the 
final decision on life or death. About 40 of these experts 
are known, 7 of them stood trial (Artur Schreck, Hermann 
Pfannmüller, Fritz Mennecke, Friedrich Panse, Kurt 
Pohlisch, Walter Schmidt and Valentin Faltlhauser), but 
they were mainly indicted for their activities in the mental 
institutions as such rather than their expert opinions on 
the registration forms (Meldebogen). Trials were also ini-
tiated against ministerial bureaucracy (the ministries of 
the interior of the Länder and provincial administrations) 
in Düsseldorf, Freiburg, Hannover, Münster and Munich, 
but most of them were acquitted or investigations were 
dropped, but the head of public health in the ministry of 
the interior in Baden was sentenced to 11 years.
Trials referring to the Zwischenanstalten always re-
volved around the cardinal question whether the staff 
in these asylums knew the purpose of the transfers. As 
is well known, in some institutions even the patients 
were in the know of their intended fate. In Andernach 
patients insulted each other during quarrels with the 
words: “Du wirst auch verbrannt.” (“You will also be 
burned.”) Two patients who had fled the killing asylum 
Meseritz-Obrawalde and returned to their institution in 
Hamburg-Langenhorn told the doctors about the kill-
ings, who in turn informed the public health department 
in Hamburg. Still, most of the trials against the staff of 
Zwischenanstalten ended in acquittals as the defendants 
insisted irrefutably on not having been aware of the pur-
pose of the transports. Others referred to their belief in a 
valid legal basis for the killings. In 1949, the head of the 
asylum in Lübeck referred to a conversation he had had 
with the mayor of Lübeck in 1941, who asked him how 
much room there would be in the asylum when all the 
many insane patients had been killed. This points to the 
fact that knowledge on the killings was widespread in 
larger parts of the population.
The killings in ‘euthanasia’ institutions during the sec-
ond phase (i. e. with lethal injections) led to three death 
sentences in 1946 before a court in Berlin and in Frank-
furt: two against a female doctor and nurse for murders 
(with base motifs) committed in Meseritz-Obrawalde, 
who were executed, and one against the head of the Eich-
berg asylum and ‘expert’ Dr. Fritz Mennecke, who died 
before the execution.
In the 1960s, the state prosecutor at Frankfurt am Main 
took the trouble to systematically search for all former 
staff members at the killing centres. This led to several 
new trials against former doctors of Bernburg, Branden-
burg, Sonnenstein, and Hartheim. Two of them were 
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sentenced for abetment of murder (Ullrich, Bunke), oth-
ers acquitted (Kurt Borm) or the trials aborted because 
of ill health of the defendant (Renno, Endruweit, Schu-
mann). A former ‘expert’ who had filled out the registra-
tion forms died before the trial started (Viktor Ratka). Le-
gal proceedings against the administrative level of ‘T4’ 
were more successful: Reinhold Vorberg, responsible 
for transport (Leiter Gekrat), and Dietrich Allers, man-
ager of the mental institutions (Geschäftsführer der Ge­
meinnützigen Stiftung für Anstaltspflege) were sentenced 
to 10 and 8 years imprisonment; the head of the clear-
ing house (Leiter der Zentralverrechnungsstelle) Hans-
Joachim Becker to 10 years, the ‘T4’ economic manag-
er (Hauptwirtschaftsleiter) Friedrich Lorent to 7 years. 
Again, legal proceedings came to a halt due to suicides 
(head of department of ‘T4’, Friedrich Tillmann, as well 
as Prof. Heyde) and due to ill-health of the defendants 
(Dr. Gerhard Bohne, Hans Hefelmann) [217]. 
“Euthanasia” trials in East Germany
Three of the killing centres of the first phase were locat-
ed in East Germany: Brandenburg, Bernburg and Sonn-
enstein. As in West Germany, investigations started al-
most immediately after the end of the war, often initiated 
by victims’ relatives. The best-known trial is the doctors’ 
trial in Dresden [218]. The first suspects were arrested in 
autumn 1945 by Soviet Security. In 1946, investigations 
were handed over to German legal authorities. The tri-
al intended to cover all ‘euthanasia’ crimes committed 
in the Land Saxony, thus not only concerning itself with 
the killing center Sonnenstein near Pirna, but also with 
asylums such as Arnsdorf, Großschweidnitz and Leip-
zig. The main defendant was Hermann Paul Nitsche, who 
had been director of Sonnenstein before he transferred 
to T4 to become ‘chief expert’ (Obergutachter) and medi-
cal head of ‘T4’. The trial received enormous press cover-
age in East Germany not least because it was scheduled 
to take place at the same time as the American Medical 
Trial in Nuremberg. In July 1947, the court case based on 
Control Council Law No. 10 ended with four death sen-
tences. Nitsche and a male nurse were executed in March 
1948, two others (a doctor and another male nurse), who 
had been sentenced to death, committed suicide in pris-
on. Others received severe sentences, too, and three were 
acquitted.
While this trial and an even earlier trial of the year 1946 
at Schwerin (concerning the second phase of ‘euthana-
sia’ killings) seem to point to an effective dealing with 
‘euthanasia’ crimes in East Germany, the whole picture 
is somewhat less convincing. First of all, the three doctors 
responsible for the gassings in Sonnenstein had not been 
investigated, much less put on trial (Schumann, Endru-
weit, Borm). Furthermore, there is a striking and rather 
conspicuous absence of major trials concerning the two 
other killing centers Brandenburg and Bernburg. In 1948, 
a janitor and a female nurse were indicted and sentenced 
for killings in Bernburg. However, the Brandenburg and 
Bernburg doctors remained unpunished until investiga-
tions started in West Germany in the 1960s. 
Second, a substantial amount of cases in East Germa-
ny were initiated by West German investigations. No less 
than 6 of the East German ‘euthanasia’ trials were the re-
sult of West German investigations transferred to East 
German judicial authorities: The former administrative 
head of Hadamar, Hans Raeder-Grossmann, and his wife 
were tried in Meiningen in the Soviet Zone. The head of 
the Hadamar institutions’s registry, Kriminalobersekretär 
Walter Bünger, was sentenced to 10 years imprisonment 
in East Berlin. Four days later he committed suicide. The 
Hadamar nurses Käthe Hackbarth, Emma Bellin and 
Hedwig Michael were sentenced in Magdeburg, East Ber-
lin and Weimar. Hackbarth received a verdict of 15 years, 
Emma Bellin 7 years, Hedwig Michael two-and-a-half 
years imprisonment.
Third, unlike investigators in West Germany, police 
and state attorneys in East Germany failed to understand 
the connection between ‘euthanasia’ murders and ‘Ak-
tion Reinhard’ killings in the Lublin district. In Magde-
burg, Josef Kaspar Oberhauser, who had worked in the 
crematorium in Grafeneck, Brandenburg and Bernburg, 
was sentenced to 15 years imprisonment, but his partici-
pation in mass murder in the Government General went 
unmentioned. So several years later Oberhauser would 
again stand trial, this time in the Federal Republic of Ger-
many for his crimes in Belzec. 
Fourth, contrary to common opinion, the German 
Democratic Republic (GDR) did not always mete out 
more severe verdicts. In 1952, Richard von Hegener, a 
member of the Kanzlei des Führers, was sentenced to life 
imprisonment. However, he was released after a mere 
four years, as were several other ‘euthanasia’ perpetra-
tors, due to an amnesty in 1956. Nor was the GDR more 
successful in preventing break-outs. As is well known, 
the chief expert and head of ‘T4’, Prof. Dr. Werner Heyde, 
managed to escape in Würzburg from an American pris-
oner transport from Nuremberg to Frankfurt in 1947. In 
East Germany, it was the male nurse Fritz Erich Schmidt, 
who had worked in Sonnenstein and Bernburg as well as 
Treblinka, who absconded from East German custody in 
1949 and thus escaped all judicial reckoning. When in-
vestigations in West Germany concerning Treblinka were 
initiated, Schmidt had long died. 
Conclusion
The law professor Friedrich Dencker characterized the 
courts’ record with regards to the ‘euthanasia’ killings 
as a ‘Skandalgeschichte’, a ‘scandal’, not least due to the 
discrepancy between severe sentences in the immediate 
post-war period, and very lenient verdicts in later years 
[219]. 
However, prosecution of the ‘euthanasia’ killings was 
was not without success, especially when compared to 
the prosecution of Holocaust perpetrators. The bulk of 
legal proceedings in West and East took place during the 
occupation period. While the importance of the Central 
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Ageny in Ludwigsburg (founded in 1958) cannot be over-
stated for investigations into the Holocaust, it played a 
much lesser role in the prosecution of the ‘euthanasia’ 
killings. 
The early West German trials of Grafeneck and Had-
amar remained outstanding examples of judicial coping 
with the criminal legacy of the Third Reich. They were so 
thoroughly researched that in later years no further tri-
als against forgotten, omitted or escaped suspects had to 
be initiated. If it was established that a suspect was liv-
ing in East Germany, proceedings were transferred to 
East German legal authorities to pursue the cases. In East 
Germany, where the majority of ‘euthanasia’ killing cen-
tres was located, judicial proceedings petered out quickly 
after the much publicized Dresden trial. Later East Ger-
man trials against ‘euthanasia’ personnel were often just 
follow-up cases handed over by West German state at-
torneys. East German trials also missed the link between 
‘euthanasia’ killings and ‘Aktion Reinhard’. Thus, when 
the attorney general in Frankfurt am Main opened in-
vestigations again in the 1960s, he had to deal with both 
the neglected ‘euthanasia’ institutions of Brandenburg, 
Bernburg, Sonnenstein and Hartheim and the national 
level of T4.
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Introduction
Hans Joachim Sewering was one of the most influen-
tial public figures in the German medical establishment 
from the 1950s to the 1990s [220]. Despite his National 
Socialist past, he was president of the Bavarian Medical 
Association from 1955 to 1991, president of the German 
Medical Association from 1973 to 1978, and directed the 
Kassenärztliche Vereinigung (Association of Health Insur-
ance Physicians) in Bavaria for decades. When he died 
in June 2010, former presidents of the German Medical 
Association Prof. Dr. Jörg-Dietrich Hoppe and Prof. Dr. 
Karsten Vilmar wrote an obituary in the German Medical 
Journal which had a quasi-official character. The authors 
described his life’s work for the improvement of medical 
education for physicians and students, for the implemen-
tation of quality management in medicine, and for the 
freedom of the physician in the health care system. They 
concluded with the statement that Sewering had rendered 
9  This paper was already published in a more detailed version in: 
Roelcke V, Topp S, Lepicard E, editors. Silence, Scapegoats, Self-
Reflection: The Shadow of Nazi Medical Crimes on Medicine and 
Bioethics. Göttingen: V&R unipress; 2012; pp. 131–46.
outstanding services to the preservation of ethical norms 
in the work of the physician [221]. The authors excluded 
the National Socialist era from their short biography of 
Sewering and mentioned neither his membership in the 
SS and the National Socialist Party nor his involvement in 
National Socialist “euthanasia” measures. This obituary 
provoked critical letters to the editor of the German Medi­
cal Journal and a letter of protest signed by about 80 med-
ical historians, physicians and psychotherapists. In this 
letter, it was argued that the obituary does not satisfy the 
duty of the German medical profession to accept histori-
cal responsibility for its National Socialist past [222]. The 
dispute about the Sewering’s obituary shows that, even in 
2010, the German medical profession had not fully come 
to terms with its National Socialist past.
In 2008, the Professional Association of German Spe-
cialists in Internal Medicine honored the then 92-year-
old Hans Joachim Sewering with its highest decoration 
for his merits in the field of professional independence 
and freedom of the physician. In defence of Sewering’s 
Nazi past, it was argued that public prosecution had been 
suspended and that Sewering’s statements were fully 
credible. Outside of Germany—especially in the US—
Sewering is regarded as an example of the inability of the 
German medical establishment to critically examine the 
role of the German medical profession in National So-
cialism [223, 224]. The Sewering affair in 1992/1993 cre-
ated a much greater stir internationally than in Germany 
itself [225, 226].
The Sewering Affair 1992/1993
What was the Sewering affair about? Hans Joachim Sew-
ering was active not only in national professional poli-
tics but was also a member of the executive board of the 
World Medical Association (WMA) as treasurer since 
1971 and was nominated “President elect” at the WMA 
assembly of delegates in Marbella in September 1992. 
Before he could take up office as President of the WMA, 
accusations were made at the turn of the year 1992/1993 
that he had been a member of the SS since 1933 and of 
the NSDAP since 193410 and was responsible for the death 
by “euthanasia” of at least one child, the 14-year-old Ba-
bette Fröwis in 1943, when Sewering worked as a consult-
ing physician at the Catholic institution of Schönbrunn. 
These accusations had already been public knowledge 
since 1978, when the German weekly news magazine Der 
Spiegel reported critically about Sewering’s rise to pow-
er after the Second World War. Der Spiegel published ex-
cerpts from Babette Fröwis’ patient files, including nude 
photographs of Babette and the medical order for admis-
sion to the Eglfing-Haar asylum, signed by Dr. Sewer-
10  Bundesarchiv Berlin (Berlin Document Center) R 9345, Reichs-
ärztekartei, film no. 60, Sewering, Hans; SSEM film 62xx R 59: 
Sewering entered the “SS-Sturm 2/ I/31” on 1 November 1933 
as “SS-Mann”. PK film C 242 picture 1236–1238 Gaupersonalamt 
München-Oberbayern, Reference of the Kreispersonalleiter from 13 
August 1942: Sewering entered the NSDAP on 1 August 1934. 
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ing [227, 228: 264]. Der Spiegel already asked the crucial 
question here: Did Sewering really not know at that time 
what such a transfer to Eglfing-Haar meant?
The protest against Sewering’s nomination as Presi-
dent of the WMA was initiated in Germany by the Göt-
tingen professor for general medicine, Michael Kochen 
[229]; in North America, William Seidelman [230], Mi-
chael Kater [228: 3–4], Michael Grodin, and Michael 
Franz blau were active, as was Michael Weingarten in Tel 
Aviv. In January 1993, the American Medical Association 
finally intervened and drew up a resolution of protest un-
der its chairperson Raymond Scalettar. The World Jew-
ish Congress declared a former Nazi as unacceptable for 
president of the WMA and threatened to call the national 
medical associations to withdraw from the WMA.11 The 
German Medical Association, however, stood by Sew-
ering and announced in the German Medical Journal: 
“Prof. Dr. Dr. h. c. Hans J. Sewering  … is the target of a 
smear campaign.” According to the journal, the accusa-
tions raised against him of being involved in Nazi “eutha-
nasia” had never been proven. In defence of Sewering, 
the German Medical Association mentioned that Sewer-
ing was supported by the Catholic Church and received 
the German Order of Merit [231]. After the U. S. Justice 
Department stated on 21 January 1993 that it wanted to 
put Sewering on the “Watch List” with the consequence 
of being denied entry into the U. S., and the Munich Arch-
bishop’s Ordinariate abandoned its unreserved support 
of Sewering on 22 January 1993, Sewering declared his 
resignation from the office of President elect on 23 Janu-
ary 1993. He stated that he wanted to avert great damage 
to the World Medical Association because of the impend-
ing boycott of the “World Jewish Congress” [232].
The Sewering affair led to some trouble in the rela-
tionship between the German Medical Association, the 
American Medical Association and the WMA; the AMA 
representatives claimed that they had not been properly 
informed by the the German Medical Association about 
Sewering’s Nazi past when he was elected as incoming 
president of the WMA in Marbella in 1992 [233, 234]. As a 
counterpoint, the president of the German Medical Asso-
ciation, Karsten Vilmar, argued that the “claims were al-
ready raised against Professor Sewering many years ago. 
He was previously exonerated by a ruling of the 1st Court 
Division in Dachau on September 7, 1946, on the basis of 
factual investigations and testimonies in a due process of 
law as part of Allied denazification process instigated by 
the allied military government” [235]. His main argument 
was that, according to the German constitution, Sewer-
ing must be considered as innocent as long as there is no 
conviction by a court of law. Thus, the German Medical 
Association was neither obliged nor had the possibility 
to prove the accusations against him, which were mainly 
based on conjecture.
11  Reuters News Service, January 22nd 1993: “The World Jewish 
Congress said on Thursday it was considering calling on national 
medical groups to withdraw from the World Medical Association if 
it confirmed a former Nazi as its president.”
Nevertheless, the World Medical Association was in-
terested in coming to terms with the Sewering affair after 
Sewering’s resignation and declared that such a situation 
should never occur again [234].12 Despite his vigorous 
support of Sewering, Karsten Vilmar was elected treas-
urer of the WMA in 1993.
The German Medical Association consequently made 
an effort to limit the damage and the 96th German Ärzte­
tag (an annual medical conference) in Dresden issued 
a statement, in which events surrounding Sewering’s 
candidacy were described as unfortunate and his resig-
nation was welcomed: “With this, the Ärztetag sees the 
matter as settled.“ [236, 237] The matter was not settled 
for the dermatologist Dr. Franzblau in California, who 
founded a “Committee to bring Dr. Hans Joachim Sewer-
ing to Justice”, and appealed to the German and the Ba-
varian state governments [238].13 In July 1996, a full page 
advertisement was published in the New York Times with 
the following question: “Why is the German State of Ba-
varia harbouring an accused war criminal?” The public 
prosecutor’s office of Munich I actually conducted sev-
eral preliminary inquiries, inspected all surviving re-
cords of patients from Schönbrunn who were transferred 
to Eglfing-Haar, and questioned the last four remaining 
witnesses, who were nuns at Schönbrunn. However, as of 
2003, the office did not see any grounds for opening for-
mal preliminary proceedings against Sewering. The main 
argument of the Munich public prosecutor was that the 
National Socialist “euthanasia” program, especially the 
“euthanasia” of children, was a secret affair of the Reich, 
about which an outsider, like Sewering, knew nothing 
and could not have known anything [239: 241–54].
The unresolved shadows of the past as well as Hans 
Joachim Sewering’s political influence in Bavaria to 
this day are reasons for the existence of three different, 
contradictory stories about one and the same historical 
event. These stories are able to coexist, unconnected next 
to each other, because there are still blank spaces in the 
landscape of memory about National Socialist medicine 
and “euthanasia”, which have resisted historical elucida-
tion until the beginning of the 21st Century. 
Franzblau’s account of the Sewering case
The Sewering case, in the view of Michael Franzblau 
[238], is shaped by the construct of the Nazi doctor, who, 
through his membership in the National Socialist party 
and the SS, is an enthusiastic adherent of the National 
Socialist ideology of “racial hygiene” and who thus inev-
itably developed an inclination towards medical crimes 
12  Cf. Letter from James S. Todd, Executive Vice President of the 
American Medical Association to Michael A. Grodin, April 16th 
1993: “The AMA will continue to take strong measures to try to as-
sure that the WMA never has a problem like this again.”
13  Under www.badnazidoctor.com [accessed in 2008] the “Com-
mittee to Bring Dr. Hans-Joachim Sewering to Justice” offered 
information about the Sewering Case and claims that during Sew-
ering’s duty as physician at the Schönbrunn asylum, 900 patients 
have been transferred to “euthanasia” facilities.
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and especially towards Nazi “euthanasia”. The early SS 
and party membership of Hans Joachim Sewering, who 
joined the general SS as early as 1933 and the NSDAP in 
1934, fits into this image [238: 85]. From this perspec-
tive, it seems logical that Sewering also took part in the 
so-called “wild euthanasia” program between 1942 and 
1945 and was responsible for the transfer of 900 patients 
to “euthanasia” facilities, during his work as a doctor in 
the hospital for tuberculosis patients in Schönbrunn. The 
transfer order of 14-year-old Babette Fröwis from Schön-
brunn to Eglfing-Haar, signed by Sewering, represents 
the crucial document in this story. Sewering’s case ap-
pears to be the quintessential symbol of the unprocessed 
National Socialist past of German medicine.
Sewering’s self-account of the story
Sewering’s autobiographical version of the story could 
not be more different from the preceding one [240].14 His 
memberships in the NSDAP and the SS were, as he tells 
it, a forgivable youthful folly, carried along by a wave of 
enthusiasm for National Socialism. In addition, he al-
leged that his membership in a National Socialist organi-
zation had been a prerequisite for finishing his medical 
studies.15 He claimed to have withdrawn inwardly from 
National Socialism on the occurrence of the pogrom of 
9 November 1938. In May 1942, he began working in the 
Munich Tuberculosis Hospital in the buildings of the 
Schönbrunn asylum. After the asylum’s resident doc-
tor was drafted into the military, Sewering took over the 
medical care of the women in the whole asylum. In his 
eyes, the case of Babette Fröwis was purely a tale con-
cocted by Spiegel magazine. The nuns had asked him for 
his signature on various occasions, as they did for the 
transfer of the 14-year-old girl, whose care they were no 
longer able to cope with. Words of regret considering Ba-
bette’s fate never crossed his lips. On the contrary, he was 
not even able to comprehend the question about such an 
emotional reaction. And so it seems that Sewering has a 
clear conscience, confirmed by the fact that no official in-
vestigative proceedings were opened against him.
The Story in the view of Schönbrunn and church 
authorities
At the Bavarian Medical Conference in 1978, the Munich 
Archbishop’s Ordinariate stated that aspersions cast on 
doctors working in church institutions during the time of 
National Socialism were without foundation, a statement 
which could only have been refering to Sewering, whose 
involvement in Babette Fröwis’ death had just been made 
public by the Spiegel news magazine [227]. In the dena-
zification court’s proceedings, the director of the Schön-
brunn institution Josef Steininger exonerated Hans 
14  Sewering told this story in an interview with the author on 19 
June 2006 in his home in Dachau.
15  As the BDC documents show, Sewering entered the General SS, 
see above.
Joachim Sewering to the extent that he was absolutely not 
a National Socialist [239: 238, 246]. Sewering remained 
connected to Schönbrunn as a consulting physician un-
til the 1970s, under the prerequisite that the account of 
the rescue of Schönbrunn should not be questioned. This 
very consensus on “historical facts” between Sewering 
and the church institution Schönbrunn were doomed to 
fall apart once the question of who was responsible for 
the transfer of 14-year-old Babette Fröwis to the asylum 
Eglfing-Haar could no longer be avoided [241]. 
Sewering’s attempt to make the nuns from Schön-
brunn responsible for Babette Fröwis’ move to Eglfing-
Haar elicited an official response from the Munich Or-
dinariate: namely that the asylum’s nuns knew very well 
that deportation between 1940 and 1944 meant death for 
the patients in their care [239: 249; 242, 243].
Historical Sources
With this, we leave the level of legends and finally turn 
to the historical sources available today. To do this, it is 
necessary to recall the various forms of National Socialist 
“euthanasia” and the function of the mental hospital and 
asylum Eglfing-Haar [47, 244–251]:
1. Even after the formal end of the “T4 program” in 
August 1941, transportations of patients to institu-
tions with high mortality rates continued; to be pre-
cise, another 172 patients had been transferred from 
Schönbrunn to the institution of Eglfing-Haar by De-
cember 1943. In June 1944, the negotiations between 
Stei ninger and the spiritual head of the Third Order 
Hospital in Munich concerning the implementation 
of an auxiliary hospital in Schönbrunn made it clear 
that if any information about the upcoming trans-
fers reached the nuns, they could become very agitat-
ed [239: 218]. The transcript of the negotiations clear-
ly proves that it was generally known in Schönbrunn 
that the killing of patients, especially in Eglfing-Haar, 
continued after the end of the “T4 program”. Sewer-
ing’s involvement in the collective transports in 1943 
and 1944 cannot be proven by the existing sources, but 
it seems implausible that he did not know anything 
about the context of these transports. Indeed, after 
the halt of the “T4 program” in August 1941, the kill-
ing of patients in German asylums continued in var-
ious forms, especially by the use of overdosed medi-
cation and by starvation. In Bavaria, the Ministry of 
the Interior gave an order to establish a special star-
vation diet for non-working patients [252: 95–147; 253: 
177–88]. Between 1939 and 1945, about 3,000 patients 
died in the asylum of Egl fing-Haar. A study of all the 
deaths of patients from Munich in this period showed 
that only a third of the patients in Eglfing-Haar died 
from natural causes. About two thirds of the death cas-
es in Egl fing-Haar were caused by systematic neglect 
of nursing and medical care, by starvation and prob-
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ably—also in the case of adult patients—by overdosed 
medication.16
2. Babette Fröwis’ transfer did not take place in the con-
text of one of the collective transports mentioned 
above. It was an individual transfer due to disturb-
ing behavior. Babette was probably registered with the 
“Reich Committee for the Research of Serious Heredi-
tary and Constitutional Illnesses”, the so-called “chil-
dren’s euthanasia” camouflage organization, by the 
asylum Eglfing-Haar and admitted to the Kinderfach­
abteilung. She was killed with repeated doses of Lu-
minal, simulating a natural death by bronchial pneu-
monia.17 According to present knowledge, Sewering 
admitted a total of nine patients from Schön brunn to 
Eglfing-Haar between June 1943 and February 1945, of 
whom five died.18 Aside from the aforementioned kill-
ing of Babette Fröwis in the Kinderfachabteilung, most 
of them were starved to death, some of them in the no-
torious “House of Hunger” 22. The grounds for trans-
fer written in the short transfer papers from Dr. Sewer-
ing range from restlessness, bothering other patients 
and attempts to flee, to assault and battery of the staff. 
In all cases, Sewering confirmed in writing that the pa-
tients could not be kept in Schönbrunn and that ad-
mittance to a locked ward was necessary.
3. Between 1939 and 1945, out of a total of 905 inhabit-
ants of the Schönbrunn institution who were trans-
ferred to state institutions, most of them to the asylum 
of Eglfing-Haar, 546 did not survive the war and prob-
ably fell victim to the National Socialist “euthanasia” 
program [254: 132–3].
Conclusion
When we critically compare the three accounts on the 
basis of source materials, their constructed character be-
comes clear: the real Sewering can neither be identified 
in the narrative of the perpetrator of “wild euthanasia” or 
as the prototype of the Nazi doctor and war criminal; nor 
can his version of himself as unknowing and innocent be 
supported by the sources. The legend of the heroic res-
cue of Schönbrunn by Prelate Steininger is also nothing 
more than a skillful reinterpretation of events document-
ed in the sources, as the institution was saved at the end 
of the war, but almost all of the patients in its care had 
disappeared [239: 98–9]. It is not plausible that Sewering 
16  This study was conducted by the working group “Psychiatry 
and welfare care in National Socialism in Munich” (Michael von 
Cranach, Annette Eberle, Gerrit Hohendorf and Sibylle von Tiede-
mann) with support from the Documentation Center on National 
Socialism in Munich and the District of Upper Bavaria. The results 
will be published in form of a Remembrance Book for the Munich 
“euthanasia”victims in 2018 edited by Michael von Cranach, An-
nette Eberle, Gerrit Hohendorf and Sibylle von Tiedemann.
17  Archiv des Bezirks Oberbayern, München, stock Eglfing-Haar, 
patient file 7179.
18  Archiv des Bezirks Oberbayern, München, stock Eglfing-Haar, 
patient files 7179, 7709, 7893, 8662, 8702, 10607, 11906, 11107, 
12101.
was as unaware as he declared 50 years later. This is ei-
ther a conscious deception of the public, or else the cre-
ative and self-exonerating efforts of autobiography. In 
fact, the sources tell the story of two men who in the end 
functioned within the machinery of transfers controlled 
by the Bavarian Ministry of the Interior Department of 
Health and who did what was expected of them, namely 
making space to be used for the medical requirements of 
war by transferring mentally disabled and ill patients in 
their care. In addition, Sewering, as well as his predeces-
sors, exposed disruptive patients to the danger of being 
killed in the mental hospital and asylum of Eglfing-Haar. 
Even if one were to accept the unlikely supposition that 
Sewering knew nothing about the impending danger, 
the real scandal would still be that the discovery of the 
death of Babette Fröwis, whom he had transferred, did 
not arouse any emotional expression of regret at all; the 
fact that he had played into the hands of the murderers 
only led him to shift the blame onto the nuns in Schön-
brunn. In this respect, Sewering’s case is a late example 
of the “inability to mourn”, as Alexander and Margarethe 
Mitscherlich diagnosed in the 1960s [255].
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The history of the prosecution of Nazi medical war crimes 
and the Nuremberg Code’s impact on the development of 
medical ethics in France are complex historical subjects 
[256]. First, trial investigations were a matter of interna-
tional collaboration and rivalry [257]. Second, follow-up 
trials for French (medical) war crimes were still in prepa-
ration when the first accounts of the Nuremberg trial were 
published [256–260]. Specific book-length accounts of the 
Nuremberg Medical Trial (NMT), written by Mitscherlich 
and Mielke (1947/1949) in German, appeared during the 
preparation of the French legal procedures [261]. Simi-
larly, the French edition of selected documents from the 
NMT by Bayle (1950) was published before the Struthof/
Natzweiler concentration camp medical war crimes trials 
(SMT) were held in Metz in 1952 and in Lyon in 1954 [31]. 
In both cases, important NMT documents were published 
before the French judgment. The Nuremberg Code was 
part of the NMT judgment and therefore could not been 
included in the first edition of Mitscherlich and Mielke’s 
(1947) book, while the second edition published in 1949 
as well as Bayle’s French edition of 1950 documented the 
Nuremberg Code [30, 31, 261]. These editions therefore 
could have had an impact on French judges and physi-
cians, but as our analysis will show, this was not the case. 
Our central contention is that differences arose between 
professional groups and their respective cultures and un-
derstandings, especially between judges and physicians 
and prosecuting lawyers and scientific experts. This con-
flict between professional agencies, which emerged dur-
ing the preparation for the French trials, continued to play 
a role in the debates about medical ethics later on.
In the context of this paper, “impact” will be defined as 
direct influence, for example, when the Nuremberg Code 
was openly acknowledged or referenced in citation. “In-
direct” influence would include echoing the code’s prin-
ciples without directly mentioning the code or a precise 
quotation. 
This contribution examines the influence of the 
Nuremberg Code in France in five stages: first, the ne-
gotiations and events during prosecution prior to the 
Nuremberg trial (1944–1946); second, the immediate 
portrayal of the NMT in the French professional medical 
press; third, its influence in the early debates on medical 
ethics in the context of the WMA, and in particular the 
French representative Paul Cibrie’s role within the WMA; 
fourth, the discussions about the prosecution of (medi-
cal) war crimes by the Monaco Commission in the early 
1950s; and finally, the impact of these debates during the 
French SMT (1952–1954) [256–260].
(1) Negotiations and events during prosecution prior 
to the Nuremberg Trial (1944–1946)
Inter-allied discussions on experimental research in 
the concentration camps and ethical guidelines for the 
protection of human subjects in medical research pre-
ceding the NMT started in summer 1946 [14]. On May 15, 
1946, British members of the Field Information Agency, 
Technical (FIAT) held an initial meeting with French sci-
entists from the Pasteur Institute. On this occasion Pro-
fessor Pierre Lépine from the Pasteur Institute suggested, 
on behalf of the French delegation, that scientific bodies 
representing the four powers should issue a moral con-
demnation of the unethical practice of German scientists 
[30]. The British delegate, Chairman Brigadier Raymond 
John Maunsell, held a contradictory view, insisting that it 
was essential to have a trial first and that national scien-
tific bodies could subsequently publicly condemn crim-
inal medical practices [262]. Here, the issue at stake was 
priority, namely whether judges or medical professionals 
should first get to define what was criminal or admissible, 
and who should get to convey this judgment to the gen-
eral public. Half a year before the opening of the NMT, a 
second meeting in Paris on July 31, 1946 led to the foun-
dation of the International Scientific Commission (ISC) 
on War Crimes of a Medical Nature [263]. Here Andrew C. 
Ivy, physician and Special Consultant to the U. S. Secre-
tary of War, warned attendees that the publicity associat-
ed with a trial of concentration camp experimenters could 
“so stir public opinion against the use of humans in any 
experimental manner whatsoever that a hindrance will 
thereby result to the progress of science” [30]. Instead, Ivy 
presented the first draft of an ethical code [263]. A short 
while later it became clear that another international tri-
al would be doomed. At the last meeting of the ISC on 
January 15, 1947 in Paris—six weeks after the beginning 
of the NMT—Leo Alexander, the second initiator of the 
“Nuremberg Code”, and present as a guest of the ISC, an-
nounced his plan to publish two articles on medical ethics 
and the Nazi war crimes. Dissent arose when Lord Moran, 
Churchill’s physician and President of the Royal College 
of Physicians, insisted with the support of the British and 
French delegates that no such publication should take 
place [193: 201–2]. The ISC never met again. In short, the 
above example shows how, in the French case, guidelines 
reaffirming and demarking legitimate clinical research 
from criminal experiments for legal purposes were a low-
er priority than a professional condemnation that should 
precede and inform judicial action.
(2) Immediate reception in the professional press af-
ter the NMT
The historian Etienne Lepicard has examined the im-
pact of the NMT and the Nuremberg Code in detail in two 
leading French medical journals, La Presse médicale—an 
elite medical journal—and the Concours médical—a pro-
fessional journal with close ties to the French medical 
trade unions. Beginning in 1946, the Presse médicale fea-
history of medicine
Medical Ethics in the 70 Years after the Nuremberg Code, 1947 to the Present 1 3S200
tured eyewitness accounts by Charles Richet, Jean Braine, 
André Ravina, Robert Waitz, and Marian Ciepielowsky, 
and covered the NMT in 1947, including a precise trans-
lation of the accusations but no direct mention of the 
Nuremberg Code. Camp experimentation and “eutha-
nasia” remained rather undifferentiated in the accounts 
and genuine questions about extermination prevailed 
over those concerning experimentation and research. In 
contrast to La Presse médicale, the professionally-orient-
ed Concours médical hardly made any reference to the 
NMT in its columns; when the issue surfaced, it did so 
mainly in the context of professional debates about the 
creation and actions of the WMA and the (re)structur-
ing of the French medical profession in the form of the 
French Medical Association (Ordre) and its deontologi-
cal code of 1947. Thus, the influence of the Nuremberg 
Code on the post-war debates in the professional medical 
press in France may be characterized as being strongly 
divided between an elite medical public with reports on 
the NMT but not the Code per se, and a discourse of gen-
eral physicians with an “almost complete silence about 
what happened to medicine under the ‘Third Reich’ and 
about the NMT” [264: 71]. Generally, eyewitness ac-
counts from physicians who had survived German con-
centration and extermination camps were placed at the 
forefront, including direct testimonies on atrocities and 
the moral condemnation of unethical practices by Ger-
man physicians and scientists, lumping together “eutha-
nasia”, forced sterilization, and experimentation under 
the general heading of “medically assisted extermina-
tion”. According to Lepicard, the Nuremberg Code does 
not seem to have had any direct influence on professional 
audiences at this point. In short, it seems that condemna-
tion, rather than preventing unethical and criminal prac-
tices and experiments, was the central concern of the re-
ports from French medical professionals. 
(3) The role of French representatives in side-lining 
the Nuremberg Code in early debates about medical eth-
ics in the WMA
In late November 1944 and on June 6, 1945, barely one 
month after the end of World War II and three weeks after 
the initial ISC meeting described above, the British Med-
ical Association (BMA) gathered physicians from over 30 
countries to discuss the (re)creation of an internation-
al association of doctors. Due to the late reorganization 
of the French Medical Association (Ordre des Médecins), 
Paul Cibrie (1881–1965) represented the French medical 
profession at the initial WMA meetings in 1945 and 1946 
and continued to act as French liaison. He inevitably be-
came a key player when he was appointed temporary 
secretary-general of the WMA in September 1946, to-
gether with Charles Hill, the secretary of the BMA. Cibrie 
was a longstanding medical-union activist and had been 
compromised by his membership in the second Higher 
Vichy Council which, from 1942 to 1944, participated in 
the implementation of anti-Jewish laws. [265]
In June 1947, two months before the final verdict of the 
Nuremberg Doctor’s trial, John A. Pridham presented a 
BMA-supported request and draft for a declaration on 
war crimes and medicine, classifying the different medi-
cal war crimes for the preparatory assembly of the WMA. 
One month after the Nuremberg verdict, the first Gen-
eral Assembly of the WMA in Paris established a specific 
committee for the question of war crimes in September 
1947. In 1947 this committee adopted a medical charter, 
including the WMA physician’s oath, without any direct 
reference to the NMT Code [266, 267]. The initiative ech-
oed British physicians’ demands for a post-trial declara-
tion, a step that the ISC discussed but never had the time 
to make. Paul Cibrie, one of the four members of the war 
crimes committee, specifically insisted on the necessity 
of an oath at the conclusion of medical studies, comple-
menting or rivalling the binding deontological code of 
the French Ordre des Médecins, then barely established 
[266]. The medical vow was adopted and became known 
as the Declaration of Geneva at the second WMA General 
Assembly in Geneva in September 1948 [268]. 
Four months earlier in April 1948, at the second coun-
cil meeting in New York, Cibrie had suggested the ne-
cessity for a more comprehensive and obligatory inter-
national code of medical ethics. His efforts led to the 
appointment of a study committee on the matter under 
his presidency at the second General Assembly in Ge-
neva [269]. The code was conceived in a comprehensive 
way and was to include the Geneva declaration as a pre-
amble and the code of ethics of the Canadian Medical As-
sociation as an introduction. A complete first version of 
this ethical code was then presented to the WMA council 
at its fifth meeting in Madrid in April 1949 [270]. A direct 
reference to the Nuremberg Code never appeared dur-
ing the nine years that Cibrie served the WMA at the in-
tersection of the committees on war crimes and medical 
ethics. From the outset, he sought to distance the WMA’s 
considerations on international medical ethics from the 
“scientific crimes” of German physicians, especially be-
cause they were initially addressed in a single commit-
tee on war crimes that led to the adoption of the Gene-
va Declaration. The dividing line for Cibrie was a simple 
one: crimes fell into the domain of law and the compe-
tence of judges with their merciless justice, while medi-
cal ethics belonged to the realm of the medical profes-
sion, which was defined by professional autonomy [271].
(4) The Monaco Commission and the NMT
The early 1950s were further marked by an initiative of 
a group of continental jurists and physicians led by the 
Belgian military physician Surgeon General Jules Vonck-
en and the Swiss jurist Jean Graven, who actively engaged 
the public in establishing international medical law. On 
December 23, 1950, Voncken, as one of the founders of 
the International Committee of Military Medicine and in 
the context of the debates mentioned above, published a 
harsh critique of the WMA International Code of Medical 
Ethics in the French medical journal Presse médicale [272]. 
He called for a lesson to be learned from the NMT and 
referenced the Nuremberg judgment and code directly. 
His conclusion was that without international law, inter-
national courts, and penalties, the code only represent-
ed a simple statement lacking any sort of practical con-
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sequences. At the following WMA council meeting Cibrie 
resented the attack and insisted that international medi-
cal law did not exist and that international medical tribu-
nals in wartime were impossible since a neutral location 
for impartial judgment would be impossible to find [271]. 
In Cibrie’s view, Voncken’s activities, as well as those of 
the ICMM, were unduly interfering with internation-
al and professional organizations rightfully concerned 
with medical ethics. In April 1951, Cibrie, in his role as 
the WMA’s mandatory observer, attended the ICMM and 
the medico-legal Monaco Commission founding meet-
ing for an Institute for the Study of International Law. He 
reported to the eleventh council meeting of the WMA that 
Voncken, the Monaco Commission, and the ICMM had 
no mandate to interfere with medical ethics affairs that 
belonged to the joint competence of WMA, WHO, and 
the International Commission of the Red Cross (ICRC). 
In October, 1951 the WMA General Assembly adopted a 
resolution concluding that “given that the Monaco Com-
mission is not mandated to treat these questions, if it per-
sists in elaborating a Code of Medical Ethics, the code will 
not be recognized by the medical profession” [273]. Side-
lining the Monaco Commission’s initiative, the first ex-
plicit reference to the Nuremberg Code was marginalized 
as well, and when the WMA transformed the Study Com-
mittee on Medical Ethics into a Permanent Committee in 
1952 under the presidency of Paul Cibrie, the Nuremberg 
Code continued to be widely ignored. 
(5) French medical war crimes trials: the Struthof 
Medical Trials (1952–1954)
It is in this context that the preparations for the French 
follow-up military trials of a group of Nazi physicians 
who conducted medical research at the Struthof/Natz-
weiler concentration camp in formerly-occupied Al-
sace (Struthof Medical Trials, SMT) were actively taken 
up on July 18, 1952. Four weeks prior to the trial opening 
in Metz, the French Academy of Medicine (FAM) pub-
lished a public statement on experiments with human 
subjects in November 1952 [274]. The SMT offers a note-
worthy and complementary perspective for studies con-
cerned with the impact of the NMT and the influence of 
the Nuremberg Code in France. Did the French judges 
refer to the guidelines for “permissible medical experi-
ments” established by the NMT in 1947? 
A detailed analysis of the arguments used by the pros-
ecution and the defence, and whether or not they echo ed 
the NMT’s “ten principles”, is beyond the scope of this pa-
per [257–260]; however, an overview is possible. First, the 
prosecuting magistrate Captain Lorich issued, on April 20, 
1948, letters rogatory to the typhus expert Professor Georg-
es Blanc, director of the Pasteur Institute in Casablanca, 
and Colonel André Jude, director of the Central Labora-
tory of the French Army and military hospital specialist 
physician, requesting written statements on ten questions 
based on the defendants’ declarations and their scientific 
publications, which were essentially of a technical-medi-
cal nature. The Nuremberg principles did not surface and 
neither explicit nor implicit reference was made to them by 
the prosecution or by the two experts [275]. Defence law-
yer Frédéric Hoffet interpreted the scientific experts’ state-
ments as a testimony to normal medical experiments de-
void of any objectionable deed. Echoing individual points 
of the Nuremberg Code, but without referring to it explic-
itly, Hoffet noted that the experiments were made in ac-
cordance with societal necessity and usefulness, and that 
requirements such as prior animal and laboratory studies, 
a favourable risk-benefit analysis, and the execution by 
qualified personnel were respected [257–260]. 
Active preparations for the trial sparked an initiative by 
the French National Academy of Medicine (FAM) to hold 
a secret committee on human experimentation ethics. A 
public statement by this committee was rendered nec-
essary by the pressure imposed, on the one hand, by the 
repeated accounts of medical atrocities reported to the 
Academy by physicians who had survived German con-
centration camps, and on the other by expert statements 
from Jude and Blanc which discharged the NS physicians 
on trial in Metz, purveying the FMA with the role of a me-
diating moral authority for the entire medical profession. 
The short statement emphasized a distinction between 
non-therapeutic and therapeutic research, meaning 
that the FAM reaffirmed different consent requirements 
for therapeutic and non-therapeutic research [257–259]. 
Therapeutic research, which associated experiment and 
care, was exempt from obtaining patient consent in writ-
ing. The FAM declaration suggested that the medical pro-
fession had the basic power to define what was therapeu-
tic or not, and therefore what required consent or not. It 
was therefore in great contrast with the Nuremberg Code, 
which had abolished this distinction and declared that all 
research with coerced subjects and without consent was 
unlawful. To distance itself from coerced concentration 
camp medical research the FAM committee added a final 
paragraph to its statement. It concluded that, in applying 
the above-mentioned principle, the National Academy 
considered experimental activities committed in certain 
concentration camps during the past war criminal and 
contrary to the principles formulated in the Geneva Con-
vention [257–259]. In the end, the judges of the Military 
Tribunal at Metz disregarded the medical experts’ appre-
ciations and condemned the two German physicians Eu-
gen Haagen and Otto Bickenbach to lifelong forced labour 
on December 24, 1952. The audience notes from the SMT 
make no mention either of the NMT judgment or of the 
Nuremberg Code rendered five years earlier [256–259].
As described above, the example of the SMT, which 
was intensely covered by the French general press, high-
lighted the differences of opinion between medical scien-
tists and physicians on the one hand, and jurists on the 
other. The debates at the trial made clear that the distinc-
tion upheld by the FAM conclusion and by Cibrie at the 
WMA, namely between normal medical practice and bio-
medical research on the one side and German medical 
war crimes on the other, was not as evident as the med-
ical profession’s representatives were inclined to think. 
In practice, the borderline between medical practice and 
research, and between lawful and criminal medical acts, 
was blurred, and the debates of the jurists at the SMT 
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hinted at this problem—as had the ICMM and the Mo-
naco Commission. When the Royal Netherlands Medi-
cal Association—some of the Struthof victims serving as 
witnesses at the SMT in Metz were Dutch physicians—
requested in early 1953 that the WMA consider the ethi-
cal issues concerning the use of human subjects in scien-
tific experiments and develop guidelines to protect test 
subjects in practice, the Monaco Commission issue again 
became a burning one. In the context of this internation-
al competition for moral authority in the field of medi-
cal research ethics and international medical law and the 
preparation of the appeal court trial of the SMT in 1954, 
the Committee on Medical Ethics of the WMA under the 
leadership of Cibrie drafted the first version of the WMA’s 
ethical guidelines for human experimentation, which 
were presented in Rome in 1954 [276]. In February, 1953 
the American journal Science had published the Nurem-
berg Code as a guide [277]. When the British physician 
Hugh Clegg was appointed as chair of the Committee 
in 1959, he submitted a report to the WMA Committee 
on Medical Ethics in 1960 that stated that the WMA had 
briefly considered adopting the Nuremberg Code in 1953 
but that Cibrie had dismissed the idea [278: 2]. Instead 
of adopting the Code, Cibrie and his committee import-
ed the 1952 FAM formulation separating therapeutic and 
non-therapeutic research because they questioned the 
wisdom of laying down hard and fast rules that would 
constrain researchers; they especially wanted to defend 
professional autonomy [276]. It was this French influ-
ence in the competition between post-war internation-
al organizations, and in the confrontation between med-
ical and juridical values and professional cultures, that 
reinserted the distinction between therapeutic and non-
thera peutic human experiments. This was one of the 
characteristic traits of the sidelining of the Nuremberg 
Code in France and, through Cibrie, its eventual sidelin-
ing within the WMA Helsinki Declaration of 1964.
Conclusion
The reception of the Nuremberg Code and its impact on 
medical ethics in France was troublesome at best. The 
period between 1946 and 1964 may be interpreted as the 
result of a continued, hidden, and forgotten internation-
al disagreement and negotiation about the essential di-
vide between an internal professional moral code and 
external legal control over the rules and principles that 
differentiate lawful and unlawful clinical research prac-
tices. In the French case, reception of the Nuremberg 
Code was very limited—if not absent—whether in the 
medical press or in the French military follow-up trials. 
The aforementioned discussions and disagreements in 
the late 1940s and 1950s about drafting an internation-
al code for clinical research echoed, directly or indirect-
ly, issues that were at stake in ongoing legal procedures. 
They have rarely been connected to the wider contextual 
framework and the (non)reception and limited influence 
of the Nuremberg Code in France.
The perpetuation or reintroduction of the therapeu-
tic versus non-therapeutic biomedical research divide, 
abandoned by the Nuremberg Code for the first time in 
biomedical research ethics, was a significant difference 
concerning the situation in France and had long lasting 
consequences. As a consequence of the reintroduction of 
the category of therapeutic research that could forego sub-
ject consent, the French medical profession and the FAM 
introduced a “pseudo-medical” research category based 
on the idea that Nazi concentration camp research was 
criminal because it was “pseudo” or biomedical research 
that was scientifically invalid. “Pseudo-medical” was de-
fined here as the fact that these experiments could not be 
integrated into the framework of the normal role of med-
ical diagnosis and treatment of unhealthy individuals. 
The FAM favoured a definition that attempted to demar-
cate between lawful therapeutic experiments and crimi-
nal Nazi experimental practices in concentration camps, 
while maintaining the medical profession as the defining 
authority, whereas the Nuremberg Code introduced the 
experimental subject as the supreme authority who could 
refuse, consent to or halt an experiment. The role that the 
“French case” played in the immediate post-war reorgan-
ization of biomedical research ethics was to extend the 
therapeutic versus non-therapeutic biomedical research 
divide into the 1960s, and to influence the 1964 Helsinki 
declaration. From there it took three decades to recover 
the essential influence of the Nuremberg Code’s central 
principle: general experimental subject consent. 
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Introduction
According to the Moscow Agreement of 30 October 1943 
and the London Agreement of 8 August 1945, after the 
end of the war, war criminals were to be either judged by 
an International Military Tribunal or to stand a trial in 
the country where they committed their crimes. The Pol-
ish media reported on the Nuremberg trials extensively, 
the Doctors’ Trial (9 December 1946–20 August 1947) in 
particular,19 familiarizing the readers with facts mostly 
unknown to the public at the time. At the same time, the 
perspective of extraditing hundreds of war criminals to 
Poland triggered efforts to create a Tribunal, which, due 
19  Stanisławska E. Procesy hitlerowskich zbrodniarzy wojennych 
w Niemczech na łamach prasy polskiej 1945–49. Wrocław 1977; 
unpublished MA dissertation.
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to the significance of the proceedings, could act as a na-
tional equivalent to the International Military Tribunal in 
Nuremberg. 
The National Supreme Tribunal (Najwyższy Trybunał 
Narodowy—NTN) was brought into being on 22 Janu-
ary 1946 in order to judge the main decision-makers and 
perpetrators responsible for the most horrific atrocities 
and exploitation of Poles and other nationals who found 
themselves in Poland during the years of occupation. The 
NTN judged in seven cases, including the First Auschwitz 
Trial, known as the Auschwitz Garrison Trial (24 Novem-
ber to 16 December 1947), which brought 40 members of 
KL Auschwitz staff to justice, including two SS physicians.
Sentences were rather severe—23 of the convicts were 
sentenced to death and 6 to life in prison, with the re-
mainder facing 3 to 15 years in prison, with only one ac-
quittal: doctor Hans Münch. According to Piotr Setkie-
wicz, “the collected evidence made it rather clear that 
he would be acquitted. Here again, propaganda reasons 
were at play; with the assumption that all the others will 
be sentenced, Münch’s acquittal was to speak for the im-
partiality of the Polish ruling team and the Polish justice 
system in general” [279: 11].
The ‘good man of Auschwitz’?
Hans Wilhelm Münch (1911–2001) had been recruited as 
a bacteriologist by the Waffen-SS and was sent to the Hy-
giene Institute of the Waffen-SS in Rajsko, 4 km from the 
main camp Auschwitz in 1943, where he continued his re-
search and supervised the serological laboratory in Block 
10 until the evacuation of the camp in January 1945. In 
1946, having been identified as an Auschwitz physician, 
he was extradited to Poland to stand trial in Cracow. He 
was accused of conducting malaria experiments in which 
he injected blood samples taken from infected patients 
into healthy inmates, and also administering injections 
of serum that caused rheumatism [280: 150]. 
During the trial Münch claimed that he had never 
been a member of the NSDAP—in fact he had joined the 
party in 1937—and that he had attempted to enlist in the 
Wehrmacht in order to avoid recruitment into the SS, into 
which he was eventually inducted in 1943. The justifica-
tion of the court’s decision reads: “the work done in Raj-
sko was generally speaking honest, although there were 
cases of criminal medical practices, in which the accused 
has never participated. The accused did not conduct ma-
laria experiments but worked on medicaments against 
rheumatism, administered both to SS-men and the pris-
oners, only for healing and not experimental purposes” 
[280: 215] 
Hans Münch was the only one acquitted in the Ausch-
witz Trial. This decision was to a large extent based on 
his own insistance that he vehemently refused participa-
tion in prisoner selections [279: 254], and witnesses’ tes-
timonies that spoke in his favor. “According to witness-
es Dr Kieta and Dr Reimann”—reads the justification of 
acquittal—“the accused conducted a series of experi-
ments to find a treatment for rheumatism and the serum 
produced in the Institute was administered exclusively 
for healing purposes. It has happened that the patient’s 
condition did not improve and he was back within a few 
weeks with fingers deformed, but witness Kieta could 
not determine whether that was an effect produced by 
the injections. Also, the expert opinion by Professor Ol-
brycht confirms that the serum produced in Rajsko was 
used for treatment. Additionally, witness Pleszkowska 
testified that the accused tested serum on him, in the in-
mates’ presence, in order to alleviate their anxiety. All 
mentioned witnesses, as well as witnesses Dr Fajkiel and 
Dr Kowalczykowa, stated that the accused had always 
had a benevolent attitude towards the camp inmates and 
tried to be helpful, even putting at risk his own safety, by 
helping to smuggle correspondence, organizing meet-
ings of spouses, providing medicament for a sick Jewish 
doctor and intervening on behalf of two prisoners placed 
in a punitive unit” [280: 215–6]. The court concluded that 
it was not possible to establish whether Münch took part 
in the experiments conducted by doctor Bruno Weber 
(1915–1956), the director of the Institute. 
Almost twenty years later, a similarly favorable opin-
ion of Münch was published in ‘Medical Review—Ausch-
witz’. The author, former prisoner and doctor Dorota Lor-
ska, maintained that Münch saved her from the punitive 
unit, thus saving her life, and vividly remembered that on 
his arrival to Block 10 he introduced himself and shook 
her hand. She admitted that Münch conducted experi-
ments, immediately adding, however, that they were not 
harmful, but more like a cover up to be able to show some 
results to his superiors [281]. This reputation as a unique 
Nazi doctor in Auschwitz was later strengthened by Rob-
ert Jay Lifton in his classic “The Nazi Doctors”, in which 
Münch, under the pseudonym Ernst B., was described as 
‘a human being in an SS-uniform’ [282]. In the Polish lit-
erature, he also served as an example of a German phy-
sician who dared to refuse to follow criminal orders and 
tried to help the prisoners as much as he could in the cir-
cumstances given [283–285]. 
More recent studies do not share this enthusiasm, re-
ferring to Münch as a ‘figure in all respects ambivalent’ 
[286: 176] and ‘controversial’ [256: 85]. Research by Hans 
Joachim Lang and Paul Weindling indicates that painful 
injections received by the inmates of experimental Block 
10 after chemical sterilization, as well as the extraction 
of multiple teeth without any anesthetic measures could 
have been in service of Münch’s projects (given that teeth 
present a source of infection). In Paul Weindling’s view 
“Münch’s experiments were very much opportunistic 
and an individual sphere of activity” [287: 165]. More-
over, even though the Polish Tribunal did not find suf-
ficient evidence to support the accusations regarding 
malaria experiments, it cannot be excluded that Münch 
may have loosely collaborated with his close friend Josef 
Mengele [288: 45, 289: 442] on a specific protein project. 
There is no need to question the National Supreme 
Tribunal’s proceedings or the credibility of witness state-
ments during the 1947 trial. Many of them were former 
prisoner-physicians and, indeed, may have been treated 
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differently by their German colleague. Additionally, hav-
ing been assistant-collaborators in experimental proce-
dures, rather than experimental subjects, they certainly 
had a different perspective on and memory of the events. 
The Polish medical community accepted proof of 
Münch’s moral standards to the extent that a much short-
ened version of his work titled “Hunger und Lebenserwar­
tung in Auschwitz” (Starvation and Life Expectatancy in 
Auschwitz) was published in ‘Medical Review—Ausch-
witz’—the only journal devoted exclusively to medicine 
during the Holocaust [290]. While under arrest and await-
ing trial (he was in Poland from 18 December 1946) Hans 
Münch analyzed and organized the files of the Hygiene 
Institute in Rajsko and compiled the results in a detailed 
120-page study that he finished on the day of the begin-
ning of the First Auschwitz Trial, 24 November 1947.
“I appeal for pardon not so much for myself but for 
science”
The second physician judged during the First Auschwitz 
Trial, Johann Paul Kremer (1883–1965), is much better 
known due to the publication of his famously infamous 
diary, which documents, among other events, his 2.5 
months in Auschwitz (30 August to 18 November 1942) 
[291]. In this short period of time he selected at least 
10,717 deported prisoners for death in the gas chambers 
(documentation incomplete) [291: 20] and took part in 14 
Sonderaktionen (special actions) [291: 158] in addition to 
pursuing his research interests.
According to Kremer’s line of defense, he was sent 
to Auschwitz as a form of punishment for a publication 
which supported the theory of inheritance of acquired 
characteristics, a concept not much favored by race-ori-
ented scientists. The article, titled ‘Ein bemerkenswerter 
Beitrag zur Frage der Vererbung erworbener Verstuemme­
lung’ (An important contribution to the question of the 
inheritance of injuries) was published in spring 1942 and 
presented the case of a child born without four fingers, 
whose father had lost fingers on the same hand in an ear-
lier work accident. In fact, Kremer had demonstrated an 
inclination towards Lamarckism much earlier when he 
received his post-doctoral degree in 1929 based on a dis-
sertation ‘Ueber die Veraenderungen des Muskelgewebes 
im Hungerzustande’ (On changes in muscle tissue under 
starvation conditions) [279: 131]. Despite that, he was 
able to continue his career after 1933.
While in Auschwitz, he continued pursuing his re-
search interests using camp inmates to study the rela-
tionship between starvation disease and alterations in 
internal organs (the liver, pancreas and spleen) under 
conditions of extreme exhaustion. In his statement, he 
described how he used to visit Block 28, where the pris-
oners were categorized as able or unable to work, and he 
would ask them to keep prisoners with advanced hun-
ger disease for him and inform him of the date of their 
execution. “Selected prisoners were brought back to the 
Block 28 […], placed alive on the dissection table and I ap-
proached them and could ask questions significant for my 
research, for instance their body weight before the arrest, 
how much lost since then, whether there were any medic-
aments administered recently. After I’d collected the nec-
essary information the prisoner was killed with a phenol 
injection by a paramedic. […] I myself have never done in-
jections. I was waiting with the jars for the specimens that 
prisoner physicians cut out from those organs that I need-
ed to examine for my research. In some cases, I ordered 
to take a photo of those patients who were to be killed for 
me, so that I could collect specimens” [279: 138–9]. 
Johann Paul Kremer was sentenced to death on 16 De-
cember 1947. On 24 December 1947, on the eve of his 
65th birthday, he appealed to the President of the Polish 
Republic for pardon. In keeping with his main line of de-
fense, he maintained that he had become a victim of sci-
ence and continued: “I appeal for pardon not so much 
for myself as for science, because I am in possession of a 
number of significant research results, ready for publica-
tion, for instance the building of gallstones in insects, in-
flammations, the problem of cancer and, finally, a satis-
fying answer to the question of inheritance of acquired 
characteristics” [284: 379]. 
The president granted the pardon and Kremer’s sen-
tence was commuted to life in prison. However, in 1958 
the court in Bydgoszcz decided that, due to his age and 
proper conduct in prison, one should assume that he 
would not commit additional crimes, and he was extra-
dited to Germany [292]. Initially welcomed as a ‘martyr 
from the East,’ thanks to a media campaign Kremer stood 
another trial and was sentenced to 10 years in prison, but 
the years that he had served in a Polish prison were taken 
into account.
The case of Roman Zenkteller20
The First Auschwitz Trial was initially planned as a big 
trial with 100 accused, including the most brutal func-
tion prisoners. Piotr Setkiewicz argues that “doubts were 
voiced with the case of physicians Roman Zenkteller and 
Władysław Dering, whose coarseness and sometimes 
even brutality towards fellow inmates was rashly inter-
preted as a sign of betrayal and sellout to the Nazis. Soon, 
however,”—Setkiewicz continues—“witnesses began to 
turn up presenting activities of these two physicians in 
a more favorable light, hence, not to increase confusion, 
the decision was made that only SS staff members would 
be indicted” [279: 10].
Polish prisoner physician Roman Zenkteller (1889–
1975)—block physician in Auschwitz I and later physi-
cian-in-chief at Birkenau hospital—earned a reputation 
for being extremely rude and cruel towards other prison-
ers, especially those who were Jewish, toward whom he 
was “evil for evil’s sake” [282: 250]. He was indicted for 
active participation in selections and ill-treatment of pa-
tients and personnel of the hospital, and stood trial be-
fore the District Court in Cracow (30 June to 20 Novem-
20  R.J. Lifton incorrectly referred to Zenkteller as Zenon [4: 249] 
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ber 1948). Even though prosecution witnesses testified 
to his notorious brutality and participation in selections 
of sick prisoners for death, he was acquitted because the 
statements of defense witnesses were considered more 
plausible, owing to the fact that they “were mostly physi-
cians, paramedics and intelligent people” [293: 196]. The 
defense argument downplayed the legendary brutality of 
the accused, describing it as a reflection of the brutality 
that was pervasive and entrenched in camp life and es-
sential to maintaining discipline, which was in the inter-
est of all prisoners, and highlighted his cooperation with 
the camp resistance movement. 
Zofia Wóycicka demonstrated that in court proceed-
ings former function prisoners were often considered 
more credible than “normal” prisoners as it was assumed 
that they had better insight in camp life and “were more 
aware of the situation and circumstances than those who 
based their opinion on isolated events that they had wit-
nessed” due to their privileged position in the camp hier-
archy [293: 196]. Here again, it can be supposed that the 
concept of colleagueship, deeply rooted in the medical 
profession, was not without influence on the court’s pro-
ceedings and decision. In 1949 the case was reopened, 
but the result of the proceedings remains unknown [293: 
190]. It is known, however, that in 1950, Zenkteller prac-
ticed in a small town in the district of Greater Poland.
In general, camp physicians were poorly represented 
in the trials conducted in Poland [294: 188]. This might 
have been caused by the fact that the immediate postwar 
years were characterized by tracing the ‘main war crim-
inals’ and also by increasing tensions between the East 
and West, which led to decreasing numbers of extradi-
tions, which were eventually suspended from the Amer-
ican and British zones in 1949. Apart from Johann Paul 
Kremer and Hans Münch, only Erwin von Helmersen 
(1914–1949) was extradited to Poland and on 17 January 
1949 sentenced to death by the District Court in Cracow. 
The sentence was executed on 12 April 1949.
Conflicting solidarities?
Trials of function prisoners triggered public discussion 
and substantial controversy as “their activities were per-
ceived differently by ‘camp aristocracy’, inclined to de-
fend the indicted, and those who found themselves on 
the lower level in the camp hierarchy” [293: 194]. Ad-
ditionally, former prisoners often expressed doubts as 
to whether those who had never experienced life in the 
camps were in a position to judge those who had. Simi-
lar controversies erupted in the case of Roman Zenkteller 
and found their way into the media [293: 193–200].
It is interesting to note that the most important jour-
nal devoted to medicine during the years of occupa-
tion, Medical Review—Auschwitz (Przegląd Lekarski—
Oświęcim), refrained from comment. With the exception 
of two papers discussing the problem of function prison-
ers [295], ethically dubious activities of prisoner physi-
cians, dentists and paramedics remained shrouded in si-
lence. Apart from numerous memoires and reports from 
the camps, an abundance of articles published over the 
course of thirty years (1961–1991) deal mostly with the 
mental and physical health conditions of the survivors, 
the loss of Polish medical personnel, heroic actions un-
dertaken by Polish physicians to save other prisoners, 
sanitary conditions in places of incarceration, the fate 
of Polish children, killing of the mentally ill, and medi-
cal experiments, in particular those on mass sterilization 
and tuberculosis. The case of J. P. Kremer warranted one 
article, written by a lawyer [292].
There is no doubt that the majority of prisoner physi-
cians did their best to improve conditions and save lives; 
however, in this hagiography of Polish medical profession-
als during the war there is no space for negative figures 
and even potentially harmful activities are transformed 
into actions carried out for the common good. At the same 
time, German perpetrators responsible for experiments or 
medical murder often are labeled as ‘psychopaths’, ‘crimi-
nals’, ‘killers under the Nazi swastika’, evoking the image 
of monsters, rather than that of unscrupulous physicians 
driven by an urge to pursue their scientific careers. One 
can develop the impression that the ethos of the profes-
sion took precedence over an in-depth debate of the dan-
gerous potential inherent in medical vocations. 
The ethical standards of the medical profession seem 
not to have been the main focus of interest in the post-
war decades. One of the few to speak out on the matter 
was Ludwik Fleck, who in 1948 tried and failed to gen-
erate a national debate in regard to experiments on hu-
mans [296]. Surprisingly, he did not refer to the Nurem-
berg Code and argued that the increasing demand for 
experimentation on humans required clear regulations 
in order to protect experimental subjects. In his view, in 
case of potentially harmful procedures the persons in-
volved should be fully informed about the consequences 
and their voluntary consent should be conditio sine qua 
non, whereas in non-risky experiments consent would 
not necessarily need to be obtained. Fleck condemned 
experiments on the mentally ill and prisoners, unless for 
healing purposes, however, in the case of convicts sen-
tenced to death he proposed that they could be given 
an opportunity to volunteer, even for risky experiments, 
thus “rendering an important service to society” [295: 
302]; should they survive, they should be granted pardon. 
A national debate on medical ethics could have been 
orchestrated by the Chamber of Polish Physicians, which 
was dissolved in 1950 and replaced by the Physicians 
Sections attached to the Trade Union of Employees of the 
Health Service System which, however, “dealt mostly 
with various existential matters rather than questions of 
medical ethics” [285: 284].
Postscriptum
While World War II has been a very important field of 
study in Poland, medicine in the years of occupation has 
only intermittently attracted the attention of Polish his-
torians, and research on medicine-related issues has pri-
marily been the domain of physicians and other health-
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service professionals. Additionally, the last two decades 
saw a shift in interest among researchers of WWII and 
the postwar decades. After the political transition of 
1989, research focused largely on the history of the an-
ticommunist underground movement and Soviet occu-
pation. This shift has been mirrored in the name chang-
es of the special commission tasked with documenting 
and disseminating knowledge of war crimes: founded as 
the Main Commission to Investigate German Crimes in 
Poland (1945–1949), altered to Main Commission to In-
vestigate Nazi Crimes in Poland (1949–1984), followed 
by the designation Main Commission to Investigate Nazi 
Crimes in Poland—Institute for National Remembrance 
(1984–1991) and eventually the Main Commission to In-
vestigate Crimes against the Polish Nation—Institute for 
National Remembrance (1991–1999), which was incor-
porated into the Institute as its investigative unit in 2000. 
While it is not surprising that Russian-Soviet crimes at-
tract the attention of researchers and general readers af-
ter decades of silence and suppression, there is a risk that 
German-Nazi atrocities may gradually fade into collec-
tive post-memory21 as less severe. After 1989 “Katyń be-
came an equally, if not more important, symbol of Polish 
martyrdom as Oświęcim or Majdanek” [297: 254].
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On August 10–14, 1952, the Second World Congress of 
Jewish Physicians gathered in Jerusalem. On its last day 
it passed a resolution on medical ethics, which became 
known as the Jerusalem Declaration on Medical Eth-
ics (JD). Explicitly connected to what had happened in 
Nazi Germany, it actually constitutes one of the rare ex-
pressions of concern within the young state of Israel, and 
links the evolution of modern medicine and Nazi med-
ical crimes. As far as we know, only one prior text pre-
21  “According to anthropologists, memory includes what an 
individual or collectivity experienced. They distinguish between 
individual and collective memory. In literature there exist post-
memories, which relate to events not experienced but deeply 
rooted in our conciousness thanks to stories important to us, told 
by our relatives, or known via education (school, books, film, 
museum, family). One can distinguish individual and collective 
post-memory. The majority of Poles did not personally experience 
World War II and ‘embrace’ these years as post-memory.” R. Wnuk, 
II wojna światowa w pamięci historycznej Polaków, In: T. Nasiero-
wski, G. Herczyńska, D.M. Myszka, Zagłada chorych psychicznie. 
Pamięć i historia. Warszawa: Eneteia 2012, p.249
sented such an attempt: The motion called “Let us throw 
the anathema against the murderer-doctors”, which had 
been presented at the funding meeting of the World Med-
ical Association (WMA) in September 1947 in Paris by the 
Jewish Medical Association of Palestine (JMAP) [298]. 
Toward the end of 1952, the JD has been published 
in three languages—Hebrew, French and English—in a 
very local and not easily accessible journal, Dapim Refui­
yim, literally “Medical Leaves”, the organ of the Hebrew 
General Sick-Fund. The French version received a great-
er exposure when issued in La Presse médicale, the jour-
nal of the Paris medical establishment [299]. The origi-
nal 1952 English version is included as an attachment to 
this paper. However, as this version is relatively different 
from the French and Hebrew ones, the text has been an-
notated accordingly in order to ensure the readers per-
ceive these differences and their significance. 
Having presented elsewhere the broader context of the 
declaration [264], I will focus here on a close reading of the 
text within its immediate context, i. e. the two lectures the 
JD was taken from. In addition, comparisons will be made 
with the so-called Nuremberg medical code and the mo-
tion presented by the JMAP at the founding meeting of 
the WMA, both from 1947. In conclusion, the structure of 
the declaration will be clarified as well as its significance. 
I claim that it represents, in a sense, a failure to furnish an 
ethical framework based on Nazi medical crimes beyond 
a narrow focus on the ethics of human experimentation. 
The Jerusalem Declaration – general presentation
The JD is a one-page text. It is divided into four parts: A 
summary of Nazi medical crimes (A), two transitional 
paragraphs (B and C) and four points of medical ethics 
(D). Globally speaking, as we will see later, the Hebrew 
and French versions are soberer and less emotional than 
the English one.
Formally, the declaration speaks in the name of the 
Congress in which it was passed: “The Second World 
Congress of Jewish physicians, which gathered in Jeru-
salem on August 10–14, 1952, exposes … [146: 330]” This 
formal voice is actually enhanced as the cap of the article 
states that it was passed “unanimously”. From the same 
cap, we also learn that the declaration is “a summary of 
the lectures [given] by Prof. H. Baruk (Paris) and Dr. M. 
Dvorjetski (Tel Aviv) at a session dedicated to the prob-
lems of medical ethics and the Nazi physicians’ crimes” 
[146: 329]. Thus, these two lectures give us the immediate 
literary context of the declaration. It is worth noting that 
one of the authors, Dvorjetski, had also been the author 
of the 1947 motion mentioned above.
Henri Baruk (1897–1999) was a French psychiatrist 
who renovated the Charenton asylum before World War 
II (WWII) and remained head of it throughout the war 
years [300, 301]. A disciple of Babinski, he developed his 
practice at the crossroads of Jewish tradition, Pinel’s mor-
al therapy and research work on experimental psychopa-
thology. He had just been appointed associate professor 
at the Paris Medical School when he first met Dvorjetski 
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at the founding meeting of the WMA mentioned above by 
mid-September 194722.
Mark (Meir) Dvorjetski (1908–1975) was born in Vilni-
us (today’s Lithuania) and raised in Poland and France. A 
physician (Vilnius, 1935), he survived various concentra-
tion camps and had arrived in Paris after the war, with the 
intention of immigrating to Israel [143, 302]. Zionist from 
his early years as a student, he was connected with the Zi-
onist movement and, although he had not yet immigrated 
to Israel, he has been called to be part of the delegation of 
the Jewish Medical Association of Palestine at the WMA 
founding meeting. His lecture “Let us throw the anathe-
ma against the murderer-doctors” at that meeting great-
ly impressed people, especially (recalled Krieger, head of 
the Jewish delegation) the moment when “he took out a 
piece of soap made out of the bodies of Jews (!) and placed 
it on the president’s table” [303, referred to in 304: 201].
Dvorjetski’s 1952 lecture
The lecture Dvorjetski gave on August 12, 1952 at the 2nd 
World Congress of Jewish Physicians in Jerusalem was 
entitled “The Jewish Medical Resistance and Nazi Crimi-
nal Medicine during Disastrous Period.”23 As indicated in 
the title, the first part of the paper (roughly a third of it) 
describes various figures of Jewish medical resistance to 
Nazism. Dvorjetski utilizes this framework to contrast the 
decline of morality in medicine under the Third Reich to 
the moral righteousness of the victims: “(the) discover-
ies of marvelous moral rising among the mortified (sic) 
doctors in the occupied countries.”24 The last two thirds of 
the lecture are a description of Nazi physicians’ actions. 
Many of these deeds found their way into the first part 
of the Jerusalem Declaration, but here the lecture echoes 
the author in questioning: “How did the medical giants 
in Germany degraded (sic)? How did they come to moral 
decline and how did they come to paralyse (sic) the hu-
man feeling?”25 Toward the end of his lecture, Dvorjetski 
called to found medicine anew on morality and on “the 
holiness of human life.”26
Dvorjetski’s general framework of a declining morali-
ty actually expresses the main idea of the first transition-
22  Actually, I am positing that they first met at the Paris WMA 
meeting because the correspondence held in Dvorjetski’s papers 
at Yad vashem began immediately after that meeting; see the Dr. 
Mark Dvorjetski Archive (MDA). RG P 10, File 20/1 (1947–1960). 
Jerusalem: Yad Vashem library.
23  A copy of Dvorjetski’s lecture is among his papers in Yad 
vashem, see Dr. M. Dvorjetski (Tel Aviv), “The Jewish Medical 
Resistance and Nazi Criminal Medicine during Disasterous (sic) 
Period—A lecture at The World Jewish Medical Congress in Jerusa-
lem on 12th August 1952,” typescript annotated, 17 pages, MDA RG 
P 10 File 61 (now Dvorjetski, 1952).
24  Dvorjetski, 1952, p.1. In this part, the author describes the 
famine research in Warsaw ghetto, three figures (J. Kortshak, J. 
Wigodsky and G. Gershuny) subsumed under the section title 
of “Images”, “the medical underground” in various camps and 
countries, “Doctors in concentration camps”, and “The doctors in 
Partisan Movement”. 
25  Ibid., p.7.
26  Ibid., p.18.
al section (B) of the Jerusalem declaration—the idea that 
German physicians “surrendered medical science to the 
service of Hitler’s racism, and […] initiated false and trans-
gressing biologic theories [JD, section B]”. Or in the words 
of the lecture: “A lot of German doctors had joined the ra-
cial idea to the medical science, and willingly they have 
become the […] founders of the technic [to] exterminate 
nations and executed it.”27 This idea, which, compared to 
the results of the Nuremberg medical trial (NMT) for in-
stance, greatly extends the responsibility of German phy-
sicians regarding all that happened in Nazi Germany, was 
already present in Dvorjetski’s Anathema paper of 1947 
[298]. The idea remains the same in 1952, but while the 
1947 paper sounds mostly based on Dvorjetski’s own ex-
perience and reflections as a survivor, this time the author 
explicitly and at various places indicates that his conclu-
sions are based on an examination of the Nuremberg trials 
documentation—all of the Nuremberg trials, not only the 
medical one.28 This is worth noting, because not all read-
ers of this documentation went on to emphasize the link 
between eugenicist theories (called “racial hygiene” in 
Germany) and Nazi medical crimes. The 1947 account of 
the NMT by Mitscherlich and Mielke did, but the official 
American one, for instance, did not [305: 213]. Dvorjets-
ki’s lecture constitutes one of the first broad readings and 
interpretations of the Nuremberg trials documentation, in 
which his own personal experience may have helped him 
not to be constrained by the published accounts of the tri-
als. Further research may be necessary here, but it is clear 
that Dvorjetski did not reduce “Nazi medical experiments” 
to those defined by the NMT [306], in contrast to many ac-
counts, including quite recent ones like Alfred Pasternak’s 
2006 book [307].
This broad view of what happened to medicine under 
the Third Reich and the criminal deeds of the German 
medical community is largely reflected in the four catego-
ries of Nazi medical crimes, which constitute point num-
ber one (A) of the JD [146]. The ranking of these crimes as 
well as the fact that they are taken almost word by word 
from Dvorjetski’s lecture constitute notable points. It be-
gins with euthanasia, which is followed by forced sterili-
zation and general hygienic negligence in concentration 
camps, and ends with medical experiments, which were 
relatively limited in scope. The insistence on ranking 
“mass euthanasia” first is remarkable, as are the various 
steps of it described by Dvorjetski in his lecture in a pe-
culiar section entitled “The Psychiaters (sic) of Germany 
executors of mass slaughter”. Although euthanasia had 
been debated during the Nuremberg medical trial, it did 
not find its way into the Nuremberg ten points of medi-
cal ethics, which focused only on the ethics of human ex-
27  Ibid., p.8.
28  At the beginning of the section on Nazi Medical Crimes, the 
author states generally: “Names and facts herewith shown, are 
based upon documents issued during trials against war criminals 
at Nirenberg (sic!), and also during the trial of 23 murder-doctors”, 
cf. Ibid., p.7–8. Later, he quotes documents presented at the trials, 
like a letter from gynecologist Clauberg to Himmler, and other 
documents. Ibid. p.15–16.
history of medicine
Medical Ethics in the 70 Years after the Nuremberg Code, 1947 to the Present 1 3S208
perimentation. The Jerusalem Declaration is construct-
ed differently than the Nuremberg Code. It first looks to 
establish what the Nazi medical crimes were before con-
cluding with some points of medical ethics. The fact that 
it ranks mass euthanasia first opens the door to the pos-
sibility of a broader ethical ruling.
The other three categories of the Jerusalem Declara-
tion (A) are forced sterilization, degradation of human 
beings and criminal experiments. In his lecture, after 
having presented the euthanasia of psychiatric patients, 
Dvorjetski dealt with “The German doctors on Geno-
side (sic) operations”, which he divided between what he 
called “the slow death operation” and “the operation of 
gas-chambers.”29 The former is reflected in point three of 
JD part A:
Physical and moral degradation of human beings 
by systematic and well planned hunger, thirst, cold, 
whipping and other tortures. Serving the same pur-
pose were the exposures to filth and absolute lack of 
hygiene, the instilling of fear and a sense of hopeless-
ness, and the stripping the victims naked. All these di-
abolic abominations were designed to deprive the vic-
tims of their human image and dignity.
Earlier, I pointed out that the English version of the Je-
rusalem Declaration uses more emotional language than 
the French and Hebrew ones. This is one of the first in-
stances of that pathos. The phrase “all these diabolic 
abominations” does not appear in the French or Hebrew 
versions; instead, the one-sentence paragraph merely 
summarizes the effects of such degrading treatments—
the loss of human image, or dehumanization.30
The fourth category of Nazi medical crimes of the dec-
laration is a summary of the next two sections of Dvor-
jetski’s lecture: “The sadistic medical experiments in 
concentration camps” and “The desecration of medi-
cal sciences.”31 While the former is an enumeration of 
the various experiments shortened (sometimes word by 
word like “typhoid, typhus and malaria”) in JD, the lat-
ter is a summary of the ethical principles, largely inspired 
by the Nuremberg Code, which according to Dvorjetski 
should regulate human experimentation. It ends by not-
ing the violation of these rules “by the Nazi Doctors.”32 To 
29  Ibid., p.11.
30  The operation of gas chambers did not appear as such in the 
Jerusalem Declaration. It may be subsumed that it is part of the 
first point (mass euthanasia) which did not concern only psychiat-
ric patients but “the extermination of children, old people, mental 
patients, incurables and cripples”. JD, part A, point 1. 
31  Dvorjetski, 1952, p.12–14.
32  Ibid., p.13. The first part of the section, where the Nuremberg 
Code sounds inspirational, is preserved here. As far as I know, this 
is the first instance in which these ten points of medical ethics 
issued at the NMT were ever published in Israel: “They [the Nazi 
doctors] have desecrated the medical experiment work done in 
hospitals and cure institutes:—by consent of the patient and for 
his benefit.—conditionally the man considered for it is mentally 
fit to grant his agreement.—conditionally the man is in a condi-
tion of understanding, which prepare him to make use of his free 
consent, with intervention of no factor—of force, cheat, deception, 
the best of my knowledge, this was the first use of any sec-
tion of the Nuremberg Code in Israel.33
Finally, point two of part A of the Jerusalem Decla-
ration, which refers to forced sterilization, appeared in 
the next section of Dvorjetski’s lecture under the title: 
“Preparation for sterilization of millions of European 
inhabitants.”34 From this title, the author’s main idea re-
garding the Nazi sterilization program is already explic-
it—he did not consider to be just another experiment, but 
rather the tip of an iceberg of a much greater project, i. e. 
the enslavement of large parts of the European popula-
tion. Given this stance, it makes sense that it ranks sec-
ond in JD, just after mass euthanasia. What had just been 
a line without any specific purpose mentioned in the 1947 
Anathema motion, has now been elaborated. By the end 
of the 1950s, Dvorjetski’s main idea about Nazi steriliza-
tion programs would even develop into a book published 
in Hebrew and Yiddish: Europe Without Children [308].
Based on analysis conducted thus far, it is quite clear 
that the two first parts of the Jerusalem Declaration sum-
marize Dvorjetski’s lecture at the Congress. 
Baruk’s 1952 paper
Given that a copy of Dvorjetski’s lecture has been pre-
served, it could have been more difficult to assert that the 
two next parts were drawn from Baruk’s lecture, in the 
absence of a copy of the latter. However, upon his return 
to France, Baruk published an account of the Congress in 
La Presse médicale, a professional journal reflecting the 
Paris medical establishment to which Baruk belonged. 
In the absence of the text of the lecture itself, this article 
constitutes a good point of comparison in order to con-
textualize the declaration [299].
The second transitional part of the Jerusalem Decla-
ration, part C, expresses in the name of the congress a 
shrewdness or any other means of forcing.—conditionally the man 
is able to demand, any moment convinient (sic) to him, to stop the 
experiments.—conditionally the experiment would be carried on 
with maximum hygienic conditions, scientific care at the outmost, 
based on former experiments upon beasts.—conditionally he (sic) 
would be prevented any physical and spiritual suffering, and con-
ditionally that death would not be unesential (sic) and unavoidable 
as a result of the experiment.—conditionally it would be taken 
care of the object in experiment and protect against invalidity, 
dangerous wounds or death.—and conditionally that the executors 
of the experiments are men of scientific authority, handling their 
profession according to pure medical conscience, and according to 
human morals, the moral of justice and love for the suffering; and 
according to the recognition of the mankind life holiness—which 
applies: the holiness of life of the man upon who the experiment is 
executed.”
33  Actually, some passages may be found also in the JMAP 
Anathema motion of 1947 through the references to the absence of 
people’s “consent and against their wishes” regarding experiments 
on freezing water and drinking sea-water on the one hand, and 
the practice of sterilization on the other [298: 321–2]. A translation 
of the Nuremberg Code into Hebrew appears among Dvorjetski’s 
papers but it is undated. The next explicit reference to it in Israel 
would be the 1977 regulations on human experimentation that fol-
lowed the Helsinki Declaration as reworked at Tokyo (1975).
34  Dvorjetski, 1952, p.14–15.
history of medicine
Medical Ethics in the 70 Years after the Nuremberg Code, 1947 to the Present1 3 S209
fear and concern that “Nazi criminal biologic doctrines” 
would surreptitiously penetrate the contemporary—i. e. 
post-WWII—medical and biological sciences. This wor-
ry was typical of Baruk’s fights at the time on two topics 
in psychiatry—psychosurgery and shock therapy. Moreo-
ver, it brought him to suggest a clear distinction regarding 
the ethics of human experimentation between supposed-
ly-permitted therapeutic interventions while human ex-
perimentation per se would remain forbidden [309, 310]. 
These two topics formed the core of the four points of 
medical ethics developed in the Jerusalem Declaration, 
part D.
From Baruk’s November 1952 article, we learn that he, 
Baruk, gave apparently two talks at the congress. One was 
at its opening session on August 10 and the other, on Au-
gust 12, was held with Dvorjetski at the session dedicated 
to “The problems of medical ethics and the Nazi physi-
cians’ crimes”. However, based solely on the article, it is 
difficult to fully understand what was part of the inaugu-
ral address and what was part of what he called himself 
his “report” [299: 1545, col. 1]. He apparently addressed 
more general considerations on the nature of medicine in 
the former and dealt more specifically with the ethics of 
human experimentation in the report. On medicine, we 
learn that according to him it results “from the merging 
of an intimate unity of both parties, technical knowledge 
and moral and human factors, such as people’s respect or 
trust, which is an essential factor for recovery” [299: 1544, 
col. 2 (my translation)]. While a medicine that is purely 
spiritual would have no scientific value, a purely scientif-
ic one would risk “sacrificing everything [on the altar of ] 
scientific curiosity and transforming every patient into a 
test animal” [Ibid.]. In contrast, monotheism in gener-
al and the Jewish tradition in particular have always op-
posed human sacrifice, asking that humans be replaced 
by animals in rituals. Baruk draws from this ancient tra-
dition, emphasizing the possibilities opened to scientific 
medicine by animal experimentation. It reiterates, thus, 
a “total, rigorous and absolute” condemnation of hu-
man sacrifice [299: 1544, col. 3]; a condemnation, which 
is adopted in the first of the four points of medical ethics 
that end the JD: “Nobody is granted the right to sacrifice 
any human being for the needs of scientific effects”.
Baruk goes on in the article to question the distinction 
between permitted therapeutic interventions and for-
bidden experimentation. This is precisely the topic of the 
second point of medical ethics within the JD: 
The medical world must elaborate definite and ex-
act standards for the differentiation between experi-
mental physiology on animals and the application of 
medical and therapeutic efforts to humans. In the for-
mer, the test animal is employed as an instrument, or 
victim, for the purpose of trying out a new remedy or 
therapeutic method, and thereby advancing our sci-
entific knowledge. In the latter, the human must be the 
servant of the patient, applying to him only those rem-
edies that have been [tried and] tested on animals and 
proven safe and effective.
In the article, Baruk presents two opposing views: the ab-
solute distinction he had just stated and a more nuanced 
one, which he attributes to Professor Delay, who is pre-
sented as a colleague and friend: “There are two spiritual 
attitudes […] which appeared to me many times, espe-
cially during my conversations and friendly discussions 
with my friend, the Professor Delay, regarding psycho-
surgery and shock treatments [299: 1544, col. 3].” Further, 
Baruk stresses again: “I have largely meditated on this 
amazing issue that my friend the Professor Delay asked 
me about […]” [299: 1545, col. 1].
Jean Delay (1907–1987) was a brilliant French psychia-
trist and writer [311].35 He was one of the French experts 
at the International Military Tribunal of Nuremberg in 
1945 and organized the First World Congress of Psychia-
try in Paris in 1950 [311: 559–60]. During WWII, he con-
ducted many experiments on animals exploring electro-
convulsive shock therapy [311: 559]. Even though Delay 
eventually became a strong supporter of pharmacologic 
treatments rather than shock therapy, his scientific repu-
tation was based on those experiments [312: 70–1]. While 
Delay was nearly ten years younger than Baruk, the latter 
had apparently been an associate professor in Delay’s de-
partment, or Deniker’s terms: “D’autres furent ses agré­
gés avant moi, comme Henri Baruk et Pierre Pichot” [311: 
559]. Like Delay, Baruk was himself a researcher and both 
of them had discussed issues of human experimentation. 
For Delay, in addition to the distinction between experi-
mentation and therapeutic attempts, it was no less impor-
tant to distinguish between “permitted enlightened use 
of human experimentation and its condemnable abuse”, 
which means that not all human experiments were forbid-
den in his views, only the abusive ones [299: 1544, col. 3].
We have seen earlier that for Baruk, the argument of 
experimentation to benefit mankind (the “greatest num-
ber” in his words) was seen as the equivalent of asking for 
the sacrifice of a few for the benefit of the whole, a con-
cept absolutely forbidden by Judaism, which instead in-
structs that animals replace human sacrifices. Baruk re-
fers here to the biblical concept of the “scapegoat” and to 
the narrative of “Isaac binding”. Indeed, this is the official 
answer of halakhic Judaism. No one can volunteer for a 
medical experiment if there is any risk to life involved, 
even for the ‘progress of science’ or the ‘benefit of man-
kind’. He may do so only if he is in an aporetic situation 
where the smallest chance of a benefit to himself opens 
again the possibilities for medical experimentation [313].
In two specific cases, psycho-surgery and shock-thera-
py, Baruk argued with Delay on the topic. These function 
as case studies. “Why do you hold a such absolute attitude 
about these methods”, asks Delay, “as, while they have in-
deed implied some abuses, they may also represent a real 
interest [for patients] if cleverly used? [299: 1545, col. 1]” 
Baruk’s answer is simple—“How, in practice, do you dis-
tinguish between justified usage and abuse?” And as if 
this was not sufficiently clear, Baruk repeats his question 
35  In the late 1950s, he was elected to the Académie française.
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introducing this time the human factor: “How do you dis-
tinguish between a justified usage performed by compe-
tent and cautious physicians and the abuse perpetrated 
by unexperimented and less cautious doctors?” In fact, 
Baruk does not develop any real argument here but that 
of the slippery slope, which is often used in connection 
with euthanasia and which he wants to extend to the two 
aforementioned case studies. Perhaps because he knew 
that his opinion was a minority one, he presents it in the 
article as a “personal position” anchored in the old Jewish 
tradition and also, according to Baruk, in the Christian one 
[299: 1545, col. 1]. Even if not explicitly cited, I think that 
Baruk is referring to the halakhic argument called “Siyag 
laTora” here, which is similar to the modern “precaution-
ary principle”. In order to be sure not to transgress a divine 
commandment, do not take the risk and put the forbid-
ding fence far away from the actual limit. Finally, Baruk 
gave a historic example that may be most understandable 
in the post-WWII context: During the 19th century, Ger-
man and French psychiatrists opposed any distinction 
between curable and incurable people, with the French 
most vigorously opposed to making such a distinction 
due to fear of the consequences. “Worries that may have 
appeared exaggerated a hundred years ago. But which 
had become reality in Germany under Hitler through the 
massacre of the supposed chronically ill mentally people 
(Fr.: Aliénés chroniques) [299: 1545, col. 1].”
Thus, we see here that in order to deal with what we have 
described as point two of the medical ethics section (D) of 
the JD, Baruk uses two case studies, which appear to con-
stitute the topic of point three of the same part of the JD:
Certain therapeutic modalities that are able to obtain 
palliative results at the cost of anatomic destruction of 
human limbs, of causing new diseases, or of the weak-
ening and dissolution of the human personality, raise 
very weighty problems of medical ethics.
It must be noted that this point is not as clear-cut as the 
others and leaves the reader in an undetermined posi-
tion. Did Baruk know that in Israel, as in France, the ma-
jority of psychiatrists did not see such a radical ethical 
issue there, and feared that, if they opposed psychosur-
gery or shock therapy in their motion too explicitly, they 
would not receive the support of the Congress? There is 
no clear answer here but conjecture. We can only add 
that Baruk and Dvorjetski were not left alone in formu-
lating the Jerusalem Declaration, but that Moshe Krieger, 
former head of the JMAP who had been in charge of pre-
senting the Jewish motion in Paris five years before, was 
also part of it [299: 1545, col. 1].
The fourth and final point of medical ethics in the dec-
laration is a general one. It does not correspond to any-
thing specific from Baruk’s lecture, but rather reiterates a 
point common to both Dvorjetski and Baruk:
We therefore have to consolidate anew the founda-
tions of medical conscience: no physician is permit-
ted, under any circumstances, to utilize scientific data 
for the destruction and damaging of a human being.
Conclusion
In this article, the “unanimously passed” resolution on 
medical ethics from the 2nd World Congress of Jewish 
Physicians held in Jerusalem, August 1952, also called 
the Jerusalem Declaration, is compared with the two (or 
three) lectures in which its concepts first emerged. The 
two first parts of the declaration appear to have been tak-
en from the lectures of Mark Dvorjetski, while the two last 
were from those of Henri Baruk. If this seems clear, it rais-
es certain questions: Did both authors agree on what the 
other had to say? And, as the declaration is quite clear-
ly structured, with a reminder of what Nazi doctors had 
done and then, after two transitional parts, the lessons to 
be drawn for contemporary medical ethics, how does it fit 
into the contemporary framework of medical ethics?
In this conclusion, I want to claim that based on the ma-
terial explored above, it is not clear whether Dvorjetski fully 
agreed with Baruk’s conclusions on the ethics of human ex-
perimentation, or if he did so, that it does not fit with his first 
reading of the Nuremberg trials documentation. Dvorjets-
ki’s position on the ethics of human experimentation pre-
sented here is a rewording of the Nuremberg Code and not 
a clear-cut distinction between experimentation (only per-
mitted on animals) and therapeutic interventions allowed 
on humans. Baruk connected two new contemporary prac-
tices in psychiatry—electroconvulsive treatment and shock 
therapy with other means like insulin—with what the Na-
zis did, but further research is needed here to determine 
whether such a conclusion was justified. Otherwise, Ba-
ruk’s conclusion might be seen as one of the first cases of 
justifying a personal ethical position through an authorita-
tive argument of sorts based on what the Nazis did.
The second claim I want to make here is that while Dvor-
jetski’s lecture, like the 1947 Jewish Medical Association 
motion (which he wrote too), widely opened the interpre-
tation of Nazi medical crimes to include pre-WWII theories 
and practices of Nazi doctors, it failed to formulate broad-
er ethical conclusions for contemporary medicine. Like in 
Nuremberg, even if based on totally different reasons, the 
medical ethics drawn from the Nuremberg trials documen-
tation in the JD mainly focused on human experimentation.
While presenting an original voice regarding the inter-
pretation of the Nuremberg trials documentation, the Je-
rusalem Declaration remains a marginal voice on medi-
cal ethics.
THE JERUSALEM DECLARATION ON MEDICAL 
ETHICS36
[(Passed at the Second World Congress of Jewish Physi-
cians, Jerusalem, 10–14 August 1952)] 37
36  In Dapim refuiyim [Medical leaves], vol. 11, Dec. 1952, p.331. 
The Hebrew version was published p.330 and the French one p.332 
of the same issue. Generally speaking the Hebrew and French ver-
sions are quite the same. Exceptions are noted below.
37  In the following all the signs and sentences put in brackets are 
lacking in the English version. The precise sentence is also missing 
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[A] The Second World Congress of Jewish physicians, 
which gathered in Jerusalem on August 10–14, 1952, ex-
poses before the entire world38 the Nazi medical crimes, 
to wit:39
1. The utilization of medical science for the extermina-
tion of children, old people, mental patients, incura-
bles and cripples, under the project that was known as 
Mass Euthanasia.40
2. Forced sterilization41 of men and women42 by chem-
ical, surgical, radiologic and other medical means,43 
that was carried out in the concentration camps. 
The sterilization in the camps was a preliminary 
experiment,44 with the view of applying it on a much 
wider scope to whole nations in Europe, in order to 
turn them into exploitable slaves45 incapable of per-
petuating themselves through offspring.46
3. Physical and moral degradation of human beings 
by systematic and well planned hunger, thirst, cold, 
whipping and other tortures. Serving the same pur-
pose were the exposures to filth and absolute lack of 
hygiene, the instilling of fear and a sense of hopeless-
ness, and the stripping the victims naked.47 All these 
diabolic abominations48 were designed to deprive the 
victims of their human image and dignity.
4. The criminal medical experiments in which human 
beings were employed as test animals.49 Such were the 
inoculation50 of humans by the germs of Typhoid, Ty-
phus or Malaria; the study of the effects of suffocat-
ing gases or various poisons on living human bod-
ies; or experiments in the transferring of living tissues, 
nerves51 and muscles from person to person; or exper-
iments in prolonged freezing of living humans by im-
in the French version.
38  Hb: use of the rare expression Mokiya kabel olam.
39  Fr: Differently organized. The Congress just “declares” and then 
adds “that it renews its indignation” before describing the four 
categories of Nazi medical crimes.
40  Hb: a project known by the name mass euthanasia (emphasis in 
the Hb text).
41  Hb: Forced sterilization emphasized.
42  “Of men and women” lacking in Hb and Fr.
43  Hb and Fr: “etc.” instead of “and other medical means”.
44  Hb: One sentence: “… concentration camps as preliminary ex-
periments in view of broadening this action on to whole nations…”
45  Hb: “for their entire life”.
46  Hb and Fr: “but unable to leave offspring”.
47  Hb and Fr: One sentence with, in parenthesis, an enumera-
tion (hunger, thirst, cold, whipping and all sorts of tortures, naked 
contempt and degradation of honor, filth and complete lack of 
hygiene, an everlasting atmosphere of fear and hopelessness).
48  “All these diabolic abominations” lacking in Hb and Fr. Instead, 
the same sentence goes on in Hb: “in order to deprive the human 
being of [his] human image” and in Fr, “in order to dehumanize 
human beings”.
49  Hb: “based on the use of the human being as test animal”.
50  Hb: same sentence but in parenthesis: (experimental inocula-
tion of various infectious diseases like Typhoid fever, Typhus, 
Malaria; etc.).
51  Fr: “Bones” instead of “nerves” in Eng and Hb. Actually, 
operations on bones, muscles and nerves are described. See, for 
instance, the documents presented in [298: 161–80]. “Bones and 
muscles” is the expression used by Dvorjetski in his lecture: “They 
mersing them in ice water,52 or in determining53 the in-
fluence of a lack of air54 on a human being. All these 
experiments, and many others, were bestial acts,55 in 
which a living human being was used as the test ani-
mal in experimental physiology.
[B] The Congress rises up and protests against the in-
difference and the desire to forget56 these crimes that 
have become evident of late.57 The Congress recognizes 
in58 this apathy a silent moral partnership59 with those 
German60 physicians who surrendered medical science 
to the service of Hitler’s racism,61 and who initiated false 
and transgressing62 biologic theories.
[C] The Congress expresses its deep fear and63 anxi-
ety, lest64 these transgressing65 Nazi biologic doctrines, 
and their distorted66 trend of thought, be transferred and 
implanted,67 knowingly or unknowingly, into the medical 
and biologic science of our time.
[D] The Congress therefore68 declares:
1) Nobody is granted the right69 to sacrifice any70 human 
being for the needs of scientific effects.71
2) The medical world must elaborate definite and ex-
act standards72 for the differentiation between experi-
mental physiology on animals and the application of 
medical73 and therapeutic efforts74 to humans. In the 
former, the test animal is employed as an instrument, 
or victim,75 for the purpose of trying out a new remedy 
have cut their bones and muscles off of their flesh for transplanta-
tions”, there, p.12.
52  “Of living humans by immersing them” is lacking in Hb.
53  “Or in determining” is lacking in Hb., and instead of it appears 
[and the influence…].
54  Fr: “Effet du vide sur l’homme”.
55  “All these experiments, and many others, were bestial acts” 
lacking in Hb and instead of it, the same sentence in parenthesis 
goes on: experiments, in which, etc.
56  Hb: the oblivion and the indifference toward these crimes.
57  “That have become evident of late” lacking in Hb and Fr.
58  “The Congress recognizes in” lacking in Hb and Fr. Instead of 
it, the same sentence goes on: “this apathy, which constituted in 
those days a moral partnership with those physicians…”
59  Fr: “complicité morale”.
60  “German”, lacking in Hb and Fr.
61  Original English: “Hitlerite racism”.
62  “False and transgressing”, lacking in Hb and Fr. Instead of it, ap-
pears: “criminal biological theories”.
63  “Deep fear and”, lacking in Hb and Fr.
64  Hb and Fr: “about the possibility”.
65  Hb: “criminal”.
66  “Their distorted”, lacking in Hb and Fr.
67  “And implemented” lacking in Hb and Fr. Instead of “trans-
ferred”, the Fr speaks about the “survival” of these theories into the 
current sciences.
68  Fr and Hb: “in light of this anxiety”.
69  Hb: “permission”.
70  Fr and Hb: “another”.
71  Hb: “efficiency, effectiveness”. Fr: “utility”.
72  Fr and Hb: “precise studies”.
73  “And the application of medical”, lacking in Hb.
74  Fr: “Therapeutic trials”.
75  Hb: “and sometimes a victim”. Fr: “and sometimes sacrificed”.
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or76 therapeutic method,77 and thereby advancing our 
scientific knowledge [for living beings]. In the latter, 
the human must be the servant of the patient,78 apply-
ing to him only those remedies that have been [tried 
and] tested on animals and proven safe and effective,79 
[on a scientific basis, in order to heal the person and 
prevent him from any injury or disability].
3) Certain therapeutic ways that are willing to obtain 
palliative results at the cost of anatomic destruction 
of human limbs,80 of causing new diseases, or of the 
weakening and dissolution of the human personality, 
raise very weighty problems of medical ethics [; meth-
ods, which may, from an imaginary healing purpose, 
cause damage to human beings.]
4) We therefore have to consolidate81 anew the founda-
tions82 of medical conscience: no physician is permit-
ted, under any circumstances, to utilize scientific data 
for the destruction and damaging83 of a human being.
The role of the Council of Europe 
Elmar Doppelfeld, Prof. Dr. med., former Chair 
of the Steering Committee on Bioethics (CDBI) 
and of the Working Group “Biomedical Research,” 
member of the German Delegation to the 
Committee on Bioethics, Council of Europe 
elmar-doppelfeld@t-online.de 
The Council of Europe
The Council of Europe is often erroneously confused 
with the European Union. For a better understanding of 
its obligations some introductory remarks are justified. 
Both, the EU and the Council, may be considered as “in-
tergovernmental bodies”, but have different intentions. 
The Council, established in 1951, with its 47 member 
states—and additionally Canada, the Holy See, Japan, 
Mexico, and the USA with the status of observers—repre-
sents around 900 million citizens. Its main mission is pro-
moting and harmonising human rights and fundamental 
freedoms through appropriate legislation. This is mainly 
based on the “Convention for the Protection of Human 
Rights and Fundamental Freedoms of 4 November 1950” 
[314]. To perform its mission, the Council uses instru-
76  “Remedy or” lacking in Hb and Fr.
77  Hb: plural: “new therapeutic methods”. Fr: “later, new human 
therapeutics”.
78  “The human must be the servant of the patient”, is lacking in 
Hb and Fr. Instead there is in both languages: [The human being 
is not an instrument for medical science, on the contrary, medical 
science is at the disposal of the human being].
79  “And proven safe and effective”, lacking in Hb and Fr.
80  Lobotomy was in sight of the writers, and especially Henry 
Baruk, at that time, as well as Insulin shocks.
81  Hb: “fortify”. The Fr adds “and specify”.
82  Fr: “foundations” is lacking.
83  “And damaging”, lacking in Hb and Fr. All the last sentence (“no 
physician, etc.”) is emphasized in Hb.
ments of the international law: Conventions and addi-
tional protocols to these Conventions. These treaties en-
ter only into legal force by signature and ratification of a 
member state to safeguard the democratic procedure and 
basis. In addition, the Council may adopt recommenda-
tions as a proposal to the member states for the regula-
tion of specific fields. Recommendations are however in 
structure and content imbedded in the legal framework 
of the Council. In contrast to the EU, the Council has no 
right to issue regulations with binding force for its mem-
ber states. The Council never includes proposals of NGOs 
or of other sources in its official documents. Therefore, 
neither the Nuremberg Code nor the Declaration of Hel-
sinki are mentioned in the documents concerning medi-
cal ethics. However, a national legislator may decide how 
and to what extent proposals from NGOs will be accepted 
during the implementation procedure of legal provisions 
of the Council into national law. A very important insti-
tution attached to the Council is the European Court of 
Human Rights.
Engagement and structure for bioethics
Scientific progress in medicine and biology in the late 
1970s has attracted more and more attention from the 
Council. The first successful in-vitro fertilisation is ac-
cepted to be the beginning of this increased scrutiny, 
from the perspective of the protection of human rights. 
In 1985, as a first step, the “Ad Hoc Committee of experts 
on Bioethics (CAHBI)” was set up under the direct au-
thority of the Committee of Ministers, the leading body 
of the Council. They were given the responsibility of as-
sessing the need for intergovernmental activities of the 
Council of Europe in the field of bioethics. In view of the 
situation whereby states in Central and Eastern Europe 
were requesting membership of the Council after 1989, 
the need to foster the implementation of bioethics in Eu-
rope more widely was recognised. Therefore, in 1992, the 
position of CAHBI was changed to the “Steering Commit-
tee on Bioethics (CDBI)” and became a standing group. 
In 2012, the “Committee on Bioethics (DH-BIO) assumed 
the full responsibilities of the “CDBI”. The general mis-
sion can be defined as the “protection of human rights 
and fundamental freedoms with regard to the applica-
tion of biology and medicine” as stated in the title of the 
Oviedo Convention. The scope of the legal system con-
tains, for example, medical routine, the transplantation 
of human organs and tissues, human genetics and bio-
medical research including biobanks. The CDBI elabo-
rated on the relevant documents following the positions 
emerging from ethical discussions around the justifica-
tion of human experimentation which begun already in 
the 19th century. These basic principles are accepted 
as “respect for persons”, “beneficence” and “justice” as 
published in The Belmont Report [315] or in a different 
version as “respect for persons”, “beneficence”, “nonma-
leficence” and “justice”, as presented by Beauchamp and 
Childress [316].
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Provisions of the Council for biomedical research 
The basic provision is the Oviedo Convention [317] which 
contains the fundamental principles and serves as a legal 
framework for the other provisions, like the Additional 
Protocol on Biomedical Research [318] with specific de-
tails for research. Conventions and protocols are instru-
ments of international law. They enter into national legal 
force when signed and ratified by the member state con-
cerned. The Recommendation on Biobanks [319] is a pro-
posal of the Committee of Ministers for Member States 
on how to regulate this sector of research. It is to under-
line that these provisions are the only legally binding in-
ternational instruments covering all kind of biomedical 
research involving human beings and compulsory for all 
researchers. To improve their implementation, the CDBI 
has elaborated on it with the “Guide for Research Ethics 
Committee Members” [320]. The following description of 
the content of these provisions is with few exceptions re-
stricted to main topics without a specific relation to the 
documents or to the wording in these documents. Word-
ing will be quoted only for clarification in the text itself or 
within footnotes.
Freedom of research 
The documents underline freedom of research which is 
limited by protective provisions, taking into account that 
researchers may argue for the preference of research for 
the benefit of humankind whereas different groups insist 
on the preference of protection. The key provision—Ar-
ticle 15 of the Oviedo Convention—formulates a synergy 
or balance: “Scientific research in the field of biology and 
medicine shall be carried out freely, subject to the provi-
sions of this Convention and the other legal provisions 
ensuring the protection of the human being.” 
Qualification and quality 
The basic conditions for the ethical acceptance of a re-
search project are its scientific quality and the qualifica-
tions of the responsible researcher. The researcher shall 
be duly qualified as physician, which means specialisa-
tion to a degree appropriate for the project. They must be 
qualified to react to contingencies or to adverse events. 
In addition, they must safeguard the duty of care, per-
sonally or through qualified healthcare professionals. An 
analogue qualification is required for e. g. psychologists, 
bio chemists or biophysicists as researchers. The quality 
of a research project is assessed under the usual points: 
scientific quality, accordance with national or interna-
tional law and ethical acceptability. The assessment of 
qualification and quality is performed by independent 
bodies like research ethics committees, scientific bodies 
or authorities.
Proportion of risk and benefit 
In biomedical research, risk and burden for the partici-
pants are foreseeable only to some extent. Therefore, as 
a general rule, minimising risk and a  clear benefit are 
obligatory. According to the different fields of research, 
the provisions contain adapted calculations for risk and 
benefit. For research without a potential direct benefit 
for the person included, often addressed as fundamen-
tal research, e. g. involving healthy volunteers, only ac-
ceptable risk and acceptable burden for the participant 
are permitted. Research with a potential direct benefit 
involving persons able or not able to consent is allowed 
if risk and burden are not disproportionate to this poten-
tial direct benefit. This potential direct benefit justifies 
authorisation by a legal representative for inclusion in a 
research project when persons are not able to consent, 
e. g. minors, victims of traffic injuries or persons suffer-
ing from dementia. For specific scientific fields, research 
on persons not able to consent is needed, even if a po-
tential direct benefit for the participants cannot seriously 
be expected. In conformity with specific legal provisions 
in place, authorisation may only be given if together with 
others the conditions of minimal risk and minimal bur-
den84 are fulfilled. “Minimal risk” means an absolute 
limitation based on statistics and is different from “mini-
mising the risk”. “Burden” addresses the reaction of the 
person concerned to the research procedure and can be 
assessed, for example, by a person who is familiar with 
those reactions. There are precise definitions given by the 
Research Protocol.85 The proportion of risk and benefit is 
subject to assessment by an ethics committee.
84  “Exceptionally and under the protective conditions prescribed 
by law, where the research has not the potential to produce results 
of direct benefit to the health of the person concerned, such 
research may be authorised subject to the conditions laid down in 
paragraph 1, sub-paragraphs i, iii, iv and v above, and to the fol-
lowing additional conditions: 
i the research has the aim of contributing, through significant 
improvement in the scientific understanding of the individual’s 
condition, disease or disorder, to the ultimate attainment of results 
capable of conferring benefit to the person concerned or to other 
persons in the same age category or afflicted with the same disease 
or disorder or having the same condition; 
ii the research entails only minimal risk and minimal burden for the 
individual concerned.” (Article 17, §2, Oviedo Convention; identi-
cal wording in Article 15, Research Protocol)
85  Research with minimal risk and minimal burden: 1. For the 
purposes of this Protocol it is deemed that the research bears a 
minimal risk if, having regard to the nature and scale of the inter-
vention, it is to be expected that it will result, at the most, in a very 
slight and temporary negative impact on the health of the person 
concerned. 2. It is deemed that it bears a minimal burden if it is to 
be expected that the discomfort will be, at the most, temporary and 
very slight for the person concerned. In assessing the burden for an 
individual, a person enjoying the special confidence of the person 
concerned shall assess the burden where appropriate. (Article 17, 
Research Protocol)
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Research on persons able to consent 
If a research project fulfils the conditions of “scientific 
quality, conformity with law and ethical acceptability” as 
assessed by the competent bodies—only an ethics com-
mittee or in addition bodies to prove the scientific qual-
ity and legal questions—and, if national law requires, has 
been approved by a competent authority, persons may 
be included after having declared their free and informed 
consent. “Free” means that there is no undue influence, 
no vulnerability and no coercion. Disadvantages like the 
withholding of healthcare are not allowed in the case of 
refusal or of withdrawal of consent, possible at any time. 
“Informed” addresses all relevant information before 
starting a project including information on foreseen or 
foreseeable further use of the results, alternatives to the 
foreseen methods, and legal or other protective provi-
sions. The person concerned may be asked to give free 
informed consent to a specific project or projects in the 
future, which cannot be specified in the moment of that 
specific research project. The latter form of free informed 
consent is more and more accepted as broad consent.
Research on persons not able to consent
All conditions for research as outlined above must be ful-
filled. In addition, a justification is required for the need 
to carry out research on this specific group. Any alterna-
tive of comparable effectiveness must be excluded. For 
the involvement of a person not able to consent in a re-
search project the authorisation by the legal represent-
ative according to national law is compulsory. Assent 
of the represented person should be asked if appropri-
ate. The represented person should be included in the 
information and authorisation procedure to the extent 
of their understanding. In most cases, research on per-
sons not able to consent is carried out for their poten-
tial direct benefit. Only in exceptional cases is research 
without a potential direct benefit on persons not able to 
consent justified. For these cases, protective provisions 
prescribed by law and the conditions of minimal risk and 
minimal burden among others are compulsory. Addi-
tionally, the field for such research and the reasons ac-
cepted for its justification are defined.86
Specific situations
The provisions of the Council cover specific research 
fields. Research during pregnancy and breastfeeding 
may be performed for the benefit of other women in re-
lation to reproduction or for other embryos, foetuses or 
children. Any adverse impact on the health of a breastfed 
child must be avoided. Research on persons deprived of 
liberty, e. g. prisoners in jails, has its own ethical implica-
tions and procedures and is forbidden in some countries. 
For such research, a permission by law is required. The 
86 idem.
research should be performed exclusively for the benefit 
of persons deprived of liberty. The research on these two 
specific groups can be justified only in the absence of any 
alternative of comparable effectiveness. This states clear-
ly that such research when carried out on non-pregnant 
women or on non-prisoners would not be able to gain 
the specific scientific results. The principles of minimal 
risk and minimal burden apply.
Emergency situations
Research on persons in emergency clinical situations is 
a specific case. Free informed consent cannot be given 
in view of the urgency of that research and of the person 
envisaged as a participant. To respect autonomy as much 
as possible and to safeguard the progress of medical sci-
ence, the provisions list a number of conditions: a legal 
regulation is in force; the person concerned is not able to 
consent; due to the urgency of the situation, no authori-
sation of any kind can be sought; research of comparable 
effectiveness cannot be carried out on persons in non-
emergency situations; the competent body in conformity 
with the legal regulation has approved the project specif-
ically for emergency research after ethical assessment; a 
potential direct benefit is not disproportionate to the risk 
and if there is no potential direct benefit expected, the 
absolute conditions of minimal risk and minimal burden 
apply; any previously expressed objection to research, if 
known in the emergency situation, has to be respected. 
The information on inclusion in an emergency research 
project must be given as soon as possible to the person 
concerned or to the legal representative to decide wheth-
er they stay in the project or end participation.
Examination and approval
Before starting a biomedical research project, the re-
searcher must apply for it to be examined and gain con-
firmation that it is in conformity with national law. The 
provisions state rather strictly that every research pro-
ject must be submitted for independent examination of 
its ethical acceptability to an ethics committee. The pro-
ject as such has to undergo an independent examina-
tion of its scientific merit, including assessment of the 
importance of the aim of the research. If these examina-
tions have positive results, a competent body may give 
the approval for the project to begin after a multidisci-
plinary review of its ethical acceptability. It is clearly stat-
ed that the ethical assessment has to be carried out prior 
to approval by a competent body. The Research Protocol 
entails specific provisions on the responsibilities of eth-
ics committees, including a list of information that must 
be presented for the ethical assessment. This list can be 
completed on request of the ethics committee in view of 
the project to be assessed.
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Collections – biobanks 
The relevant provision in this matter is in the form of a 
recommendation: the “Recommendation of the Com-
mittee of Ministers” [319]. A stronger solution with more 
legal binding force was not accepted by the member 
states, not even when preparing the second, more recent 
version. The positions of the member states obvious-
ly differ too much. The Recommendation entails provi-
sions on establishing, guiding and overseeing biobanks, 
which are not addressed here. The following description 
is restricted to protective points. The removal of human 
tissue for an immediate research project is regulated by 
the Research Protocol. In contrast, the Recommenda-
tion covers the removal of human tissue and storage for 
future research use. “Broad” free informed consent of a 
person able to consent or “broad” authorisation by the 
legal representative of a person not able to consent is ac-
cepted. The same conditions apply if human tissue is re-
moved for other purposes. e. g. initially intended only for 
a single project or in the course of clinical routine, will be 
used for scientific purposes and are stored for this aim. A 
confirmation or a withdrawal of a previous authorisation 
by the person concerned after gaining or regaining the 
ability to consent completes this part of protective pro-
visions. The person may agree or not on the further use 
of the stored material. The donor decides whether they 
want to be contacted in the future by representatives of 
the biobanks. This decision may include the wish to be 
informed or not in case of incidental findings with impact 
on the health of the donor or of his family. Before any an-
onymization of tissue or related data, the donor has to be 
informed of the consequences. The donor has the right to 
restrict anonymization in view of the use for specific re-
search fields. If the research is in the scope given by the 
donor, the project may start if the other conditions laid 
down in the Recommendation and the Research Proto-
col are fulfilled. If the project is outside a given scope, 
the researcher has to undertake “reasonable efforts” to 
contact the donor unless such a contact has been refused 
during the information and consent procedure. If such 
a contact—the “reasonable efforts” shall be explained 
to the competent ethics committee—is not possible, the 
tissue may be used under strong protective conditions.87 
All projects must be assessed by an ethics committee to 
which apply the provisions for the assessment as stated 
87  “Where the attempt to contact the person concerned proves 
unsuccessful, these biological materials should only be used in the 
research project subject to an independent evaluation of the fulfil-
ment of the following conditions: i evidence is provided that rea-
sonable efforts have been made to contact the person concerned; 
ii. the research addresses an important scientific interest and is 
in accordance with the principle of proportionality; iii. the aims 
of the research could not reasonably be achieved using biological 
materials for which consent or authorisation can be obtained; and 
iv. there is no evidence that the person concerned has expressly 
opposed such research use.” (Extract, Article 21, Recommendation)
in the Research Protocol. If required by national law, an 
approval by the competent body is required. 
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Introduction
Voluntary consent is the first and absolutely essential 
premise of the normative framework set out in the Nurem-
berg Code. The heinous crimes perpetrated by Nazi doc-
tors provided tragic evidence that “the theme of human 
rights in human experimentation is a universal one. The 
need to respect the humanity and self-determination of 
all humans is central to the ethos not only of medicine and 
human experimentation but of all civilized societies” [321: 
7]. In order to avoid the risk of exploitation, the Code in-
troduced some fundamental criteria, which today appear 
obvious and well-established:88 a) legal capacity; b) free 
power of choice, “without the intervention of any element 
of force, fraud, deceit, duress, over-reaching, or other ul-
terior form of constraint or coercion;” c) sufficient knowl-
edge and comprehension “of the elements of the subject 
matter involved”, as to en able persons “to make an under-
standing and enlightened decision” (art. 1). Suffice it to 
mention, as illustrative examples, the Declaration of Hel-
sinki as last amended in Fortaleza in October 2013 and the 
new Ethical Guidelines issued by CIOMS in 2016. Accord-
ing to art. 25 of the Declaration, “no individual capable 
of giving informed consent may be enrolled in a research 
study unless he or she freely agrees”. Researchers—ac-
cording to the Guidelines—“have a duty to provide po-
tential research participants with the information and the 
opportunity to give their free and informed consent”. This 
consent should be understood as a “process”, which en-
tails the duty to ensure “that the person has adequately 
understood the material facts and has decided or refused 
to participate without having been subjected to coercion, 
undue influence, or deception” [322: 33 (GL 9)].
Against this consolidated background, the UNESCO 
Universal Declaration on Bioethics and Human Rights, 
adopted in 2005, is no exception. Art.  6.2 reaffirms the 
88  In this perspective, it is correct to say that a “critical historical 
analysis of the Nuremberg medical maelstrom” remains a premise 
for the understanding of the meaning and implications of the 
evidence that “informed consent permeates modern medicine” 
[256: 8].
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principle that scientific research “should only be carried 
out with the prior, free, express and informed consent 
of the person concerned”. Art.  7 recalls that, in accord-
ance with domestic law, “special protection is to be giv-
en to persons who do not have the capacity to consent”. 
Such protection is to be ensured with reference to con-
cepts and provisions which are easy to find in many other 
international documents: the best interest of the person 
concerned, his or her involvement in the decision-mak-
ing process, the potential direct health benefit for the 
participant as a premise (provided that there is no alter-
native of comparable effectiveness that can be tested on 
participants able to consent), the principles of minimal 
risk and minimal burden (to consider and apply “with 
the utmost restraint”) in those exceptional cases where 
the benefit to the individual subject is absent and “the 
research is expected to contribute to the health benefit 
of other persons in the same category”. Immediately af-
ter art. 7, the Declaration of 2005 focuses in art. 8 on the 
concepts of integrity and vulnerability: “In applying and 
advancing scientific knowledge, medical practice and 
associated technologies, human vulnerability should 
be taken into account. Individuals and groups of special 
vulnerability should be protected and the personal integ-
rity of such individuals respected”. 
Integrity, vulnerability, special vulnerability. As I have 
said, even though these concepts are deeply rooted in 
contemporary medical ethics and research ethics, the 
reference to human vulnerability as such deserves spe-
cific attention. It is possible to use art. 8 (it goes without 
saying that other starting points could be as fruitful) as 
a kind of magnifying glass to look at some aspects of the 
Nuremberg Code which have undergone substantial re-
finements or extensions and focus on the very crucial re-
lationship between voluntary consent as a premise and 
special vulnerability as a condition which can under-
mine voluntary consent and consequently pave the way 
for more subtle, not immediately apparent forms of dis-
crimination, marginalization and exploitation.
The duty to respect and protect 
The first point to make refers to the scope of medical and 
scientific activities which are addressed. The Guidelines 
for New Therapies and Human Experimentation, which 
were issued by the German Reich Ministry of the Interior 
in 1931 and have been long discussed as a literal though 
not explicitly-acknowledged forerunner of the essential 
content of the Nuremberg Code (hereafter referred to as 
the Code) itself,89 had already made a differentiation be-
tween “innovative therapy” related to a therapeutic pur-
89  According to Grodin, who underlines the role played by Julius 
Moses by alerting the public to the deaths of many children in Lue-
beck in the course of experiments with tuberculosis vaccination, 
these guidelines, in many ways, “are more extensive than either 
the subsequent Nuremberg Code or the later Declaration of Hel-
sinki recommendations” [94]. The Guidelines and their historical 
premises as well as their influence have been the object of several 
studies [323, 19].
pose and “scientific experimentation”. The former refers 
to interventions and treatment methods “that are carried 
out in a particular, individual case in order to diagnose, 
treat, or prevent a disease or suffering or to eliminate a 
physical defect”. The latter “means interventions and 
treatment methods that involve humans and are under-
taken for research purposes without serving a therapeu-
tic purpose in an individual case”. The same provisions 
should apply to both activities, with some “additional re-
quirements” for scientific experimentation. The first one 
is about consent: experimentation “shall be prohibited 
in all cases where consent has not been given”, whereas 
an innovative therapy may be initiated “if it constitutes 
an urgent procedure to preserve life or prevent serious 
damage to health and prior consent could not be ob-
tained under the circumstances” [324: GL 2, 3, 12 and 5]. 
It has been correctly pointed out that the atrocities com-
mitted in concentration camps simply ignored this dis-
tinction. It is true that drug trials were carried out to test 
the efficacy and potential side effects of new substances. 
However, not only were these studies “clearly not intend-
ed to be of benefit for the research subjects themselves”: 
the conditions which were treated experimentally “were 
systematically inflicted on previously healthy prisoners”, 
who were indeed used “like guinea pigs” [19: 44]. Nowa-
days, fortunately, we are not often confronted with such 
extreme practices of exploitation, even though there have 
been other situations where the treatment of human be-
ings has been considered as resembling that of guinea 
pigs, which immediately evokes the title of the book pub-
lished in 1967 by Maurice Pappworth [325]. However, the 
extension of the situations and research fields where the 
principles set in the Code are at stake has gained increas-
ing importance, prompting updates, refinement and fur-
ther elaboration. A clinical trial is a process which can 
be looked at as combining elements of experimentation 
and therapy. An urgent procedure to preserve life can 
be invoked as a last hope in the absence of consolidat-
ed therapies, to the point of blurring the difference be-
tween innovation and compassionate use. By pointing at 
the same time at scientific knowledge, medical practice 
and associated technologies, art. 8 of the Declaration of 
2005 hints at this broad scope: biobanks, all evidence in-
dicates, cannot be established and managed according 
to the same rules developed for clinical trials.
The duty “to avoid all unnecessary physical and men-
tal suffering and injury” (Code, art. 4) while pursuing 
“fruitful results for the good of society” (art. 2), and a 
willingness to terminate experiments when their contin-
uation “is likely to result in injury, disability, or death to 
the experimental subject” (art. 10),90 paved the way for 
the pivotal role of a strong, broad notion of integrity in 
post-paternalistic medicine. Respect for integrity has 
been increasingly understood in the sense of a strict obli-
90  The exception introduced dubiously in art. 5, with regard to 
“those experiments where the experimental physicians also serve 
as subjects”, is probably the most controversial provision of the 
Code and was rapidly dropped.
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gation to not touch, a negative right to non-interference, 
that obviously does not dismiss the idea of integrity “as 
a responsibility or virtue that the investigator should de-
velop and society should demand”, that is a disposition 
to act which is “attributed to all those who remain un-
alterable, incorruptible, particularly by outside influenc-
es or pressures” [326: 160].91 The Declaration of Helsin-
ki includes integrity in a list of goods to protect, together 
with life, health, dignity, right to self-determination, pri-
vacy, and confidentiality of personal information, inde-
pendent of the consent that individuals may have given 
(art. 9). As is clearly illustrated by this list, integrity is not 
simply about being safe from physical violence, because 
it implicitly refers to the totality of individual experience 
as a project of life relying on values, feelings and the mul-
tifaceted flourishing of a narrative identity. Not coinci-
dentally, this article immediately follows one that affirms 
unequivocally that the goal of generating new knowledge 
“can never take precedence over the rights and interests 
of individual research subjects” (art. 8). It is the same 
provision included—among other texts—in the Oviedo 
Convention: “the interests and welfare of the human be-
ing shall prevail over the sole interest of society or sci-
ence” (art. 2). 
The idea that respect for integrity and protection of 
people living in conditions of special vulnerability are 
intrinsically linked builds on these premises, with par-
ticular reference to two crucial points highlighted in the 
UNESCO Declaration. 
1) The application and advancements of scientific 
knowledge should always take into account the general 
experience of human vulnerability, that is the fact that all 
human beings may lack, at some point of their life, the 
ability and the means to avoid wounds to their “physi-
cal, mental and social well-being”, to quote the contro-
versial definition of health proposed in the Constitution 
of the WHO. The notion of integrity, which is embedded 
in the most private dimension of life, cannot therefore be 
conceived in opposition to that of solidarity. It is precise-
ly because of the fact that integrity implies a biography 
and not only the physical limit of the body, that the re-
spect for this irreplaceable oneness refers necessarily to 
the experience of and with others. It is one and the same 
humanity (often referred to as intrinsic dignity) which is 
at stake in the efforts of science to ameliorate the conse-
quences of our natural finitude and fragility. Vulnerabil-
ity is a fundamental touchstone for equality. This is why 
the circumstances where vulnerability impinges more on 
the sphere of freedom and capabilities (Sen, Nussbaum) 
require special attention, in order to avoid that advantag-
es for few be created at the expense of others.
91  Patrão Neves underlines that this notion of integrity as virtue 
or disposition is used in other UNESCO documents such as the 
Universal Declaration on the Human Genome and Human Rights 
of 1997 and the International Declaration on Human Genetic Data 
of 2003. 
2) No condition can be seen as more vulnerable than 
that of prisoners in Nazi concentration camps. How can 
the challenge of special vulnerability be addressed when 
the vulnerability in question is not the consequence of 
a blatant case of crimes against humanity but of the dif-
ferences and inequalities that are likely to increase the 
risk of exploitation in everyday life? The distinction be-
tween the duty to protect individuals and groups ex-
posed to more serious risks and to respect their personal 
integrity is a crucial one. This distinction, which is un-
fortunately lost in the title of art. 8, which refers only to 
respect for human vulnerability (which sounds inappro-
priate if not downright misleading) and personal integ-
rity, could be interpreted along the line of the tripartite 
typology92 exemplified by the UN Committee on Eco-
nomic, Social and Cultural Rights in General Comment 
No. 14 on the right to the highest attainable standard of 
health: “The obligation to respect requires States to re-
frain from interfering directly or indirectly with the en-
joyment of the right to health. The obligation to protect 
requires States to take measures that prevent third par-
ties from interfering with article 12 guarantees. Finally, 
the obligation to fulfil requires States to adopt appropri-
ate legislative, administrative, budgetary, judicial, pro-
motional and other measures towards the full realization 
of the right to health” [328: 33]. By all evidence, the duty 
to protect enshrined in art. 8 of the UNESCO Declaration 
is not limited to preventing third parties from interfering 
and includes all positive actions which can help improve 
these determinants of inequality among human beings 
and promote effective sharing of the benefits of scientific 
progress. It is also not uncalled for to state that the same 
provision should be applied here as in art. 14 with regard 
to the promotion of health and social development: this 
is “a central purpose of governments that all sectors of 
society share”. 
Special vulnerability as social vulnerability
Focusing on consent, it is easy to observe that this aware-
ness has encouraged in-depth research into the elements 
which could constitute constraint or coercion. The Bel-
mont Report, for instance, considers both coercion that 
occurs “when an overt threat of harm is intentionally 
presented” and undue influence that occurs “through 
an offer of an excessive, unwarranted, inappropriate or 
improper reward”, pointing out that “inducements that 
would ordinarily be acceptable may become undue in-
fluence if the subject is especially vulnerable”. Accord-
ing to the Report, unjustifiable pressures usually occur 
“when persons in positions of authority or commanding 
influence […] urge a course of action for a subject”. It may 
be difficult “to state precisely where justifiable persua-
sion ends and undue influence begins. But undue influ-
92  The idea of tripartite typology goes back to Henry Shue’s study 
on Basic Rights, Subsistence, Affluence and U.S. Foreign Policy, 
published in 1980 [327: 68–70].
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ence would include actions such as manipulating a per-
son’s choice through the controlling influence of a close 
relative and threatening to withdraw health services to 
which an individual would otherwise be entitled” [329].
In the Richtlinien of 1931, unlike the Code of 1947, 
“exploitation of social hardship (Ausnutzung der sozi­
alen Notlage) in order to undertake innovative therapy” 
(and consequently scientific experimentation) was ex-
plicitly labelled as “incompatible with the principles of 
medical ethics” (GL 7). The Belmont Report underlines 
the relevance of questions of justice in research involv-
ing human beings. Poor ward patients who serve as sub-
jects to produce scientific benefits that flow primarily to 
private patients, the unwilling prisoners in Nazi camps 
whose exploitation “was condemned as a particular-
ly flagrant injustice”, and the disadvantaged rural Afri-
can American men “used” in the Tuskegee syphilis study 
are mentioned as illustrative examples. The crucial role 
of social injustice in the ethics of research as well as ef-
fective access to quality health care has been widely ac-
knowledged in recent decades. The International Bioeth-
ics Committee of UNESCO proposed to distinguish two 
fundamental categories of possible determinants of spe-
cial vulnerability. The first one includes “special (tempo-
rary or permanent) disabilities, disease and limitations 
imposed by the stages of human life”, which are determi-
nants of special individual vulnerability. The second cat-
egory refers to “social, political and environmental deter-
minants”, which can generate and increase not only the 
individual, but also the collective risks of being wound­
ed, discriminated against, or exploited: “Many individu-
als, groups and population nowadays become especially 
vulnerable because of factors created and implemented 
by other human beings, in many cases in blatant viola-
tion of fundamental human rights”. Poverty and inequali-
ties “in income, social conditions, education and access 
to information” lead the list of examples of determinants 
of special social vulnerability, which goes on to mention 
gender discrimination, limitation or deprivation of per-
sonal liberty, hierarchical relations, and marginalization 
on various grounds [330: 14–5 (§§ 12 and 14)].
Voluntary consent to be a research subject may be un-
dermined in many ways. Even though impairment can 
affect both the initial choice and the different stages of 
ongoing studies, recruitment stands out as a decisive test 
to assess the ability and willingness to address the condi-
tions that increase the “likelihood of being wronged or of 
incurring additional harm” for some groups and individ-
uals (Declaration of Helsinki, art. 19). The Report of the 
International Bioethics Committee on vulnerability and 
personal integrity offers several examples concerning re-
search ethics as well as ethics in a healthcare setting and 
the development and application of emerging technolo-
gies in the biomedical sciences: “First, the personal, eco-
nomic or socio-political situation of potential research 
participants may render them vulnerable to exploitation. 
Second, again because of the so-called ‘therapeutic mis-
conception’, people may agree to participate in research 
in the mistaken belief that there may be some benefit for 
them; this is particularly likely where healthcare services 
are inadequate or unavailable”. Thus, the responsibility to 
respect and protect encompasses issues such as double 
standard research, equivocal donations, inappropriate 
research, and social vulnerability, but also that specific 
kind of vulnerability which is “a result of lack of research”, 
resulting from pharmaceutical companies’ minimal in-
terest in developing treatments for diseases that affect 
poor populations primarily if not exclusively [330: 16, 
25–7 (§§ 19 and 29–33)]. 
The new Guidelines issued by CIOMS dismiss the “tra-
ditional approach” of labelling entire classes of individ-
uals as “inherently vulnerable”, pointing instead to the 
“specific characteristics” to which “special protections” 
should correspond: limited capacity to consent; hierar-
chical relationships; institutions such as nursing homes, 
mental institutions, and prisons; and circumstances in 
which women could be vulnerable are mentioned. The 
actual level of individual vulnerability remains however 
“highly dependent on the context”, so that “persons who 
are illiterate, marginalized by virtue of their social status 
or behaviour, or living in an authoritarian environment, 
may have multiple factors that make them vulnerable”. 
Other social conditions are listed extensively as potential 
determinants of vulnerability: “people receiving welfare 
benefits or social assistance and other poor people and 
the unemployed; people who perceive participation as 
the only means of accessing medical care; some ethnic 
and racial minorities; homeless persons, nomads, refu-
gees or displaced persons; […] individuals who are polit-
ically powerless; and members of communities unfamil-
iar with modern medical concepts”. Group vulnerability 
itself is eventually admitted as a possible, “context de-
pendent” challenge, when there is “empirical evidence” 
of circumstances that require ethics committees “to pay 
special attention to research involving certain groups” 
[322: 57–9 (GL 15)].
Social vulnerability, in particular, may be a premise 
for improper inducement. The Universal Declaration on 
Bioethics and Human Rights underlines this risk with re-
gard to the principle of benefit-sharing, as do many oth-
er documents: “Benefits should not constitute improper 
inducements to participate in research” (art. 15.2). Open, 
brutal coercion is relatively rare as compared to the many 
situations where a person’s ability to make a free choice 
can be undermined either by incomplete, inappropri-
ate or even misleading information or because of condi-
tions which impel the subject to accept something that 
he or she would otherwise not be willing to: “The fact 
that participating in a clinical trial can be in some con-
texts the only way to get access to some treatment under-
lines a serious and persisting challenge for the principles 
of equality and justice” [331: 8–9 (§ 20)]. As soon as vol-
untary consent is acknowledged as the essential premise, 
questions arise regarding the determinants of inequali-
ty, starting with poverty, which impinge upon individual 
freedom as conditions of special vulnerability, which re-
quire therefore special protection.
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Conclusions
“Medical progress is based on research that ultimately 
must include studies involving human subjects” (Dec-
laration of Helsinki, art. 5). It is exactly this observation 
that underlines the importance of preventing individuals 
from serving as research subjects under the pressure of 
improper inducements and constraints. We honour the 
philosopher Immanuel Kant for his statement that we 
should treat humanity, in our person or in the person of 
any other, “never merely as a means to an end, but always 
at the same time as an end” [332: 429]. Never merely as a 
means, always at the same time as an end. Scientific re-
search is no exception to the rule.
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Introduction
In order to discuss “bioethics in Austria”, it is important 
to first clarify the term “bioethics”. Medical ethics has a 
special focus on human disease and health. The advanc-
es in medicine in the past 70 years, especially in regard to 
intensive care, organ replacement therapy, organ trans-
plantation, reproductive medicine and genetics have 
been so revolutionary that a much wider approach to 
new moral questions became necessary. Since the 1970s 
the term “bioethics” has been used for this much wider 
ethical debate [333].
The Nuremberg Medical Trial is widely seen as the be-
ginning of a new era of transparency and ethics in clinical 
research. Although single initiatives to codify clinical re-
search have been undertaken prior to the Second World 
War, especially in Germany, the atrocities committed in 
Nazi Germany during the war made a new start neces-
sary. The Nuremberg Code can be seen as the first doc-
ument of medical ethics directed at physicians involved 
in research with human participants that originated out-
side the medical field. The hallmark of the code was the 
requirement of the free and voluntary consent of the pa-
tient or the volunteer prior to being included in the med-
ical research experiment [96: 343–5].
Since 1947 and the publication of the Nuremberg 
Code, a constant and continuous development with re-
gards to a governance of clinical research under the view-
point of medical ethics can be seen. This development 
has been driven by many regions, countries and institu-
tions worldwide and is ongoing as the advances in medi-
cine continue to be challenging in regard to our ethical 
re-evaluations in this field.
The shift from paternalism to patient autonomy
The central aspect of the Nuremberg Code is the in-
formed consent of the patient, a direct consequence of 
the doctors’ trial. Beyond that, there was a more gener-
al shift towards self-determination and autonomy in so-
ciety, not only in medicine or medical research. Previ-
ously, patients literally put “their lives into the hands” 
of the doctors, while in the second half of the 20th cen-
tury, information, strong respect for the opinions of oth-
ers, for human rights, and, for the very first time, the spe-
cific and factual attribution of human dignity in the field 
of ethics and medicine led to a developed acceptance of 
the autonomous decisions of the patients. An acceptance 
which also recognises the notion of autonomy as person-
al right of the informed patient.
The introduction of ethics committees and ethical 
review in Austria
After the Second World War, a dramatic increase in clini-
cal research to find better diagnostics and therapies can 
be seen. Scientific and medical research developed ma-
jor technologies and pharmacological products and could 
thus improve the life span and life quality of human be-
ings. At the same time, awareness of the ethical considera-
tions of research activities increased within the worldwide 
community of clinical researchers. Scandals such as the 
Tuskegee experiment between 1932 and 1972 in the South 
of the United States, where poor African-American work-
ers were included in an observational study conducted by 
Tab. Timetable of important milestones, events and docu-
ments (selection)
1947 Promulgation of the Nuremberg Code
1964 ff. World Medical Association, Declaration of Helsinki (including 
subsequent amendments)
1966 Henry H. Beecher, Ethics and Clinical Research, New England 
Journal of Medicine
1972 Termination of the Tuskegee Experiment, US Public Health 
Service (begun 1932)
1979 ff. Tom Beauchamp & James Childress, Principles of Biomedical 
Ethics
1979 Belmont Report, USA
1996 International Conference on Harmonisation, Guideline for Good 
Clinical Practice E6
1997 Council of Europe, Oviedo Convention and Protocols
2001 European Commission, ‘Clinical Trial Directive’ (Directive 
2001/20/EC)
2002 CIOMS, International Ethical Guidelines for Health-related 
Research Involving Humans
2004 International Committee of Medical Journal Editors, Trial 
Registration
2005 UNESCO Universal Declaration on Bioethics and Human Rights
2014 REGULATION (EU) No 536/2014 repealing Directive 2001/20/
EC
2017 International Committee of Medical Journal Editors, Data 
Sharing
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the United States Public Health Service without being in-
formed or asked about their participation, nor being in-
formed after the introduction of penicillin in the 1940s that 
there would be a valid therapy for them available, made 
regulation highly desirable. This observational study ne-
glected every principle of medical ethics [334: 21–9].
In 1966 an anaesthesiologist at Harvard Medical 
School, Henry H. Beecher, published an important arti-
cle in the New England Journal of Medicine describing 
wrongful practices in clinical research. Most of the pub-
lished studies he quoted had deficiencies in regard to ob-
taining informed consent of the participating patients 
[116: 1354–60].
The World Medical Association formulated its Decla-
ration of Helsinki, “Ethics Principles for Medical Research 
Involving Human Subjects”, which was adapted at its gen-
eral assembly in 1964 in Helsinki, Finland as a document 
for physicians conducting clinical research [335]. The 
declaration—which at that time addressed only physi-
cians—also emphasised as a follow-up to the Nuremberg 
Code the requirement of free and informed consent. It 
was amended several times, including by an important 
amendment agreed on in Tokyo in 1975, by which the ad-
ditional requirement of ethical review by a specialised 
interdisciplinary external body, a so-called ethics com-
mittee, was formally established. Every experimental 
protocol involving human subjects should be submitted 
to “a specially appointed committee independent of the 
investigator and the sponsor” for “consideration, com-
ment and guidance”. However, recommendations of the 
World Medical Association are not legally binding, they 
merely constitute so-called “soft law”.
In the year 1979, the Medical Faculty of the Universi-
ty of Vienna established a first such advisory board, an 
ethics committee to advise on clinical research proto-
cols for clinical studies conducted at the Vienna Gener-
al Hospital (Allgemeines Krankenhaus der Stadt Wien or 
AKH), the teaching hospital of the Medical Faculty with 
2200 beds. At that time, the Viennese Ethics Committee 
was the second such committee established in a Ger-
man speaking country—the first being at the University 
of Münster (Westfälische Wilhelms­Universität Münster), 
established in 1978. 
At that time, the committee consisted of 16 physi-
cians (professors and assistants) as well as students of 
the Medical Faculty. There were two professors from the 
Faculty of Law and one professor of the Faculty of Theol-
ogy. The committee was intended to be a consulting body 
for the members of the Medical Faculty regarding their 
clinical trials or other ‘ethical questions’. The decisions 
were legally not binding but considered ‘recommenda-
tions’. In the first years of its existence applications were 
scarce (e.g. two protocols in 1979) and it was not until the 
early 1990s that protocol submissions numbered more 
than 100 per year. In the past years the number of appli-
cations for new protocols has increased steadily to more 
than 1000 per year. 
Since the introduction of the European Union (EU) 
GCP-guideline in 1990 [336] and its translation into the 
Austrian Medicines Act 1994, the Hospital Act of 1993 and 
the Medical Device Act of 1996, ethics committees were 
firmly established throughout Austria and the number of 
applications continued to increase. The law required the 
investigator to obtain a positive vote before commenc-
ing a trial. The Good Clinical Practice Guideline of the 
International Conference on Harmonization (GP-ICH) 
increasingly harmonised the clinical trial of medicinal 
products across the following regions: the EU, Canada, 
the United States and Japan. GCP-ICH was implemented 
as standard practice in Europe in January 1997 by the EU 
Committee for Proprietary Medicinal Products (CPMP) 
and it has led to further increased rigour in clinical re-
search [337].
An important decision was taken in 1994, when the 
Ethics Committee of the Medical Faculty was merged 
with the Ethics Committee of the Vienna General Hospi-
tal. According to the requirements of the Austrian Hospi-
tal Act 1993 additional members were appointed. Since 
1997 one technical expert was included in the commit-
tee as required in the Medical Devices Act 1996. An ex-
pert in biometry also became a member. Two members 
of the Faculty of Law, one of the Faculty of Theology and 
two students completed the 28 members [338: 1019–26].
A further important change came in 2004: First, the 
three medical faculties in Austria became separate uni-
versities by law, and to complicate matters further, a new 
European Directive changed the clinical research land-
scape in Europe fundamentally. 
In 1997, an association of the main 27 Austrian eth-
ics committees (Forum Österreichischer Ethikkommis­
sionen) was established upon the initiative of the Ethics 
Committee of the Medical Faculty of Vienna. All Austrian 
Ethics Committees were invited to join. Participation was 
free, decisions were issued as nonbinding recommenda-
tions [339].
New bioethics institutions and the Austrian Bioethics 
Commission
In 1993, the University of Vienna established a “Senate 
Institute for Ethics in Medicine” [340]. Its first director 
until 2001 was Günter Virt, a professor for moral theol-
ogy at the University of Vienna. At that time, the medical 
school was still a faculty of the University of Vienna—one 
of the founding faculties from 1365 in fact. It was only in 
2004 that the Faculty of Medicine became a separate uni-
versity, as with the other medical faculties of Austria.
Since then, the “Institute for Ethics and Law in Med-
icine” has functioned as an interdisciplinary platform–
carried by the Faculties for Catholic and Protestant The-
ology and the Faculty of Law. The Medical University of 
Vienna cooperates with the platform. This institute, it 
should be noted, anticipated issues related to the estab-
lishment of an Austrian National Bioethics Commission, 
established in 2001, by almost 10 years. The idea and im-
portance of an interdisciplinary approach had already 
been realised within the institute by the inclusion of the 
various faculties. Furthermore, the institute had the re-
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mit to give recommendations for parliamentary deliber-
ations, which is today the mandate of national bioethics 
advisory bodies. However, the “Institute for Ethics and 
Law in Medicine” is an important player in this field, cur-
rently headed by Ulrich Körtner, professor at the Protes-
tant-Theological Faculty of the University of Vienna, as 
a mere “platform”, they do not have the full possibilities 
of a university institution, such as recruiting young aca-
demics and being automatically involved in the regular 
and standard curriculum. In Austria, as opposed to oth-
er countries, there are no standard university institutes 
for ethics in medicine. In Germany, by contrast, there are 
more than 30 such institutes, mainly combinations de-
voted to the history, theory and ethics of medicine.
In 2001, bioethics advisory bodies were established 
in three neighbouring countries: “Nationale Ethikkom-
mission im Bereich der Humanmedizin” in Switzerland 
[341], “Nationaler Ethikrat” (succeeded in 2007 by the 
“Deutscher Ethikrat”) in Germany, and the “Bioethik-
kommission beim Bundeskanzleramt” in Austria [342].
In Austria, the Bioethics Commission was founded on 
29 June 2001 via decree by Federal Chancellor Wolfgang 
Schüssel from the Conservative Party as an independent 
interdisciplinary advisory body to the Federal Chancel-
lor. At first there were 19 members, four of whom were 
women. The mandates were for two years (this provision 
was valid until 2013 when the mandate was extended to 
three years). The first Chair, nominated by the Chancel-
lor like all other members, was a professor of gynaecolo-
gy and obstetrics of the Medical University of Vienna. He 
remained in this function from 2001 until 2007.
The Austrian Bioethics Commission issues recom-
mendations and documents relating to the main bioeth-
ics topics [343], and has a mandate to provide informa-
tion and debate on bioethical issues to the public. The 
commission is active—like the other bioethics advisory 
bodies—in organising (international) conferences [344] 
and participating in conferences and meetings abroad, 
especially the regular meetings of the NEC-Forum un-
der the respective presidencies of the European Union. 
The chairperson since 2007—the author of this article—
is regularly invited to give lectures, present opinions and 
explore various bioethical topics. In 2013, the Austrian 
Bioethics Commission initiated yearly meetings with the 
other two German-speaking national commissions, the 
first and fourth meetings taking place in Vienna (2013 
and 2016), the others in Berlin (2014) and Berne (2015).
In 2016, the Medical University of Vienna signed an 
agreement with the Director-General of the United Na-
tions Educational, Scientific and Cultural Organiza-
tion (UNESCO) concerning the establishment of a UN-
ESCO Chair on Bioethics. This chair is one of 15 UNESCO 
Chairs on (Bio-)Ethics in the world [345]. The purpose is 
to promote an integrated system of research, training, in-
formation and documentation on bioethics, thus facili-
tating collaboration between high-level, internationally 
recognised researchers and teaching staff of the univer-
sity and other institutions in Austria, as well as in Europe, 
Africa and Asia and in other regions of the world [346: 
229–33; 347: 137–44]. Such a Chair of Bioethics in Austria 
makes a valuable contribution towards new expertise in 
the Austrian academic field and is thus—next to the Aus-
trian Bio ethics Commission and the Institute for Ethics 
and Law in Medicine—the third important stakeholder 
in the area of bioethics.
Milestones in ethical review
Looking back at 70 years since the Nuremberg Medical 
Trial we can see a net governing biomedical research that 
has become increasingly tighter and more efficient. It is 
also easier to look back with hindsight and define impor-
tant milestones in this development.
If we take the Nuremberg Code, with its focus on the 
will (the autonomy) of the patient as starting point, we 
notice a common thread leading directly to the World 
Medical Association (WMA) and its Declaration of Hel-
sinki. The World Medical Association was founded 1947, 
is active worldwide and has as its central objective “to 
establish and promote the highest possible standards of 
ethical behaviour and care by physicians” [348]. The es-
tablishment of ethics committees is one of their achieve-
ments, only adopted much later by the European and 
various national legislations.
A further European milestone was set by the European 
Union with the formulation of its Clinical Trials Directive 
2001/20/EC on the basis of ICH-GCP and the consecu-
tive transfer into national law. Although this Directive did 
not immediately achieve a harmonised European land-
scape for clinical research, but it set the stage and estab-
lished a tight legal framework recognising ethical issues 
in biomedical research. The European Directive had to 
be transferred into national law and was a first legal step 
within Europe to harmonise the clinical research situa-
tion, although—as ethical issues are to be considered na-
tional issues—the goal of a harmonised research land-
scape in Europe was not achieved. However, the decision 
to require “one single opinion” for drug trials within the 
individual EU member states in Europe somehow estab-
lished a similar framework for ethical review within Eu-
rope. 
Unfortunately, one of the biggest pitfalls of this direc-
tive was the heterogeneity which resulted in regard to pa-
tients in intensive or emergency care medicine. The Di-
rective stated that these subjects can be included in a 
clinical trial only if informed consent of the patients “le-
gal representative” is obtained, which obviously is not 
possible for previously healthy subjects and legal provi-
sions are not easy to define for such a situation and did 
not exist in all European member states. The European 
research landscape never quite recovered from this prob-
lem, leading to discussions regarding the ethical princi-
ple of justice, where everybody should have the chance to 
receive benefits of clinical research [349]. 
Furthermore, there were global scandals that involved 
underreporting or selective reporting. A well-known ex-
ample is that of Rofecoxib (Vioxx), which was introduced 
by Merck in 1999 as an effective, and supposedly safer, 
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alternative to non-steroidal anti-inflammatory drugs 
for the treatment of pain associated with osteoarthritis. 
Studies, however, intentionally obscured the cardiovas-
cular risk associated with the drug, and, although known 
within the company, critical data on the cardiovascular 
toxicity were purposefully withheld accepting the ad-
verse cardiovascular events occurring associated with 
osteoarthritis. Up to 107 million prescriptions were dis-
pensed up until 2004 in the US alone.
This scandal led to an initiative and common decision 
of the “International Committee of Medical Journal Edi-
tors” (ICMJE) in 2004 [350: 1995–6; 351: 120].
This milestone in transparency cannot be underesti-
mated [352: 1250–1]. It required as a condition of consid-
eration for publication that every clinical trial be regis-
tered in a public trials registry at or prior to the onset of 
patient enrolment. Today, registries are part of the clini-
cal research world and have the additional effect of in-
creasing the participation of patients as the websites of 
the registries are also a very good tool for information 
about ongoing research—especially necessary for the 
rare diseases communities [353].
Conclusion and outlook
The Nuremberg Code is considered and accepted as the 
initial milestone in the history of medical ethics for for-
mulating an ethical framework for the conduct of re-
search on human subjects for the first time. Since then, 
various stakeholders, national and international institu-
tions and organisations, academia and industry, authori-
ties and professional associations as well as parliaments 
have continued to improve the frameworks for ethical re-
view and medical research. 
The conference “Medical Ethics in the 70 Years after 
the Nuremberg Code, 1947 to the Present”, organised on 
the occasion of 70 years anniversary of the Nuremberg 
Medical Trial by the Medical University of Vienna, the 
Documentation Centre of Austrian Resistance, Oxford 
Brookes University, and the Austrian Bioethics Commis-
sion aimed at summarising the developments since the 
formulation of the Nuremberg Code and its impact on to-
day’s medical research. The world has changed. Research 
is based on the principles of exchange and cooperation, 
researchers are mobile, the internet provides a support-
ing framework removing national barriers. A central fo-
cus of this conference, therefore, was the role played by 
international organisations over the past 70 years in ini-
tiating ethical guidelines and endeavouring to establish 
normative standards with a global validity, thus ensuring 
trust and transparency in clinical research. 
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Introduction
Modern international codes of ethical health research 
conduct have emerged from and been shaped in re-
sponse to the most egregious episodes of abuse in recent 
history. The Nuremberg Code—which is regarded as the 
preeminent historical document in the field of bioethics 
[108, 354]—dates to post-Second World War trials of Nazi 
scientists, and was formulated by the judges who consid-
ered their crimes [355]. The foregrounding of informed 
consent, and the elevation of the patient’s right to refuse 
to participate in an experiment, are considered to be the 
code’s key contributions to the development of modern 
bioethics [108].
The post-war trials and Nuremberg Code were fol-
lowed by the Declaration of Helsinki, first adopted in 
June 1964 by the World Medical Association (WMA), and 
last amended by the 64th WMA General Assembly in Oc-
tober 2013 [356]; the International Ethical Guidelines for 
Biomedical Research Involving Human Subjects of the 
Council for International Organisations of Medical Sci-
ences (CIOMS), last revised/updated in 2016 [357]; and 
the International Covenant on Civil and Political Rights 
of the United Nations [358], which enshrines the right to 
refuse to participate in medical research (Article 7).
Developments in Africa after the Nuremberg Code
These international guidelines, treaties and codes are 
contextualised for the African continent in the African 
Charter on Human and Peoples’ Rights of 1981 [359] and 
its subsequent protocols, codifying a cohesive expression 
of political will at the highest level. Unfortunately, uneth-
ical medical research has continued to be conducted in 
African settings well into the twenty-first century, despite 
broad political commitments to uphold human rights 
(see Ndebele et al. 2014 for an overview of some examples 
[360]). While there are cases in which attempts were ap-
parently made to exploit immature national ethical review 
and regulatory systems [360], there are also more complex 
instances in which debate regarding “ethical imperialism” 
(the application of Western ethics to non-Western con-
texts) arise [361]. In response, there has been a ground-
swell in the publication of African thought on bioethics, 
which is informing locally situated and appropriate re-
sponses to the question of ethical research conduct [360]. 
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Research oversight capacity in Africa
Ndebele et  al. [360] provide an overview of the history 
and development of research oversight bodies on the Af-
rican continent; the earliest date of establishment given 
is 1966 (for the Research Ethics Committee [REC] at the 
University of the Witwatersrand in South Africa). For-
mal oversight bodies such as ethics committees, regula-
tory bodies and medical research councils have therefore 
existed in Africa for 51 years. Yet in 2001, the Regional 
Committee for Africa of the World Health Organisation 
was sufficiently concerned about the state of ethical re-
view on the continent to implement a study on the mat-
ter [362]. Although the responses to the study questions 
indicated national commitment to ethical review, 36% of 
the countries responding did not have a REC.
Challenges to bioethics growth in Africa
Where RECs do exist in Africa, several themes consistent-
ly emerge in needs assessments. These themes include:
• Training (initial and ongoing)
• Resources (human, material, and technological)
• Capacity (increasing workload, increasing complexity 
of trials submitted for review, insufficient staff ).
REC members express a need for more training on re-
search and ethical norms, clinical trial design and phas-
es; and risks, monitoring and oversight of clinical trials, 
among other topics. REC members surveyed also com-
monly refer to lack of resources such as computers, soft-
ware to facilitate and manage reviews, and office space 
[363–365]. Other concerns relate to the independence (or 
lack thereof ) of RECs, and inadequate or absent guide­
lines, standard operating procedures, and legislation [364, 
365].
There is a clear need for sustainable development of 
bioethics capacity in Africa by providing support for ma-
terial needs and training. This need recently received 
high-level recognition at the 67th Session of the WHO 
Regional Committee for Africa, at which it was recom-
mended that member states, WHO, and partners support 
ethical review processes [366]. 
EDCTP partnerships and activities to strengthen 
bioethics capacity in Africa
Organisations involved in bioethics capacity building in 
Africa have included, among others:
• The African Malaria Network Trust (AMANET)
• Fogarty International Center at the National Institutes 
of Health (NIH)
• Wellcome Trust
• World Health Organisation (WHO)
• Council on Health Research for Development 
(COHRED)
• South African Research Ethics Training Initiative 
(SARETI)
• Advanced Research Ethics Training in South Africa 
(ARESA) 
• African Vaccine Regulatory Forum (AVAREF)
• The New Partnership for Africa’s Development 
(NEPAD)
• Cameroon Bioethics Initiative (CAMBIN)
• Pan African Bioethics Initiative (PABIN)
• United Nations Educational, Scientific and Cultural 
Organisation (UNESCO).
Activities to strengthen bioethics capacity generally fall 
into five activity streams, namely short-term training in 
a workshop environment; support for long-term degree 
training; grants to support REC material needs; online 
discussion fora; and online learning courses [360, 365]. 
EDCTP has supported RECs under its Ethics and Reg-
ulatory Capacities call for proposals in both the first 
(2003–2015) and second (2014–present) programmes. 
The Ethics and Regulatory Capacities grant scheme was 
initiated in 2005 with the aim of strengthening the eth-
ics review framework in sub-Saharan Africa at both the 
institutional and national level. Grants were awarded 
to develop the appropriate human resources and infra-
structure to establish functional, competent, independ-
ent, and sustainable RECs. Seventy five grants were made 
during the first programme, with total funding of over 
€ 4M. Through this scheme, EDCTP funded the estab-
lishment and strengthening of ethics review frameworks 
for health research in countries with little or no existing 
ethics review capacity such as Benin, Democratic Repub-
lic of Congo, Gabon, Liberia, Mozambique, Rwanda and 
Togo. Of the 75 grants awarded, 38 were intended to sup-
port an Institutional Review Board (IRB), 13 supported 
National Ethics Committees (NEC), 8 supported both an 
IRB and NEC, 11 provided support for courses on ethics, 
and 5 supported a “coordination function” [367]. 
Valuable ethics tools which have resulted from 
EDCTP-supported bioethics-initiatives have includ-
ed the “Research Ethics in Africa” free online textbook 
[368], the Mapping African Research Ethics Review and 
Medicines Regulatory Capacity (MARC) project [369], 
the TRREE online training programme [370], AMANET’s 
online training programme [371], and the Pan African 
Clinical Trial Registry, the only WHO-endorsed registry 
in Africa. This serves as a potentially very effective ethics 
compliance tool [372], among others.
The MARC project has provided crucial data to dy-
namically map and characterise existing RECs, examine 
progress, forecast needs, and provide support [373]. Data 
characterising African RECs was collected for MARC us-
ing the online database HRWeb with data input solicited 
directly from REC officials. By 2016, MARC had mapped 
167 RECs from 35 African countries; 20% were nation-
al bodies and 75% were institutional bodies; 19 African 
countries had not registered any type of ethics commit-
tee. The authors estimated that the actual number of ac-
tive African RECs could be double the number mapped, 
approximately 330 [369]. 
Data from MARC [369] indicate that a large proportion 
of RECs continue to operate on a hard copy-based sys-
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tem (48% of RECs for which data were available). There 
is clearly room for improvement in the management of 
REC applications, a gap which could be filled by technol-
ogy such as the Research for Health Innovation Organiz-
er (RHInnO) a product of the Web 4Development team of 
COHRED [374]. RHInnO is a very influential technologi-
cal development which supports and improves the func-
tion of African RECs, and fills resource gaps. This sim-
ple online product is intended to simplify the process of 
ethical review by moving RECs from a paper-based to an 
online system, and also facilitates tracking of approved 
projects. RHInnO was launched in 2012, and has already 
been found to have had a significant impact on various 
metrics of REC performance, principally in improving ef-
ficiency, communication, and data security, and reduc-
ing reliance on paper [375]. Online technologies such as 
video conferencing should also be exploited to support 
rapid review meetings in fast-moving outbreak contexts 
(such as for outbreaks of Ebola and Zika) [376].
During the second EDCTP programme (2015–2024) 
support for ethics and regulatory capacity activities has 
been scaled up and the focus re-aligned to a nation-
al and sub-regional strategic approach, with an atten-
dant increase in engagement with national governments. 
EDCTP currently encourages national RECs and regu-
latory bodies to collaborate on their submissions to our 
calls for proposals, in an effort to increase communica-
tion and harmonisation of approaches between these or-
ganisations. Integrating a requirement to register all clin-
ical trials as part of the ethical review process promotes 
and facilitates oversight of the national research land-
scape as a whole, and enhances researcher accountabil-
ity. In view of this, EDCTP has provided holistic support 
for the ethics and regulatory ecosystem by also support-
ing the Pan African Clinical Trials Registry. By the end of 
2016, six ethics and regulatory capacities grants had been 
awarded in the second EDCTP programme, with a total 
value of € 1.75M [377]. 
EDCTP participates in the TRUST project, which is a 
three-year coordination and support action funded by the 
European Union [378]. This global ethics consortium in-
cludes 13 partners and has developed a set of ethics tools 
to improve adherence to high ethical standards in low- 
and middle-income countries (LMICs). These include a 
global code of conduct for north-south research collabo-
ration (launched 15 May 2018), a fair research contract-
ing web tool and a compliance and ethics follow-up tool. 
Drawing from its vast experience of supporting north-
south collaborative research during the first EDCTP pro-
gramme, EDCTP is well poised to lead the TRUST funder 
platform which continues the “ethics dialogue” with oth-
er like-minded funders such as WHO-TDR, Calouste Gul-
benkian Foundation, MRC UK and the European Com-
mission. EDCTP is also a member of the TRUST working 
group for the Global Code of Conduct and has contribut-
ed to TRUST reports on compliance gaps and challenges, 
compliance tools and the mapping of exploitation risks 
against existing research ethics codes and guidelines. 
The Fair Research Contracting web tool will support 
health research in situations where legal support may 
be insufficient through the means of guidance booklets 
and notes, workshops, and technical consultancy [379]. 
TRUST will also produce several other outputs, includ-
ing policy briefs for ethics committees, an ethics dump-
ing case study resource and proposals for strategic ap-
proaches to compliance tailored for LMICs [378].
Discussion and conclusion: future activities
Despite numerous initiatives, the mind-set in health re-
search ethics remains in its infancy in Africa, and there is 
a high need for support in the training, resource, and ca-
pacity arenas. Future activities should focus on:
• Early introduction of bioethics into the medical cur-
ricula to instil the concept of “thinking ethically” into 
all healthcare practitioners and academic researchers
• Increased south-south collaboration, funding flow in 
general as well as local funding commitments
• Exploration of the use of technological developments 
such as video-conferencing to facilitate REC training 
and operational needs
• Increased support for publication of African thought 
on bioethical issues.
Funding support is currently available in the form of 
north-south partnerships, but the continent should also 
be looking towards increased regional collaboration and 
local governmental investment to build the capacity of 
RECs and regulatory bodies. The EDCTP-supported re-
gional Networks of Excellence (NoEs), and multidisci-
plinary consortia for research and clinical management 
of patients in poverty-related epidemics in sub-Saharan 
Africa, provide some informative examples: all four of 
the NoEs (Central Africa Network on Tuberculosis, HIV/
AIDS and Malaria (CANTAM); East African Consortium 
for Clinical Research (EACCR); West African Network 
of Excellence for TB, AIDS and Malaria (WANETAM), 
and the Trials of Excellence for Southern Africa (TESA)) 
have invested in capacity building for ethical conduct of 
health research. Their reach is not limited by geography: 
the NoEs collaborate and exchange expertise within and 
between their networks, and also engage with other bod-
ies, including northern partners [380].
Conclusion
Above all, researchers must commit to conducting their 
projects in a manner which is respectful of and in accord-
ance with non-harmful local cultural traditions and val-
ue systems. To facilitate this, populations that participate 
in health research must be encouraged to engage with 
questions of appropriate research conduct; the South Af-
rican San Institute together with the South African San 
Council recently published their “San Code of Ethics” 
[381], a reference work which guides researchers in the 
development of project proposals and interaction with 
this indigenous community, and which will be informa-
tive to other vulnerable research populations. Health re-
history of medicine
Medical Ethics in the 70 Years after the Nuremberg Code, 1947 to the Present1 3 S225
search in Africa must foreground the dignity of the peo-
ple who volunteer to participate by adhering to ethical 
codes derived from indigenous thought [382, 383].
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The legacy of the Nuremberg Code
70 years ago, on August 19th, 1947 American Justice Har-
old L. Sebring read the verdict at the trial of Nazi doc-
tors’ crimes, including a section entitled “Permissible 
Medical Experiments”. This later became known as the 
“Nuremberg Code” [193]. The Code is the basis for the 
Declaration of Helsinki as well as for the regulations for 
biomedical research involving human subjects in many 
countries, including China. Interestingly, one of the key 
figures in formulating the Code, the American neurolo-
gist with Austrian Jewish origins, Dr. Leo Alexander, was 
a doctor at Peking Union Medical College’s Department 
of Neurology during the Japanese invasion of China.
Universality of the Code
The ten principles are not deduced from any ethical the-
ories—though they are highly consistent with many of 
them—but created on the basis of learning from the his-
torical lessons on human experimentation and the fierce 
courtroom debates during the Nuremberg Trials. The 
values implied in the Code are beyond any historical lim-
it, and universal in space and time: no culture can appeal 
to its uniqueness as an excuse to exempt itself from im-
plementing these principles, though they need to be per-
fected.93 They also project into the future. The two major 
values are humanist concerns. These are sensitivity or in-
tolerance to human pain, harm, distress, and suffering, 
embodied in Principles 2–7, 9–10; and recognition of hu-
93  Criteria such as information disclosure and apprehension as 
well as proxy consent for incompetent subjects etc. should be 
added.
man autonomy, dignity and intrinsic value, embodied in 
Principles 1 and 8 [384].
The humanist values are compatible and paralleled 
by the fundamental concept of Confucianism, ren. Ren 
means care for others, a moral capacity to feel for others. 
Confucius said: “Don’t do things to others what you don’t 
want to do to yourself” (The Analects of Confucius, the 
chapter of the Duke of Wei Ling). Mencius said: “When 
we suddenly see a child about to fall into a well, we will 
have the feeling of alarm and compassion. This is not be-
cause we want to enter into good relationship with the 
parents of the child, or because we want to gain praise in 
his neighbourhood and among our fellow students and 
friends, or because we dislike the cry of the child.” (Men-
cius, the chapter of Gongsun Chou). Unfortunately, con-
temporary Confucians did not advance this concept of 
mutuality to accommodate modernity.
The birth of bioethics
It is widely accepted today that the birth of bioethics 
came with the announcement of the ten principles of the 
Nuremberg Code, implying a paradigm shift from med-
ical paternalism to a patient/research participant (as a 
living, individual person)-centred approach. Since then, 
the patient’s autonomy, right to informed consent, and 
wellbeing gradually became central to physician/pa-
tient and investigator/research participant relationships 
in both medical research and practice. Starting with re-
search ethics, this paradigm shift has extended to clini-
cal ethics, and further to public health ethics. The bulk 
of bio ethics (clinical ethics, research ethics and public 
health ethics) has then been formed. 
The assumption underlying the Code is that any indi-
vidual research participants ought to be treated as peo-
ple, “the intelligent part of the universe”, or “the most 
precious entity in the universe” (Confucius), or the ra-
tional agent, the end itself (Kant), whose safety, health 
and wellbeing deserves to be protected and respected. 
Later it was extended to patients in clinical practice and 
the broader population in the context of public health.
Respect for the patient
Respect for the patient as a person implies that the pa-
tient should be the decision-maker for their treatment 
when they are competent, and that the decision should 
comply with their values. As an individual, they know 
best what their value and meaning of life is. However, as 
professionals, physicians or surgeons are experts at diag-
nosing and treating disease and their professional duty 
is to guide their patient in making an informed and ap-
propriate decision which may integrate their guidance 
with the patient’s values. This is the so-called ‘shared de-
cision’ [385]. 
Respect for a member of a population as a person is 
also a key aspect of public health. However, unlike re-
search and clinical practice, public health has to take 
measures to limit individual freedom—in some cases—
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in order to prevent and control the further spread of epi-
demics. Even in such situations, the limiting of individual 
freedom can be ethically justified only under the follow-
ing conditions: effectiveness, proportionality, necessity, 
minimal infringement and transparency [386].
As an individual person who is a rational being as well 
as a member of humankind, the patient, research partic-
ipants or member of population has intrinsic value (not 
merely instrumental value or extrinsic value) as well as 
dignity. Their value and dignity does not depend on their 
contribution to society, wealth, rank in public office, or 
their use to others. Human dignity is absolute: it does 
not depend on whether they are rich or poor, powerful or 
powerless, have made contributions to society or com-
mitted any wrongdoing. Of course, wrongdoing or crime 
will bring about punishment, and thereby the wrongdo-
er will be deprived of some rights, but it is not the basis 
for a person to be deprived of dignity. Human dignity is 
equal: a morally vicious person enjoys equal dignity to 
a morally virtuous person, though the former lets their 
dignity down. However, the equality of the value of all ra-
tional beings does not mean that we cannot make differ-
ent evaluations of different people. But it does mean that 
regardless of what that evaluation may be, the constraint 
of treating the person with dignity must be observed. The 
Nuremberg trials are an exemple of respecting human 
dignity; even though the war criminals tried there com-
mitted horrific crimes against humanity, they were still 
granted the right to defend themselves and to a defence 
by their lawyers.
Relevance today 
Since the promotion of the Code, we have seen positive 
and negative developments in mainland China. Since 
1989, many laws and regulations have stipulated that in 
clinical practices and research/trials the consent of pa-
tients/research participants is mandatory. However, a 
few provinces have promoted eugenic regulations, the 
legislature (National People’s Congress) passed a law 
regulating maternal and infant healthcare which con-
tains a few eugenic articles, and the authors of some text-
books of medical ethics expressed views akin to the Nazis 
on eugenics and coercive “euthanasia”.
In the Regulation Prohibiting Reproduction of the Dull­
Witted, Idiots or Blockheads (since abolished) passed by 
the Fifth Session of the Standing Committee of Gansu 
People’s Congress on November 23rd, 1988, the defini-
tion of the “dull­witted, idiots or blockheads” is:
“1. Congenitally caused by familial inheritance, inbreed-
ing or parents under external influences;
2. Mental retardation at middle or severe degree with an 
IQ below 49; 
3. Behavioural disorders in language, memory, orienta-
tion, thinking etc.”
The regulation stipulates: “Prohibiting the reproduction 
of dull-witted, idiots or blockheads. Dull-witted, idiots 
or blockheads may be married only after sterilisation. If 
a couple are both dull-witted, idiots or blockheads, only 
one has to be sterilised; if only one of the couple is dull-
witted, idiot or blockhead, only he or she must be steri-
lised.” 94
In the Law on Maternal and Infant Care passed by the 
legislature (National People’s Congress) in 1994, Article 
10 stipulated:
“Physicians shall  … explain and give medical advice 
to both the male and female (applying to marry at the 
civil affairs administration) who have been diagnosed 
with certain genetic diseases of a serious nature con-
sidered to be inappropriate for childbearing from a 
medical point of view; the two may be married only if 
both sides agree to take long-term contraceptive meas-
ures or to undergo a ligation operation for sterility.”95
The authors of some textbooks on medical ethics during 
the 1980s and 1990s categorised physically disabled peo-
ple or those with learning difficulties as “inferior”, a dis-
criminatory term, and even claimed that medicine is a 
learning of promoting “inferior” and impeding the strug-
gle for survival (Social Darwinism). This term “inferior” 
was also used in some governmental documents and 
ministers’ speeches. They defined those couples with 
severe genetic diseases, severe schizophrenia, inbreed-
ing and old age as “persons without reproductive value”, 
another discriminatory term. They favour an ideology in 
which priority was given to the social good or state inter-
est, regardless of individual interest [389–393].
The authors of the textbooks of medical ethics in 2013–
2016 argue for compulsory euthanasia killing and sterili-
sation of the mentally retarded:
“When a patient suffers from a fatal illness or is in a 
terminal state, they should not request futile and 
wasteful treatment, but should accept euthanasia. 
This is their moral obligation. On the basis of this mor-
al obligation, their family and friends also should as-
sent to euthanasia”. 
“A human being has an extremely low quality of life, 
their value to society and others is also extremely low, 
or only has a negative value. Their survival does not 
assume any obligation for society and others, but only 
ceaselessly ask for something from the society and 
others, and impose heavy burdens on them.” [394–398]
This is not far from the rhetoric of the Nazi period. At sev-
eral meetings—including three meetings to commemo-
rate the 70th anniversary of the Nuremberg Code in Bei-
jing and Wuhan—all these Nazi-style measures were 
criticised and the critiques published [399, 400]. 
The approach to bioethics in Mainland China
Important events for the development of bioethics in 
mainland China include: 
94  The debate on the regulations of that sort, please see [387]. 
95  The debate on the law, please see [388].
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• 1979—National Conference on Philosophy of Medi-
cine in Guangzhou
• 1980—Founding of the journal Medicine & Philosophy 
in Dalian, Liaoning Province
• 1986–1987—Legal cases: Hanzhong (Shaanxi Prov-
ince) case on euthanasia; Shanghai case on AID (arti-
ficial insemination by domor)
• 1987—Publication of the book Bioethics 
• 1988 July—National Conference on Social, Ethical and 
Legal Issues in Euthanasia, Shanghai
• 1988 November—National Conference on Social, Eth-
ical and Legal Issues in Artificial Reproduction, Yuey-
ang, Hunan Province
• 1988—Founding of the journal Chinese Medical Ethics 
in Xian, Shaanxi Province
Challenges to the ABA’s definition of bioethics
In the Asian Bioethics Association’s constitution,96 bio-
ethics is defined as follows:
“Bioethics is the interdisciplinary study of philosoph-
ical, ethical, social, legal, economic, medical, thera-
peutic, ethnological, religious, environmental, and 
other related issues arising from biological sciences 
and technologies, and their applications in human so-
ciety and the biosphere.” 
This definition deprives bioethics of the status of being a 
discipline in its own right, and only defines it as an inter-
disciplinary study, with the issues being studied assigned 
to different disciplines or fields. If so, bioethics becomes 
a patchwork or a mere platform on which scholars from 
different disciplines talk about issues in which they are 
all interested in. This misleading definition has led to a 
number of negative consequences. On a practical level, 
there is a tendency towards what I have termed “deethi­
calisation”. There are many ethics committees (IRBs) in 
which ethical review became a technical or mechani-
cal process according to existing standards of practices 
(SOPs), but not a moral judgment on the basis of weigh-
ing values of stakeholders. At an academic level, the qual-
ity of academic publications on medical ethics or confer-
ences on the subject, seems stalled and without visible 
progress. Ethics has become empty preaching or ideolog-
ical propaganda without serious arguments.
Characteristics of bioethics
There are five characteristics of bioethics shared with 
other disciplines of practical ethics:
Normative: Bioethics is a normative discipline which 
addresses the substantial and procedural ethical issues 
raised in clinical medicine, biomedical and health re-
search, public health and innovation, R&D and the appli-
cation of novel biotechnologies, and provides an ethical 
framework to evaluate human action in certain fields as 
96  http://www.eubios.info/abacon.htm
an ethical guidance for human action/decision-making. 
Bioethics contains important descriptive elements, but 
it should not be reduced to descriptive ethics. The mor-
al judgment is value-laden, and cannot be induced from 
the empirical facts. Otherwise the naturalistic fallacy will 
have been inflicted. 
Rational: Bioethics is a rational discipline and relies 
on human rational capability, and its rational activities 
are mainly on argumentation. Some argued for bioeth-
ics being the love for life [401], the thesis was widely criti-
cised by Chinese bioethicists [402–407].
Practical: Bioethics aims to provide ethical guidance 
or criteria for human action or decision-making in clini-
cal, research and public health practices, not to directly 
develop ethical theories. We prefer the term “practical” 
to the term “applied”, because the “applied” may lead to 
the misunderstanding that the solution of ethical issues 
is deduced from ethical theory. Instead, the solution re-
lies on “drawing” (conceptual analysis) and “weighing” 
(balancing different values) as well as argumentation.
Evidence/experience-informed: Different from the-
oretical ethicists, bioethicist have to know the actu-
al practices and their contexts, as Ross claimed that we 
must know non-moral properties before we make moral 
judgment [408]. Case studies and surveys as descriptive 
ethics are important to bioethics.
Secular: Bioethics is neither religious nor theological, 
but secular, although the perspectives from religions and 
theologies are also important in our dealing with practi-
cal issues in various human social fields. For me the term 
“Christian bioethics” or “Confucian bioethics” is self-
contradictory: rational reason and irrational faith are not 
compatible. If bioethics is to help solve practical issues 
or take an appropriate action/make a rational decision, 
it cannot be purely moral preaching, breaking away from 
reality.
Features of the Chinese approach to bioethics
Following the bicycle-riding model: (1) we start with an 
ethical issue raised in clinical, research or public health 
practices and is closely relevant to the health and basic 
human rights of individuals, a certain social group or 
whole population as a logical starting point; (2) use ma-
jor ethical theories, basic ethical principles and ethical 
methods to address these ethical issues and find the op-
tions for providing a solution, then weigh critical argu-
ments for and against these options and finally choose 
an appropriate solution which often challenges the in-
adequacies or drawbacks of existing laws, regulations or 
policies related to the issues; (3) translate the results of 
ethical inquiries into action by producing recommen-
dations on improving policy, law or regulations; and 
(4) finally check and review whether our recommenda-
tion and its implementation serve our ultimate goal, i. e. 
protecting the health, wellbeing, rights and interests of 
patients, research participants, the public, vulnerable 
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groups, systematically disadvantaged groups, and sen-
tient animals97 [409–412].
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Epitaph
The Institute of Anatomy in Berlin
received during the years from 1939–1945
the bodies
of 269 executed women
Rolf Hochhuth 1963 [413: 15]
Libertas
• On December 19th, 1942, the trial at the People’s 
Court in Berlin against Libertas Schulze-Boysen and 
her husband Harro ended in a death sentence for high 
treason. Libertas was a 29-year-old publicist for the 
German movie industry and 33-year-old Harro served 
as an officer in the Reich’s Aviation Ministry. They had 
been married for five years, opposed Hitler’s regime 
and had worked together with other political dissi-
dents in an organisation that later became known as 
the Red Orchestra. The group was discovered in the 
summer of 1942, and most of the members were sen-
tenced to death [414, 415].
• As all prisoners on death row, Libertas was allowed to 
write a letter of farewell to her loved ones. She wrote 
hers to her mother on the day of her execution, De-
cember 2nd, 1942. In this letter, Libertas expressed 
very clear ideas of what should happen to her body af-
ter her death. She wrote: “As a last wish I have asked 
that my ‘material substance’ be left to you. If possible, 
97  Please see Asian Bioethics Review 2014 6(2) for the articles 
‘Ethical Issues in Medical Security System in Mainland China’ 
(Qiu, R), ‘The Tort Law of P.R. China and the Implementation of 
Informed Consent’ (Zhu, W), ‘Can the No Fault Approach to Com-
pensation for HIV Infection through Blood Transfusion be Ethically 
Justified?’ (Zhai, X), ‘Ethical Challenges to Punitive Law on Drug 
Users in China’ (Huang, W), ‘Ethical Inquiry into the Conditions 
under which Involuntary Commitment of Mentally Ill Can be Ethi-
cally Justified?’ (Liu, R), and “An Ethical Reflection on the ‘Danger 
Criterion’ in China’s Mental Health Law” (Hu, L)
bury me in a beautiful place amidst sunny nature.” 
[416: 141, translation by SH]. However, Libertas’ wish-
es were ignored. Indeed, something very different 
happened, as remembered by young physician Char-
lotte Pommer, who worked as an assistant for Profes-
sor Hermann Stieve, the director of the Anatomical 
Department at the University of Berlin [417]. Charlotte 
remembered: “On 22nd of December 1942, eleven men 
were hanged and five women were decapitated. Fifteen 
minutes later they were laid out on the dissection tables 
in the anatomical institute. [She, Libertas] lay on the 
first table, […] on the third table the big lifeless body of 
her husband […] I felt paralysed and could hardly assist 
Professor Stieve, who—as always—carried out his sci­
entific exploration with great care and uncommon dili­
gence […] After the impressions of that night, I resigned 
from my position” [417, translation by SH].
The researchers
• While Charlotte Pommer quit her job, Hermann Stieve 
continued with his research and in his position as 
chair of anatomy in Berlin, without interruption until 
his death in 1952 [418]. This was possible because he 
had never joined the NSDAP (the Nazi Party). His pub-
lications reveal that he dissected hundreds of bodies 
of executed persons for his work. Before 1920 he had 
performed animal experiments on the influence of the 
nervous system on the reproductive organs. He then 
realised that he could interpret the situation of death 
row inmates in a similar manner to his animal experi-
ments; he saw the imprisonment and fear of execution 
as the equivalent of chronic and acute stressors on the 
reproductive system of these persons. He studied the 
bodies of men executed in the 1920s, as women were 
not executed during this period. However, in 1935, as 
soon as the National Socialists started with the execu-
tion of women, Stieve began studies on the effect of se-
vere psychological trauma on menstruation patterns 
and the morphology of reproductive organs. There is 
no evidence that he ever had access to these prisoners 
prior to their deaths. He received the clinical data of 
the women from the prison personnel [419].
• Heinrich von Hayek was another anatomist who made 
regular use of bodies of the executed for his research 
during his years at the University of Würzburg [420]. 
He had joined the SA stormtroopers in 1933 and the 
NSDAP in 1938. In a 1940 study on lung architecture he 
stated: “most suitable of course are the lungs of young, 
executed men, of whom I had several at my disposal” 
[421: 405, translation by SH]. His book “Die menschli­
che Lunge“ [422], on the human lung, published in 
1953 and internationally perceived as a standard work 
on the subject, was largely based on his work with the 
bodies of executed persons. In 1952, Hayek was re-
cruited as chairman of anatomy in Vienna, a position 
he continued to hold until his death in 1969. 
• Research like Stieve’s and Hayek’s was made possible 
through the close collaboration between the Nation-
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al Socialist regime and the anatomical sciences. After 
the new German government came into power in Janu-
ary 1933, one of its first goals was the reorganisation of 
academia. All science was to be organised in terms of 
the National Socialist authoritarian leadership princi-
ple and utilised for war purposes. Within a few months, 
laws were passed that led to the dismissal of all so-
called “non-Aryan” university members and those con-
sidered political opponents. Leadership of the univer-
sities was no longer the responsibility of the individual 
German states, as it was centralised and administered 
by the Ministry of Education in Berlin, which was also 
responsible for the anatomical institutes. This included 
research funding, recruitment of faculty, and the ana-
tomical professional society, the Anatomische Gesells­
chaft. In terms of procuring bodies of prisoners and ex-
ecuted persons, the Ministry of Education shared this 
responsibility with the Ministry of Justice. The effect 
of the new government’s policies was profound, as re-
flected in the data available for 176 of 233 anatomists 
employed in Germany and the occupied territories be-
tween 1933 and 1945. Of these 176, 54 saw their careers 
disrupted for so-called “racial” or political reasons, 
whereby dismissal could mean anything from having 
to change jobs to forced emigration or incarceration. Of 
the remaining 122 anatomists, 99 joined the NSDAP, 42 
the SA, 13 the SS (the Nazi elite troop) and only 10 had 
no political affiliation with the regime [423].
• One of the leading National Socialists among the ana-
tomists was the Austrian Eduard Pernkopf. He was 
recruited as chair of anatomy at Vienna University 
in 1933 and joined the NSDAP and SA in 1933/34, at 
a time when these groups were still illegal in Austria. 
Pernkopf succeeded his mentor Ferdinand Hochstet-
ter, who had headed the traditionally conservative-
nationalist second chair of anatomy at Vienna Uni-
versity, whereas the first chair was traditionally held 
by liberal scientists of Jewish descent, at that time Ju-
lius Tandler, a baptised protestant, who was ousted by 
the Austro-fascist regime in 1934. After the so-called 
“Anschluss,”—the annexation of Austria by Germa-
ny—Pernkopf was made dean of the medical school 
in March 1938, and in this capacity oversaw the re-
moval of 53% of the medical faculty for “racial” or po-
litical reasons [424]. In 1943, he also became rector of 
the University of Vienna. In 1945, he was one of the 
few anatomists who lost their academic position per-
manently, although he received a pension and was 
invited by a colleague to continue his work on top-
ographical anatomy, the atlas “Topographische Ana­
tomie des Menschen.” It was this book that made him 
well known after the war, as it became internation-
ally popular among anatomists and surgeons due to 
the level of detail and a new printing technique that 
enabled the most brilliant and exact images. The at-
las had been commissioned by the publisher Urban 
and Schwarzenberg, which also financed the work of 
the medical illustrators [425]. It took half a century, 
apparently, before the users of the atlas noticed that 
the illustrators had left signs of their National Socialist 
sympathies in the images during the war years. Erich 
Lepier used a Swastika for his signature, Karl Endtress-
er shaped the double SS in his name as the SS runes on 
uniform batches, and Franz Batke did the same with 
the double number 4 in the year 1944. This and oth-
er observations led New York oral surgeon, Howard 
Israel, and Canadian physician, William Seidelman, 
to contact Yad Vashem, the world Holocaust remem-
brance center, which in 1995 sent an official inquiry 
to the University of Vienna, asking about the political 
background and the origins of the Pernkopf atlas [426]. 
After much discussion, the university senate launched 
a historical project, the Senatsprojekt der Universität 
Wien [427], which confirmed that Pernkopf was in-
deed an avid National Socialist. In addition, it was 
found that the bodies of many victims of the National 
Socialist regime had been delivered to the anatomical 
institute, among them more than 1300 bodies of per-
sons executed following civilian and military court tri-
als. It was deemed likely that at least some of these vic-
tims’ bodies had been used in the creation of the atlas. 
Research with the dead and the “future dead”
• To understand how this was possible, it is necessary to 
look at legal body procurement in anatomy prior to the 
National Socialist regime, and at the changes that oc-
curred thereafter [428]. Since the 18th century in Ger-
many, Austria, and many other countries, the tradi-
tional legal sources for anatomical body acquisition 
were so-called “unclaimed” bodies, that is: bodies of 
persons who died in public institutions and whose 
families did not claim them for burial. They included 
the bodies of patients who had died in psychiatric in-
stitutions, persons who committed suicide, deceased 
prisoners, and executed persons. Indeed, bodies of the 
executed were the oldest legal source of anatomical 
body procurement in Europe, dating back to the 13th 
century [429]. Under the National Socialists, increas-
ing numbers of their victims fell within these tradition-
al sources. From 1939 onwards, psychiatric patients 
included persons killed within the so-called “eutha-
nasia” programmes. Rising numbers of Jewish citizens 
committed suicide, and among the deceased were 
more political prisoners due to new legislation, and 
more violent deaths, especially in the Gestapo prisons. 
Also, there were many so-called “natural deaths” in the 
new network of camps: the concentration camps and 
camps for forced labourers and prisoners of war. Final-
ly, the number of bodies from executed prisoners grew 
exponentially. During the Weimar Republic, 1919–
1933, about 200 men and no women were executed.
These numbers rose to more than 30,000 executions 
following civilian and military trials between 1933 and 
1945. From 1935 on women were also executed, and 
some of them were pregnant. Based on numbers from 
studies of individual anatomical departments, the 
overall body supply for all 31 anatomical departments 
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in Germany and the occupied territories can now be 
estimated, and a conservative evaluation arrives at 30–
35,000 bodies delivered to the anatomical institutes. At 
this point it is unclear, just how many of these bodies 
were those of victims of the regime, however, there is 
an evidence-based estimate from Tübingen, where it 
was thought to be two thirds of the anatomical body 
supply [430]. Anatomists were not only passive recipi-
ents of these bodies, but they actively lobbied with the 
authorities for increased delivery of bodies of the ex-
ecuted to their institutes [431]. All of the anatomical 
departments used these bodies, independent of the 
political convictions of the anatomists. Among the vic-
tims, there were at least 3938 bodies of executed per-
sons from 20 departments that have been documented 
so far. For a majority their names are known, however, 
biographies still have to be reconstructed for a full me-
morialisation of these victims. 
• Some anatomists were willing to further transgress the 
ethical boundaries of medical ethics. They changed 
the traditional anatomical paradigm of knowledge 
gain through work with the dead, to a new paradigm 
of anatomical knowledge gain [432] through work with 
the “future dead”, that is: human experimentation 
[433]. Professor August Hirt became the mastermind 
of the anatomical experiment with the “future dead”. 
He was chair of anatomy at the German University of 
Strasbourg in occupied Alsace, and performed inhu-
mane experiments with chemical agents on prisoners 
in the Struthof-Natzweiler Concentration Camp—near 
Strasbourg—with the aid of the Ahnenerbe, the SS or-
ganisation that studied “race” and heredity. Hirt also 
planned an anatomical-anthropological experiment: 
a so-called “Jewish skeleton collection”, for which he 
had prisoners selected by the SS anthropologists Bru-
no Beger and Hans Fleischhacker in Auschwitz in the 
summer of 1943. The prisoners were then transported 
by train to Struthof-Natzweiler, where Hirt gave cya-
nide salts to the camp commander for the murder of 
86 victims in August 1943. Their bodies were then sent 
to the anatomical department in Strasbourg, where 
they were discovered upon the liberation of the city by 
French military forces in November 1944. After the war, 
Hirt was the only anatomist named in the Nuremberg 
Medical Trial in 1946/47, and was indicted in absentia 
as a murderer in Metz/Alsace in 1953, however it was 
discovered that he committed suicide in the summer 
of 1945 [434]. 
Legacies
• There are many continuities, legacies and consequenc-
es from this history, starting with the fact that the Na-
tional Socialist history of anatomy shines a clear light 
on current critical questions in anatomy, as the un-
ethical handling of anatomical bodies still exists. One 
of the most striking legacies is that Charlotte Pommer 
remained the only voluntarily “retired” anatomist, 
whereas few German and Austrian anatomists lost their 
positions after the war. Most were reinstated after a 
short denazification period. Furthermore, while in the 
first years post-war several hundred bodies of victims 
were returned to their families at their relatives’ be-
hest, others were left in the anatomical departments for 
many more years to come, to be used in teaching and 
research. Apart from whole bodies and body parts, tis-
sue samples from victims remained in many collections 
[428]. There are currently several projects underway 
that investigate historic collections of human tissue in 
terms of their potential origin during the National So-
cialist regime. These investigations include an inde-
pendent group of historians undertaking a provenance 
analysis of the neuroanatomical collections owned by 
the Max Planck Society; the Cécilie and Oskar Vogt neu-
roanatomical collection at the University of Düsseldorf; 
the Erich Blechschmidt collection of embryos at the 
University of Göttingen; collections from the Reichsuni­
versität in Strasbourg; a comprehensive database on all 
victims and perpetrators of coerced medical research 
under National Socialism [287]; and recent archaeolog-
ical findings of bones at the Freie Universität Berlin on 
the grounds of the former Kaiser Wilhelm Institute for 
Anthropology, Human Heredity and Eugenics.
“To use or not to use”: a new Pernkopf debate
• In terms of anatomy, the answer to the question of 
whether “to use or not use data from the National So-
cialist period”, is that their use never ended. Publica-
tions of research based on tissues from victims be-
came integrated in the general anatomical body of 
knowledge, and many books by German anatomists 
continued to be used for many decades after the 
war, including works by Stieve, Hayek and Pernkopf. 
The revelation of the historical background of the 
Pernkopf atlas led to the suspension of its publication 
by the owner of the copyright and the original paint-
ings in 1994. While some libraries removed the books 
from shelves, and several anatomists and surgeons 
stopped working with the atlas, old copies of the vol-
umes in several languages, as well as digital versions 
are available and still in use. 
• A new controversy concerning the Pernkopf atlas be-
gan in 2016, initiated by the US American reconstruc-
tive surgeon, Professor Susan Mackinnon, (Director of 
the Center for Nerve Injury and Paralysis and Sydney 
M. Jr. and Robert H. Shoenberg Professor and Chief 
of the Division of Plastic and Reconstructive Surgery 
of Washington University, St. Louis Missouri), and 
her associate Andrew Yee. Mackinnon has been using 
the atlas since 1981. She knew about the book’s back-
ground and included this historical example of nefari-
ous research practices in her teaching on medical eth-
ics. Her team has developed an online video platform 
for global education on rare and difficult nerve recon-
struction surgery. For this, she wanted to use images 
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from the Pernkopf atlas, including its history, as she 
argued that no other atlas afforded the information 
necessary to understand her procedure, and that spe-
cific illustrations from the Pernkopf atlas have saved 
human lives in the surgeries she has performed. When 
she asked the publisher for the right to use some of the 
images in 2016, Elsevier refused to give her access to 
the copyright, citing ethical reasons and the politi-
cal background of the atlas. In a discussion between 
the surgeon and the authors, the question then arose 
of whether the publisher could be urged to grant the 
copyright for ethical reasons on the grounds of sav-
ing human lives? The question was then put to Rabbi 
Joseph Polak and Prof. M. Grodin of Boston, with the 
request for an opinion that addressed the ethical, re-
ligious and ritual aspects of the problem from the Jew-
ish ethical perspective, considering the concept of Pi­
kuach Nefesh, the saving of human lives. Rabbi Polak, 
the Chief Judge of the Rabbinical Court of Massachu-
setts, is an authority on Jewish medical ethics and the 
Holocaust and a childhood survivor of Bergen-Bel-
sen. Prof. Grodin, of the Elie Wiesel Center for Jew-
ish Studies at Boston University, is an internationally 
noted expert on the history of medicine and the Holo-
caust, and medicine and human rights. 
On March 3rd, 2017, at the “Medical Ethics in the 70 Years 
after the Nuremberg Code” conference sponsored by the 
Medical University of Vienna, co-author William Seidel-
man presented the following proposal for a “collabora-
tive initiative of Elsevier publishing and the Medical Uni-
versity of Vienna”: 
• Elsevier Publishing and the Medical University of Vi-
enna jointly establish a dedicated place of remem-
brance on the campus of the Medical University of Vi-
enna in honour of the victims of medical abuses by 
Vienna faculty, and exploited by the original publish-
er, during the Hitler period.
• The original Pernkopf paintings be displayed in this 
dedicated space along with documentation on the his-
tory of the paintings and as a commemoration to the 
memory of the victims.
• A joint committee of Elsevier Publishing and the Uni-
versity of Vienna be established, pending the results of 
the review by Prof. Grodin and Rabbi Polak, to consid-
er applications for the use of the Pernkopf paintings 
based on the precepts and recommendations of the 
Grodin and Polak review of the potential for the saving 
of human life and limb. 
During a panel discussion at the conference on the same 
day it was agreed to pursue this proposal. Since then, Rab-
bi Polak has formulated his opinion in the “Vienna Pro-
tocol”. In point C.12 of the protocol he recommends the 
use of Pernkopf images when lives can be saved, stipulat-
ing the connection of their use with the memorialisation 
of their historical background and the victims. The “Vi-
enna Protocol” is now part of a set of recommendations 
on “How to deal with Holocaust era human remains” for-
mulated by an interdisciplinary group of experts at a spe-
cial symposium at Yad Vashem, the World Holocaust Re-
membrance Center, Jerusalem May 4th, 2017.98
Abiding values 
The authors fully concur with Rabbi Polak’s opinion. 
The example of data from anatomy during National So-
cialism shows that there are many continuities and leg-
acies reaching into the present, and that this history 
needs to be carefully re-examined by each generation of 
medical researchers and practitioners. Decisions on the 
use of such data are dependent on context, and require 
full transparency of the specifics of the historical back-
ground. However, the principles of respect for the dead 
and their memorialisation, as well as the concept of sav-
ing human lives, are abiding values in medical ethics that 
cannot change.
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Toward 1900, medical breakthroughs led by German re-
searchers provided the impetus for better hygiene. Sur-
geries became cleaner. Deaths from infection became 
rarer. As more people faced death later in life from de-
teriorative diseases, a new topic of debate emerged: eu-
thanasia. Shouldn’t the terminally ill have a right to 
end their suffering by choosing when and how to die? 
Shouldn’t people receive a merciful death, as suffering 
animals ordinarily do? In 1913 a terminally-ill German 
Monist, Roland Gerkan, asked these questions in advo-
cating for a proposed euthanasia law. The debate that en-
sued included warnings of a slippery slope: a euthanasia 
law could expand to include patients who were not ter-
minally ill, such as incurable mental patients [244].
During World War I, the German government rationed 
food and medical supplies to support its troops, and life 
became dire for civilians. This was especially true for pa-
tients in government asylums. Of the more than 140,000 
who perished, about half evidently died of malnutrition 
98  The text of the recommendations including the “Vienna 
Protocol” is being hosted for download on the website of Boston 
University Elie Wiesel Center for Jewish Studies [435].
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and epidemic disease. Regarded by some as a necessary 
sacrifice, the deaths fuelled a debate in the economical-
ly difficult post-World War I years. Concerned above all 
with resource allocation, the most radical writers on the 
topic, Karl Binding and Alfred Hoche, argued in 1920 for 
“the destruction of life unworthy of life” [244: 15; 437].
The Nazis adopted these arguments in support of their 
Aktion T4 program for secretly killing asylum patients, 
whom their propaganda labelled “worthless eaters.” Of-
ficially established with a letter from Adolf Hitler back-
dated 1 September 1939, the first day of World War II, 
‘T4’ aimed to save money and to free hospital beds for 
wounded soldiers. The term “euthanasia” (Gnadentod in 
German for “merciful death”) became a screen to cover 
up mass murder. Eventually utilizing gas chambers and 
crematorium ovens, ‘T4’ served as a model, in 1942, for 
genocidal policy against the Jews. 
In 1946/47, the Nuremberg Medical Trial held Ger-
man physician murderers accountable for their crimes 
and established the foremost tenet of modern bioethics: 
patients and human research subjects must understand 
and consent to medical intervention. Today, euthanasia 
and physician-assisted suicide, legal in some countries 
and American states, give patients the control that early 
advocates sought more than a century ago. But these new 
developments have inspired fresh criticism that draws on 
the knowledge of German history and the fear of a slip-
pery slope. Who decides the worthiness of a life? By which 
criteria? What, if anything, constitutes a “good death”?
These are big questions, and the ten contemporary 
artists in “Mastering Death: Artistic Perspectives,” an ex-
hibition of artworks about the history and ethical chal-
lenges of euthanasia from Nazi times to the present that 
I guest-curated at the Josephinum, Medical University 
of Vienna, in March and April 2017, (fig. 1), are, on the 
whole, skittish about answering them. In contrast with 
the arrogance of Nazi doctors and perpetrators in judg-
ing who would live and die, many of these artists tend to 
undermine their own authority.
*
The intellectual underpinnings of Nazi medical think-
ing are the subjects of Tower of Babel, 2016, by Ameri-
can artist Susan Erony, (figs. 2, 3 and 4). Erony references 
the biblical story of human arrogance, which Friedrich 
 Nietzsche invoked to describe scientific knowledge itself: 
“The domain of science has expanded and the towers of 
Babel erected by the sciences have multiplied in a mon-
strous fashion” [437: 295, 438: 94]. Nietzsche saw science, 
like religion before it, as a grandiose lie because it prom-
ised comforting certainties when, he believed, there are 
none. With her triptych to a false religion, Erony simulta-
neously recalls yet another Nietzschean notion, one that 
inspired the Nazis: society as a pyramid of castes that rise 
from anonymous workers to the Übermensch (“super-
Fig. 1 Installation view of “Mastering Death: Artistic Perspectives,” 2 March – 1 April 2017, Josephinum, Medical University of 
Vienna. Photo: Martina Peters
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man”) leader on top.99 Erony imagines this pyramid as 
99  In Also Sprach Zarathustra (1883), where Nietzsche developed 
his idea of the Übermensch, the author explored the notion of 
euthanasia in a section entitled “Voluntary Death” (“Vom Freien 
Tode”). Zarathustra instructs the potential Übermensch to “die at 
the right time” (“Stirb zur rechten Zeit”). “My death, praise I unto 
you, the voluntary death, which cometh unto me because I want it” 
(“Meinen Tod lobe ich euch, den freien Tod, der mir kommt, weil ich 
will”). Nietzsche contrasts those who die nobly and heroically with 
those who cling to life, shriveled (runzelig) [439; 440: 48].
a pile of bodies represented as hands of the disenfran-
chised dead, in particular the children killed in ‘T4’, to 
whom she dedicates the piece. 
Instead of, for example, inventing an expressive style, 
Erony lets history speak for itself by accepting biblical 
and Nietzschean metaphor as givens and by incorporat-
ing photographic reproductions of historical documents 
(Hitler’s falsely dated 1 September 1939 letter authorizing 
‘T4’, and a vintage Anglo eugenics diagram reproduced 
in Tree of Races representing a now-discredited scien tific 
idea). Her reliance on different quotations, along with 
her mix of image and text, drawing and photography en-
gender a work that conceptually and formalistically em-
bodies complexity and contradiction, hallmarks of post-
modernism.100
Many Holocaust-related artists take a postmodern ap-
proach that intrinsically challenges the modernist cer-
tainty the Nazis were known for. But some promote a 
moral absolutism associated with modernism. Arie A. 
Galles, born in Uzbekistan to parents who had fled the 
Nazis, and later raised in Poland, Israel and the United 
States, where he lives today, abandoned a twenty-year 
career making semi-abstract paintings to focus on Nazi 
subject matter starting in the early-1990s, when Holo-
caust consciousness in the US reached a fever pitch.101 
To communicate historical facts without ambiguity or 
uncertainty, Galles began drawing naturalistically, re-
producing vintage photographs in charcoal, as in the 
100  Among authors who link post-Holocaust to postmodernism, 
see Eaglestone [441].
101  A commentator on the 28 December 1993 broadcast of the 
American news program Nightline went so far as to declare 1993 
“the year of the Holocaust” [442].
Fig. 2 Susan Erony, Tower of Babel: 1 September 1939, 
2016. Inkjet print, 23 × 22 inches. Courtesy of the artist
Fig. 3 Susan Erony, Tower of Babel: Tree of Races, 2016. In-
kjet print, 22 3/4 × 22 inches. Courtesy of the artist
Fig. 4 Susan Erony, Tower of Babel: Useless Eaters, 2016. 
Inkjet print, 22 5/8 × 21 7/8 inches. Courtesy of the artist
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aerial views of death camps in his magisterial Fourteen 
Stations, 1993–2002. 
In GNADENTOD, 2017, Galles leaves no doubt about 
his understanding of ‘T4’ (fig. 5). He stacks an image of 
a ‘T4’ bus that delivered asylum patients to killing cen-
tres below that of a cattle car that transported victims to 
death camps to manifest the evolution from ‘T4’ to the 
Final Solution. By highlighting MACHT from “ARBEIT 
MACHT FREI” (“work makes you free”) on various death 
camp gates together with the last syllable of GNADEN-
TOD, Galles composes a chilling phrase: MACHT TOD 
(suggesting the “power to bring about death”). A column 
of smoke, adapted from a photograph that secretly docu-
mented cremation at the Hartheim Castle asylum, joins 
smoke from death camp crematoria. Smoke underscores 
Galles’s rationale for the charcoal medium—by “drawing 
with ashes” he references the dead102 [443].
Reminiscent of work by survivor artist David Olere 
and others, GNADENTOD displays an older Expression-
ist style often associated with agitprop: writes Galles, “I 
had to walk a thin mental edge between empathy and 
propaganda” [444, unpaginated]. To my eyes, empathy is 
what matters most here. Having spent his life among sur-
vivors, Galles testifies here with the passion of a second­
102  The phrase “drawing with ashes” also serves as the title of a 
forthcoming book of Galles’s journal entries written during the 
creation of Fourteen Stations.
ary witness.103 Significantly, the paper on which Galles 
drew came from an artist-friend survivor diagnosed with 
Alzheimer’s, a disease for which ‘T4’ doctors likely would 
have slated her for Gnadentod. 
*
Erony’s postmodernism and Galles’s modernism rep-
resent different positions on the spectrum of possibility 
in art about Nazi atrocity, but they are not as far apart as 
they first appear. Both Erony and Galles have the victims 
in mind. They memorialize and honour. Notwithstand-
ing her play of meaning, Erony, no less than Galles, fo-
cuses on the criminality of medicalized murder. Among 
artists who choose to engage with that difficult sub-
ject matter, it’s quite ordinary to find the postmodern-
ist play of meanings fused with modernist authority; art 
about Nazi atrocity typically exemplifies a “postmodern 
modernism”104 [447]. 
103  Shoshana Felman explores the notion of secondary witnessing 
in an incisive essay on Claude Lanzmann’s Shoah [445].
104  This contradictory approach, which I believe develops in 
response to the subject matter itself, also describes the philosophy 
of Theodor W. Adorno, which responds to Holocaust history and 
Fig. 5 Arie A. Galles, GNADENTOD, 2017. Charcoal and con-
té on Arches BKF, 29.5 × 22 inches. Courtesy of the artist
Fig. 6 Vitaly Komar and Anna Halberstadt, Broken Cross, 
2016. Ed. 12, C-print, 30 7/16 × 19 7/8 inches. Courtesy of 
the artists
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Artist Vitaly Komar and poet Anna Halberstadt bal-
ance contradiction and certainty in Broken Cross, 2016, 
(fig. 6). The piece presents a red cross, associated with 
empathy and healing, transformed into a swastika, what 
Komar describes as a once-positive symbol that has fall-
en, like the Angel of Death, to create “a dialectical con-
tradiction of two concepts, merged into a monstrous 
mutation”105 [444]. To appreciate what’s behind the con-
tradictory overlay of symbols in Broken Cross, let’s ex-
amine an earlier work with a similar composition. In the 
lower half of Komar’s Mandala Above State Heraldry #2, 
2004–2005, (fig. 7), the wheat-sheath originates in the em-
blem of the USSR, where Komar was born and raised; the 
eagle derives from the seal of the United States, where he 
emigrated in 1978; with two heads, Komar’s eagle recalls 
memory. In general, Holocaust-related artists intuitively pursue an 
approach with affinities to Adorno’s philosophy [446].
105  While not intended by Komar, the image conjures Nazi decep-
tions: tricking international Red Cross observers at Theresienstadt 
by camouflaging inhumane conditions and, above all, murdering 
Jews at Chemno in ‘T4’-inspired gas vans marked with the red 
cross.
the emblem of Czarist Russia and pogroms of that time 
against his Jewish co-religionists. On the bird’s breast-
plate appears a photo of Komar as a boy with his parents 
shortly before his father divorced his mother and van-
ished forever. In its absurdist refusal to attempt a serious 
or coherent understanding, Komar’s complex and con-
tradictory image embraces what he considers a Kierke-
gaardian sense of irony; it tacitly accepts the mystery of 
life [448, 449]. The same may be said of the absurd fusion 
in Broken Cross. What’s more, the contrast of geometric 
abstraction (flat coloured shapes) with naturalistic rep-
resentation (the three-dimensional skulls) prohibits aes-
thetic coherence, much in the way that the juxtaposition 
of visual and literary forms do. As in Mandala with State 
Heraldry #2, the lower half affirms the autobiographi-
cal, in this case with an excerpt from an affecting poem 
by Halberstadt, a Lithuanian-born Russian émigré to the 
United States. The larger poem relates Halberstadt’s per-
spective as the child of Holocaust survivors on returning 
to visit the land of her early childhood. The excerpt po-
sitions Halberstadt as a secondary witness through her 
harrowing account of her mother’s relatives who were 
murdered by the Nazis [450].
*
Though other artworks that were in the exhibition do 
not specifically explore Nazi crime, they do destabilize 
fixed meanings to raise ethical questions about eutha-
nasia. Born in Germany and living today in the United 
States, Ruth Liberman based Humans Are Not Animals, 
2017, (fig. 8), on an image from an old medical textbook. 
As in Erony’s Tower of Babel: Useless Eaters, hands be-
come a charged metonym of human presence. Liber-
man’s haunting image shows a doctor’s hands attend-
ing to those of a patient, but the gesture is indeterminate. 
Has the patient raised a hand for a handshake or for help? 
Fig. 7 Vitaly Komar, Mandada Above State Heraldry #2, 
2004–2005. Mixed media on paper, 40 × 30 inches. Courtesy 
of the artist
Fig. 8 Ruth Liberman, Humans Are Not Animals, 2017. Inkjet 
print, 32 × 32 inches. Courtesy of the artist
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Has the doctor lifted this hand to monitor the patient’s 
heart rate or make sure it has stopped?
Descending from above, the isolated hands of a god-
like doctor suggest a traditional Christian symbol for 
God, in keeping with the Christian interpretation of the 
Second Commandment against graven images.106 With a 
whiteness that simultaneously suggests hygiene as well 
as the bright light traditionally associated with the mo-
ment of death, Liberman’s image generates multiple pos-
sible interpretations. 
The title, which may at first sound uplifting, reinforces 
the indeterminacy: Humans Are Not Animals. Which hu-
mans? The patient, possibly euthanized by the doctor as 
unceremoniously as a dog? Or the doctor, who possibly 
106  A prominent Renaissance example is Domenico Ghirlandaio’s 
Baptism of Christ, ca. 1475. Liberman also references the hands of 
God and Adam in Michelangelo’s Sistine Chapel ceiling of 1508–12.
behaves like an animal with an act that violates the phy-
sician’s Hippocratic Oath to “do no harm”? Comparison 
of humans to animals suggests depravity, but animals, of 
course, cannot commit crimes; animals are not humans. 
In the end, Liberman’s piece prompts us to ask what it 
means to be human.
Treatment of laboratory research animals today sug-
gests that the scientific method fosters much of the 
coldness associated with Nazi doctors. In 2008, Vere-
na Kaminiarz, a German-born artist who lives in Can-
ada, proposed an installation for giving retired labora-
tory mice names instead of numbers and comfortable 
cages in which to live out their natural lives, (figs. 9 and 
10). But her proposal ran afoul of her university bioethics 
board. Initially mistaking her artwork for a bona fide ex-
periment, the board argued that naming the mice would 
compromise the objectivity of the researcher and insist-
ed the mice be euthanized after the experiment to pre-
Fig. 9 Verena Kaminiarz, ‘may the mice bite me if it is not 
true’ installation detail: Felix, 2008. Inkjet print, 12 × 16 inches. 
Courtesy of the artist
Fig. 10 Verena Kaminiarz, ‘may the mice bite me if it is not 
true’ installation detail: Habitat, 2008. Inkjet print, 12 × 16 in-
ches. Courtesy of the artist
Fig. 11 Manfred Menz, EUTHANASIA SOLICITATION, 2017. 
Ed. 5, inkjet print, 23 7/16 × 29 15/16 Inches. Courtesy of the 
artist
Fig. 12 Manfred Menz, EUTHANASIA SOLICITATION, 2017. 
Detail
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vent their suffering unnecessary stress. By rejecting this 
protocol, Kaminiarz recommends a new, humbler scien-
tific approach: respect and responsibility for sustaining 
life, as suggested by the lower-case letters and oath-like 
sound of her title, ‘may the mice bite me if it is not true’. 
From lab animal to vermin, the mouse resonates with 
cultural associations. EUTHANASIA SOLICITATION, 
2017, by German-born, American-based Manfred Menz, 
presents an image of a human-size mousetrap, (figs. 11 
and 12). Menz’s Pop Art-style sculpture depicted in the 
print dates to 1995, at the height of popularity of Maus, 
Art Spiegelman’s 1991 memoir that relates the Holocaust 
experience of the author’s survivor father, Vladek, in 
comic-book form, with Jews represented as mouse-head-
ed humans. Chapter 6, “Mouse Trap,” about Vladek’s and 
wife Anja’s capture, opens with a drawing of them both 
under the hammer of a giant trap [451: 129). Nazi propa-
ganda characterized Jews as vermin that had infected the 
German body politic with disease.
The trap suggests an unwitting victim, but Menz’s un-
attributed text in the print implies otherwise. It invokes 
a person who seeks death on account of “subversion of 
public morals,” leaving a reader to wonder if that person-
al choice to die may itself be the mischievously subver-
sive act. 
“Most important human needs,” Menz explains, “are 
used as bait to terminate the desire to live” [444]. I un-
derstand this to mean that the enormous freedom to 
choose one’s partner, career, home, etc., and create one’s 
own happiness and fulfilment comes with the formidable 
risk of disappointment and even despair. For people who 
judge their lives unworthy of living, even though they 
may be physically well, Belgium and the Netherlands 
lead the way with euthanasia laws that grant the freedom 
to choose to die. Is freedom itself the ultimate trap?
Both Belgium and the Netherlands permit euthana-
sia for dementia patients who, when they were compe-
tent, had recorded their preference to die in such circum-
stances. When he was healthy, my own father insisted he 
would rather pass from the scene than languish with de-
mentia, but when vascular dementia diminished him, he 
enjoyed sharing time with family, playing checkers, and 
dining out, and expressed a desire to live. Menz’s written 
solicitation to die states darkly, “I have the right not … to 
be treated against my will  … .” Should euthanasia for a 
dementia patient be determined by someone who was, 
in effect, a different person? Must executors of a living 
Fig. 13 Julijonas Urbonas, Euthanasia Coaster, simplified technical drawing, scale 1:1000, 2010 Silkscreen on metal sheet, 
90 × 120 cm. Design, engineering: Julijonas Urbonas. Medical advisor: Dr. Michael Gresty, Spatial Disorientation Lab, Imperial 
College London. Courtesy of the artist
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will comply with a legal order to euthanize a patient who 
wants to live? When, if ever, is a patient’s life no longer 
worth living? Who decides? Menz’s artwork raises these 
questions.
If some societies already accept euthanasia by poi-
son, perhaps they will someday permit it by the gravi-
tational forces unleashed by Julijonas Urbonas’s Eutha­
nasia Coaster, a project for a frolicsome killing machine 
designed in consultation with a medical doctor (fig. 13). 
The idea is that it might deliver a euphoric death through 
deprivation of oxygen to the rider’s brain. Urbonas, a 
Lithuanian artist who worked as an amusement park di-
rector in 2004–2007, regards his piece as social science 
fiction. In a commodity culture that pitches virtually eve-
rything for consumer satisfaction, Euthanasia Coaster 
goes to an absurd extreme. The piece suggests that even 
the experience of dying itself can be supplanted by dis-
tracting, momentary excitements. Seen in profile, the 
coaster’s declining line suggests the rider’s fading heart-
beat and a literal slippery slope. 
*
Physician-assisted suicide was not theoretical for 
American artist Betsy Davis. Suffering with ALS, she chose 
to end her life surrounded by friends and family during a 
weekend-long gathering she called her “rebirth ceremo-
ny” in July 2016 [444]. With a prognosis of less than six 
months to live, a debilitating and painful disease, a clear 
mind and strong feelings, Davis offers a compelling ex-
ample of the benefits of physician-assisted suicide. Niels 
Alpert, Davis’s friend and occasional artistic collaborator, 
documented her self-determined, semi-public example, 
(figs. 14, 15 and 16). In addition to Belgium (2002) and 
the Netherlands (2002), Colombia (2015) and Luxem-
bourg (2009) now permit euthanasia, and more and more 
governments permit physician-assisted suicide: Canada 
(2015), Germany (2015), and Switzerland (since 1942), as 
does Washington, D. C. (2017) and the American states 
of Colorado (2015), Montana (2009), Oregon (1997), Ver-
mont (2013), Washington (2008), and California (2015), 
where Davis died.
In societies that normalize euthanasia and physician-
assisted suicide, people may choose to die for reasons 
quite different from Davis’s. With perhaps the most per-
missive laws, Belgium allows persons with “constant and 
unbearable physical or mental suffering that cannot be 
alleviated” to seek euthanasia. These have included Bel-
gians with autism, anorexia, borderline personality dis-
order, chronic-fatigue syndrome, partial paralysis, blind-
ness coupled with deafness, and manic depression [452]. 
In choosing to die, people may act rashly due to undiag-
nosed or untreated mental illness. Or they may wish to 
spare relatives the emotional or financial burden of pro-
longed healthcare.
As euthanasia and physician-assisted suicide increase 
in popularity, and freedoms expand to include children 
of any age, no one knows how public policies and atti-
tudes may develop.107 Through creative distillations that 
have the potential to chill and haunt, affecting viewers 
on a visceral and often a personal level that rational ar-
guments alone cannot reach, artworks have a thoughtful 
role to play in sensitizing the public to a range of ethical 
concerns and, by extension, in shaping public policy.
107  In 2014, Belgium legalized voluntary euthanasia for children of 
any age.
Fig. 14 Niels Alpert, Untitled, 2016. Inkjet print, 11.78 × 16 in-
ches. Courtesy of the artist. 
Fig. 15 Niels Alpert, Untitled, 2016. Inkjet print, 10.67 × 16 in-
ches. Courtesy of the artist
Fig. 16 Niels Alpert, Untitled, 2016. Inkjet print, 9.94 × 16 in-
ches. Courtesy of the artist
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Vienna Protocol for when Jewish or Possibly-
Jewish Human Remains are Discovered108 
Rabbi Joseph A. Polak, Chief Justice, Rabbinical 
Court of Massachusetts and Assoc. Prof. Health 
Law, Boston University School of Public Health 
rjp@bu.edu 
A) Major classical Jewish sources for the Protocol 
In this section, I list many of the classical texts informing 
the Protocol, including sources from the Bible, the Tal-
mud, Maimonides (“Rambam”), and other codes, as well 
as from the Responsa literature. It also contains my occa-
sional reflections on these sources, intended to help ease 
the way for readers unfamiliar with these types of mate-
rials. Finally—the list of texts presented is hardly exhaus-
tive, but this is because I have already considered and 
documented most others (including Noda beYehuda, 
Hatam Sofer, Maharam Schick, Igrot Moshe, Tzitz Eliezer 
etc.) in an earlier, related article.109
***
The first obligation when someone dies, often, but not al-
ways, overridden by all other considerations, is the swift 
burial of the corpse:
And if a man has committed a sin worthy of death, and 
he is put to death, and thou hang him on a tree: his 
body shall not remain all night upon the tree, but thou 
shalt surely bury him that day (for he that is hanged is 
accursed of G-d:) that thy land be not defiled, which 
the L-rd thy G-d gives thee for an inheritance.
(Deut. 21:22-3)110
The Talmud, from which the following extract is 
drawn, is composed of an early section called the Mishna 
(3rd C.), and an elaboration on the Mishna called the Ge-
mara (3rd to 6th C.). 
And not only of this one [a criminal] did they [sc. The 
Sages] say it [that the corpse not be left hanging over-
night] but whosoever lets his dead lie overnight trans-
gresses a negative command. [However] if he kept him 
overnight for the sake of his honor, to procure for him 
a coffin or a shroud, he does not transgress thereby.
(Mishna Sanhedrin 46a).111
108  Presented at a Symposium entitled “The Remains of Jewish 
Martyrs Who Were Victims of Nazi Medical Experiments,” held at 
Yad Vashem, Jerusalem, May 2017.
109 Polak, Joseph A., Exhuming Their Neighbors: A Halakhic In-
quiry, Tradition 35:4, 2001.
110 Koren Bible, trans. Harold Fisch.
111 Soncino translation, slightly adapted. See also, Nachmanides, 
Commentary on the Bible, (Deut. 21) that this prohibition applies 
with greater severity in the land of Israel. See also R Chaim David 
haLevi, Responsa Mayim Chaim, Tel Aviv, 1991, p. 28.
The Gemara following this Mishna raises the question 
of whether [immediate] burial is a means to avert dis-
grace112 or is a means of atonement.113 What is important 
here is the notion of burial itself being redemptive.114
Again, the Gemara here115 raises the question whether 
prompt burial, or for that matter, burial itself, is for the 
benefit of the deceased or for their survivors, and con-
cludes it is for the deceased, implying that the survivors 
do not have the option to delay burial unless doing so is 
of benefit to the deceased.
It is forbidden to derive benefit from the deceased, 
save for his hair, which is permitted for benefit since it 
is not part of his body. So also his coffin and shrouds 
are forbidden for benefit. However, vessels [objects, 
material] set-aside for shrouds are not forbidden for 
benefit until placed in his coffin to be buried with him. 
For things set aside [for the dead] are not prohibited 
from benefit.
Rambam, Yad, Eivel 14:21
Mishna: All things which are requiring to be buried 
must not be burned,116 and all things which are re-
quired to be burnt [e.g. certain animal sacrifices] must 
not be buried. Gemara: … And no benefit may be de-
rived from the crumbled flesh of a corpse …
(B. Temura, 14a).
Ash from cremation, where the cremation was against 
the will of the deceased, as is the case in persecu-
tions, may be buried.117 If it is not known whether all 
the burnt victims were Jews, the corpses may be bur-
ied together in a properly demarcated area of a Jewish 
cemetery.118
On the Sabbath, based on biblical injunction, it is for-
bidden to carry an object from a public to a private do-
main—say from your house (private domain) to the street 
(public domain), or vice versa. But if I carry a person on a 
112 Decomposition and putrefaction make the dead loathsome: 
burial may be intended to spare them and their relatives that dis-
grace. (Soncino note)
113 For the sins committed during the lifetime (ibid).
114 There is a broad rabbinic literature, mostly mishnaic in origin, 
which considers the disposal of the remains of sacrificial animals 
set aside for sacred purposes and subsequently incurring blem-
ishes which then precluded them from being offered at the temple 
altar (remembering that by the time the Mishna is committed to 
writing (3rd C.), animal sacrifice has been discontinued for almost 
300 years). The animals in question may neither be burnt, nor 
discarded, nor may any benefit of any kind be drawn from their re-
mains. Indeed, the only respectful thing to do with their carcasses, 
the tradition teaches, that is equal to their sacerdotal status, is to 
bury them. See M. Hulin, 10:2, M. Bechorot 1:7 and 2:3. From this 
we see that burial, in Judaism, constitutes an accordance of deep 
respect.
115 B. Sanhedrin 47a
116 This Mishna is thus the basis for the Jewish prohibition against 
cremation.
117 Shmelkes, Y. Y., Resp. Bet Yitzchak, Yoreh De’ah, 125, and Grun-
wald, Y. Y., Kol Bo al Avelut, NY, Feldheim, p. 183.
118 Resp. Harei Besamim, cited in Grunwald, op. cit, p,189.
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litter from his house to the street, the Mishna explains,119 
then I have not violated the prohibition of carrying, be-
cause a human being is never described as a burden, and 
in fact “carries himself.“120 But if one carries a corpse, one 
does indeed violate this prohibition, because a corpse 
does not “carry itself.” The Mishna now proceeds: so how 
much of the corpse—what measure—do I need to carry 
to violate the prohibition?—The size of an olive.
R. Yom Tov Lipman Heller of Kraków (18th century) in 
his commentary to this Mishna: “It is also possible, that 
[with respect to a corpse] if the [size of the remains is in-
deed] less than the size of an olive, there is [also] no ob-
ligation to bury it.”121 There are some who disagree with 
this position, including R Samuel Strashun,122 but the 
majority of decisors appear to support it, as documented 
in footnote 120.
There are three modern compendia, each widely ac-
cepted in the halakhic world, that serve as encyclopedic 
gathering-places for Jewish laws having to do with inter-
ment and the dead. The first is the Kol Bo of the late R. 
Yekutiel Grunwald of Columbus, Ohio, to which we have 
already referred. Grunwald came from the Hungarian Ye-
shiva world, known for its inexhaustible capacity to re-
member everything, and then associate with enormous 
creativity from one set of laws to the other. The second was 
the late R Yechiel Michel Tukochinsky, author of the Gesh­
er haChaim, a Jerusalem-based Yeshiva administrator, 
with origins in the Lithuanian Yeshiva world, with its con-
trasting capacity for penetrating analysis, leading often 
to surprising conclusions. The third is the Yesodai Sema­
chot of R Aaron Felder, whose work by this name, in addi-
tion to containing his own analyses and guidance, records 
most significantly the rulings of his teacher, R Moses Fein-
stein, the most widely accepted American halakhic deci-
sor of the twentieth century, and of his father, R Gedaliah 
Felder, who had the same reputation in Canada.
Our case is not uncharacteristic of the Lithuani-
an method. In a section of his work devoted to corpses 
burned during persecution, R Tukochinsky unequivocal-
ly recommends their interment, not so much because of 
a prohibition of not leaving one’s dead unburied,123 but to 
ensure that no BENEFIT (which prohibition continues to 
119 Shabbat 10:5
120 And the litter itself, insofar as it is carrying a person who “car-
ries himself”, so-to-speak, is thus not carrying anything. This is 
actually not the final ruling with respect to the litter.
121 ibid. Also cited by R Solomon Eiger [probably on behalf of his 
father, R Akiva Eiger] in his glossary to the Code of Jewish Law, 
Gilayon haMaharsha, Yoreh De’ah 362:2. R Akiva Eiger confirms this 
independently in his own Tosafot on this Mishna in Shabbat. So also 
R Isaiah Berlin-Pick, Rishon leTziyon on the Mishna Shabbat (op 
cit), and who sends us to R Judah Rozanes, Mishna 
laMelech on Maimonides, Yad, end of Eivel, to the effect that there is 
no obligation to inter olive-size portions of a corpse—what needs to 
be buried are “rosho veRubo”—the head and majority of the body.
122 Rashash on the Mishna.
123 He is not convinced that the obligation for charred remains is 
identical to that of a normal corpse.
be operative) be ever derived from these remains.124 He 
bases his decision on the Temura Gemara cited above.
Responsum of R Isser Yehuda Untermann, late Chief 
Rabbi of Israel, regarding sacks of earth containing the 
remains of Jewish martyrs prepared to be interred in Is-
rael:
” … my opinion is to bury the sacks in a separate grave 
in the cemetery, and to erect a massive monument 
over it explaining just what is buried here  …125 (This 
will from here-on-in be referred to as the Untermann 
Protocol).
B) The ensuing Preamble to the Protocol:  
Whereas:
1. The classic Jewish legal tradition requires burial of its 
dead,
2. and requires burial without delay,
3. and maintains that such burial is of benefit to the 
mourners permitting them to grieve,126
4. and because such burial is also of benefit to the dead: 
a) since the remains are now putrefying and ugly and 
should therefore not be seen by others;127 b) because 
burial is part of the process of forgiveness for the sins 
of deceased,
5. and since it is prohibited to derive any BENEFIT from 
both corpses and objects on them or in their immedi-
ate vicinity,
6. and since all cremation is strictly prohibited,
7. and since bodies burned at the request of the de-
ceased may not be interred in a Jewish cemetery,
8. but bodies cremated against the will of the deceased, 
must be buried in a Jewish cemetery,
9. and since, while body parts smaller than the size of an 
olive need not be buried, but are still prohibited from 
benefit,
10. and whereas the remains of the anonymous dead 
discovered inadvertently assume the halakhic status 
of metay mitzvah—imposing the obligation of incum-
bent, immediate burial upon its finder—to the extent 
that the discovered anonymous Jewish deceased le-
gally acquires deed and title to the earth upon which 
he is found.128 
C) The Protocol and recommendations 
1. When human remains are (inadvertently) found, local 
legal (forensic) civic and religious authorities need to 
be consulted immediately.
124 Gesher haChaim, vol. 1, p. 154.
125 Resp. Shevet mi Yehuda, vol. 2, section Yoreh Dde’ah, #54.
126 Modern psychological sources
127 Ma’avar Yabok
128 A full discussion of the parameters of “met mitzvah” may be 
found in my earlier article, Polak, op cit.
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2. If there is even a remote chance that such remains may 
be of Jewish origin, the nearest Jewish rabbinic au-
thorities need to be consulted immediately.
3. If a full cemetery or killing field is come upon, marked 
or unmarked, then except under the rarest circum-
stances, reinterment to another site is not recommend-
ed, and ignoring these remains so as to, for example, 
construct real estate (e. g. the shopping center in Vil-
nius) over them, is extraordinarily offensive to Jewish 
custom, life, traditions, and values and to the memo-
ries of victims, if victims they be, and should be vocif-
erously avoided. Under no circumstances should they 
be either cremated, or buried in a gentile cemetery.
4. Since not all rabbis are expert in these matters, a copy 
of these Protocols should be forwarded to the local 
rabbinic administration in which the remains are dis-
covered and a central clearinghouse established.
5. The remains should be immediately covered and kept 
covered, and where humanly possible, buried the 
same day,129 in a Jewish cemetery close to where dis-
covered, or sent for burial in Israel.
6. It is permitted to delay reinterment in order to do the 
forensic investigation to identify some or all of the vic-
tims or their persecutors.130
7. Survivor families who would normally mourn such 
victims need to observe shiva rites on the day itself of 
reinterment.
8. If the discoveries are likely a mixture of gentiles and 
Jews, all may be buried in a demarcated area of a Jew-
ish cemetery.131
9. If the remains found are smaller than the size of an ol-
ive, the obligation for immediate burial is lifted, but 
the prohibition against benefit is not, and so all such 
discoveries should, in fact, be buried, not forgetting 
the Untermann Protocol discussed above.
10. There is a rich body of Jewish legal literature on the 
impermissibility of photographing the dead, for rea-
sons already cited. Moreover, according to some au-
thorities including Strashun132 and others, this might 
extend to histology slides and similar minute samples 
so as to preclude violating the prohibition of “benefit.” 
Where no issues of pikuach nefesh or medical educa-
tion are involved, competent local halakhic decisors 
should be consulted regarding their disposition.
11. All graves of reinterred remains, or of remains of this 
type buried for the first time, need to bear elaborate 
explanatory markings as to their nature133 (“the Unter-
mann Protocol”)
12. In a far-ranging discussion on the permissibility of 
human autopsy in Jewish Law, Rabbi Dr Abraham 
Steinberg speaks about the permissibility of autopsy 
for the purposes of discovering the cause of death that 
could save the lives of others, as in a plague, and of 
129 The prohibition against lina kicks in upon discovery
130 Polak, op cit
131 Grunwald, Kol Bo, op cit.
132 op cit
133 Unterman, above.
its permissibility in teaching medicine, and his study 
is too nuanced and lengthy to summarise here.134 But 
the drawings in the Pernkopf Atlas, drawn by artists 
and scientists mostly with Nazi sympathies, based on 
corpses of prisoners executed by rogue civilian and 
military courts of the Third Reich, would normally fall 
under the prohibition of benefit from the dead. They 
might also likely fall under the prohibition of photo-
graphing the dead, which R Grunwald prohibits,135 
and of gazing at the dead, which is also prohibited.136 
Yet their use would certainly be permitted by most au-
thorities to help save lives (piku’ach nefesh), as dur-
ing surgery, and, following other authorities, even 
for medical education.137 In all cases where using the 
Pernkopf Atlas becomes permissible, I would invoke 
the Untermann Protocol, which requires making it 
known to one and all just exactly what these drawings 
are. In this way, the dead are accorded at least some of 
the dignity to which they are entitled.
13. If the remains found have been burned, and ap-
pear to be the result of unsought violence, then their 
charred or cremated remains must be buried in a Jew-
ish cemetery.
14. If fresh remains are found, not yet buried, which 
were clearly the result of a murder, then there is no 
need for a tahara (ritual washing of the body).138
15. A killing field or large mass grave should probably 
not be disturbed but formally designated as a Jewish 
cemetery, a ritual procedure familiar to many rabbis 
and Jewish burial societies. This ritual would include 
establishing unambiguous formal perimeters for all 
the graves in the area (for purposes of establishing sa-
cred space and for tziyon laKohanim). A broad, fully-
descriptive plaque detailing the events that took place 
on this site should be erected at once, following the 
Untermann Protocol.139
Background to the “Vienna Protocol”
This protocol is the result of a three-decade effort to ad-
dress the legacy of Nazi medical science. That effort be-
gan in earnest in 1989 with the reports in the interna-
tional press—based on the research of the historian Götz 
Aly—who had discovered that brain specimens of per-
sons murdered in the Nazi ‘euthanasia’ killing operations 
had been retained in the collections of member insti-
tutes of the Max Planck Society. The Max Planck Society 
is the postwar successor to the renowned Kaiser Wilhelm 
research organisation under whose name, sponsorship 
and funding the institutes that collected the specimens 
functioned during the Nazi regime. 
134 Steinberg, A “Autopsy,” in the Encyclopedia of Jewish Medicine.
135 Op cit, p. 36
136 Ma’avar Yabok, essay 25, p. 95.
137 Steinberg, op cit.
138 Felder, Aaron, Yesodei Smochos, N.Y., np, 1974, p. 30.
139 Protocol 15 was added in response to an inquiry about the 
ongoing forensic investigations at this time on the grounds of what 
had been the Sobibor Concentration Camp.
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Aly’s reports occurred in conjunction with revelations 
that university institutes of anatomy in Germany (and 
later Austria), included the remains of victims of Nazi ter-
ror. Investigations of two collections—the universities of 
Tübingen and Vienna—revealed that many of the victims 
had been executed following trials for political crimes or 
socialising with German women. In the case of Tübin-
gen, many of the victims were Russian or Polish slave la-
bourers who had been executed for trivial crimes or had 
died of so-called natural causes. In those instances, few 
victims were identified as Jews.
Since the reports in the 1980s, there have been contin-
uing revelations of human remains being discovered in 
the collections of esteemed universities and research in-
stitutes. Within the past three years alone, new discover-
ies have been made, including brain specimens that were 
reported to have been buried by the Max Planck Society 
in 1990.
Given the secrecy and lack of information on the prov-
enance of many of the specimens, and knowing the hor-
rific reality of the Holocaust, it was assumed, and is still 
assumed, that heretofore unknown Jewish victims will be 
discovered. It is known that the anatomist Prof August 
Hirt of the Reichsuniversität of Nazi-occupied Strasbourg 
had Jewish prisoners from Auschwitz murdered in prep-
aration for a special anthropological skeletal collection. 
Prof Hermann Voss and his technician from the Reichs-
universität of Posen (Poznan), in Nazi-occupied Poland, 
acquired the bodies of Jews from a nearby concentration 
camp from which they prepared death masks and de-
fleshed skulls, some of which were sold to the Museum of 
Natural History of Vienna. 
In 2014, the discovery of human bones on the Dahlem 
campus of the Free University of Berlin provoked a ma-
jor investigation into the possibility that the human re-
mains were from victims of Auschwitz that had been sent 
to the Kaiser Wilhelm Institute of Anthropology, Human 
Heredity and Eugenics as part of the research carried out 
by the institute’s then director, Prof Otmar von Verschuer, 
and his Auschwitz-based assistant, Josef Mengele.
The location of the discovered remains in Dahlem is 
very close by the original building (presently a university 
department) that housed the Verschuer anthropology in-
stitute, the final destination for the specimens from the 
Auschwitz victims.
It is known that a significant proportion of the victims 
of the Auschwitz twin experiments performed by Menge-
le and his associates on behalf of Verschuer were Jews, 
thus raising the possibility that the human remains dis-
covered in Dahlem were from Jewish victims. Another 
preferred victim group were the Roma-Sinti.
In addition to determining the provenance and identi-
ty of the victims and their appropriate burial and memo-
rial, there arose the question of representation and repro-
duction of images of the victims. This issue accompanied 
the revelations regarding the renowned atlas of human 
anatomy edited by Prof Eduard Pernkopf of the Univer-
sity of Vienna; Pernkopf Anatomy. Given the known Nazi 
political sympathies of Pernkopf and his medical illustra-
tors, as well as the fact that some of the published paint-
ings included Nazi iconography (swastikas and the “SS” 
rune) in the artists’ signatures, suspicions were raised as 
to the provenance of the subjects portrayed in the atlas 
and whether they may have been victims of Nazi terror.
In 1996, in response to an official request of the Israel 
Holocaust Authority, Yad Vashem, the Senate of the Uni-
versity of Vienna initiated a research project into the his-
tory of anatomy in Vienna between the years 1938 and 
1945. The Vienna investigation determined that bodies 
of over 1300 executed victims of Nazi terror were deliv-
ered to the university institute of anatomy. Despite the 
absence of documentation, it is highly likely that some of 
those victims are portrayed in the Pernkopf atlas.
The University of Vienna ordered that all collections of 
human specimens in university collections be examined 
and, where the provenance was unknown, removed from 
the collections and buried. It was decided by the Chief 
Rabbi of Vienna, given the history of the Jews of Vien-
na during the Nazi period, that it must be assumed that 
some of the unidentified remains were from Jews and 
that all of the recovered remains should be buried, ac-
cording to Jewish ritual, in a Jewish cemetery. That buri-
al, in the Jewish cemetery in Vienna, took place on March 
22nd, 2002.
With respect to the issue of “representation and re-
production of images of possible victims” portrayed in 
the Pernkopf atlas, there were many differences of opin-
ion, as expressed by letters published in journals as well 
as articles, especially by librarians. Some called for the 
destruction of the atlas, others suggested that it be with-
drawn from circulation in university libraries. Editions of 
Pernkopf Anatomy had been published in five different 
languages.
To the best of our knowledge there were never schol-
arly symposia to discuss the question of the continued 
publication and use of the atlas or the images. Original-
ly published by the Vienna-based publisher, Urban and 
Schwarzenberg, the copyright and physical ownership of 
the original paintings are held by Elsevier Publishing of 
the Netherlands. In 1994, publication of the atlas was dis-
continued. Images from the atlas can be easily found on 
the internet. It is probable that thousands of copies re-
main in private collections.
In 2016, Prof Susan Mackinnon, director of the Center 
for Nerve Injury and Paralysis; Sydney M., Jr. and Rob-
ert H. Shoenberg, professor and chief, Division of Plastic 
and Reconstructive Surgery of Washington University, St. 
Louis, Missouri, and her associate Andrew Yee, request-
ed permission from the publisher to reproduce a paint-
ing from Pernkopf Anatomy, which they used in teach-
ing residents in reconstructive surgery. Prof Mackinnon, 
who had been using the anatomy atlas since the 1980s, 
had found some paintings to be especially useful in her 
practice of reconstructive surgery and, in her words, 
these images helped save lives or significantly improved 
the quality of life. Mackinnon and Yee also assert that 
there is no other atlas of human anatomy as detailed and 
accurate for their purposes as the Pernkopf Atlas. In ad-
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dition to using the atlas for surgical instruction, Mackin-
non and Yee instruct residents in the history of the atlas. 
The educational programme they have developed using 
the Pernkopf paintings are not sold for profit; they are 
only used for educational purposes.
In 2016, Mckinnon and Yee made two requests of the 
publisher, Elsevier publishing, for permission to repro-
duce the Pernkopf paintings for their educational pro-
gramme. Their requests were denied by Elsevier, which 
argued “ethical reasons”.
After further consideration involving Dr Sabine Hilde-
brandt, who teaches at Harvard and is an anatomist/his-
torian and the author of the first comprehensive histo-
ry of anatomy in Nazi Germany, and Prof (Em.) William 
Seidelman, an expert on the history of medicine in the 
Third Reich, Prof Mackinnon and Andrew Yee, together 
with Dr Hildebrandt and Prof Seidelman, formulated a 
request for an ethical review of the use of the Pernkopf 
paintings as requested by Mackinnon and Yee to Elsevier 
Publishing. This request was formally submitted to Rab-
bi Joseph Polak, a noted Orthodox Jewish rabbinical au-
thority and expert on the question of medicine and the 
Holocaust and Prof Michael Grodin MD, director of the 
project on Medicine and the Holocaust at the Elie Wiesel 
Center for Judaic Studies, Boston University. Rabbi Polak 
and Prof Grodin were asked to advise whether the Jew-
ish precept of Pikuach Nefesh, which gives priority to the 
value of human life over all other laws and commands, 
would be applicable in the case of Mackinnon and Yee’s 
application to Elsevier Publishing. 
After a detailed discussion with Dr. Hildebrandt, Rab-
bi Polak and Prof Grodin agreed.
The submitted protocol, authored by Rabbi Polack, 
addresses the two key issues arising from this history:
Jewish law and burial practices to be followed when 
the remains of possible Jewish victims of the Holocaust 
and Nazi medical practice are discovered and,
The application of the principle of Pikuach Nefesh in 
the use of paintings or images from tainted sources such 
as Pernkopf Anatomy
It should be emphasised that while the first issue ap-
plies to Jews and Jewish law and tradition, the second is-
sue is a universal one that could have broader universal 
implications, irrespective of their faith.
The Protocol is the first known scholarly religious and 
ethical review to consider these issues arising from the 
tragic experience of the Nazi period and the Holocaust 
and their continuing legacy.
W. E. S. May 23, 2017
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